Basil C. Tarlatzis, M.D., Ph.D.
CURRICULUM VITAE
Basil C. Tarlatzis, M.D., Ph.D.
Unit for Human Reproduction
Director of the 1st Dept. of Obstetrics & Gynecology
School of Medicine
Aristotle University of Thessaloniki
Papageorgiou General Hospital
Nea Efkarpia Peripheral Road
Thessaloniki 546 03
Greece
Office: +30 2310 989160; Fax: +30 2310 989161
tarlatzis@hol.gr
BIRTHDATE:
BIRTHPLACE:
June 3,1950
Athens, Greece
MARITAL STATUS:
CHILDREN:
Married to Irene Tarlatzi
Daughter, Nonika Tarlatzi
EDUCATION:
1960 – 1968
1968 – 1974
1972 (June)
1973 (July – Aug.)
Athens College (Primary and High School)
School of Medicine,
University of Athens, Greece
Clinical Clerkship in Surgery,
2nd Dept. of Surgery,
Diakonissestiftelsen Hospital,
Copenhagen, Denmark
Clinical Clerkship in Surgery,
Dept of Surgery,
Fairview General Hospital,
Cleveland, U.S.A.
MILITARY SERVICE:
1975 - 1977
Greek Navy
RESIDENCY TRAINING:
1975 - 1976
1976 – (Feb. – Sep.)
1976 - 1977
1977 - 1980
Resident in General Surgery,
Naval Hospital of Athens, Greece
Resident in General Surgery,
Naval Hospital of Pireaus, Greece
Resident in Internal Medicine,
Naval Hospital of Pireaus, Greece
Resident in Obstetrics & Gynecology,
2nd Dept. of Obstetrics & Gynecology,
Aristotle University of Thessaloniki. Greece
POSTGRADUATE EDUCATION:
1978 (Oct. – Dec.)
1982 (Feb. – May)
Visiting Fellow,
Training in laparoscopy,
Dept. of Obstetrics & Gynecology,
St. Mary’s Hospital,
London, United Kingdom
Visiting Fellow,
Training in semen analysis and reproductive immunology,
Dept. of Obstetrics & Gynecology,
Fertility Unit,
State University of Groningen
The Netherlands
1
Basil C. Tarlatzis, M.D., Ph.D.
1982 (July – Oct.)
1982 (Oct.)
1982 - 1985
1982 (Nov. – Dec.)
1983 (Feb.)
1983 (April)
1984 (March)
1985 (Feb.)
1987 (June)
1991 (Nov.)
1993 (April)
Visiting Fellow,
Training in reporoductive physiology,
C.S. Mott Center for Human Growth and Development,
Dept. of Obstetrics & Gynecology,
Wayne State University, School of Medicine,
Detroit, Michigan, U.S.A.
Postgraduate Seminar on Human In Vitro Fertilization &
Embryo Transfer
Carmel, U.S.A.
Postdoctoral Fellow,
Training in reproductive biology/endocrinology and human in vitro
fertilization/embryo transfer
Dept. of Obstetrics & Gynecology,
Yale University School of Medicine,
New Haven, CT, U.S.A.
Training in computers and introduction in programming,
Yale Computer Center,
Yale University, U.S.A.
Postgraduate Seminar on “Ultrasound Use in Obstetrics”,
Yale University, U.S.A.
Postgraduate Seminar on Gynecological Microsurgery,
Yale University, U.S.A.
Postgraduate Seminar on Semen Analysis,
9th Annual Meeting of the American Society of Andrology,
Los Angeles, U.S.A.
Postgraduate Seminar on Hysteroscopy,
Yale University, U.S.A.
Postgraduate Seminar on Embryo Cryopreservation and
Ultrasonography,
3rd Annual Meeting of the European Society of Human Reproduction &
Embryology
Cambridge, United Kingdom
Postgraduate Seminar on “Salpingoscopy and the New Methods of
Evaluating the Fallopian Tubes”,
Bonn, Germany
Postgraduate Seminar on “Assisted Reproduction with
Intracytoplasmic Sperm Injection”,
Brussels, Belgium
CERTIFICATION:
1974
1981
1982
1983
M.D.: National University of Athens, Greece
Obstetrics and Gynecology: Board of Obstetrics and Gynecology
Greek Ministry of Health and Social Welfare
Doctoral Degree (Ph.D.): School of Medicine
Aristotle University of Thessaloniki, Greece
Postdoctoral Fellow: Department of Obstetrics and Gynecology
Yale University, School of Medicine, New Haven, CT, U.S.A.
UNIVERSITY APPOINTMENTS:
1986
1989
1993
1998
2004 - present
Consultant, Obstetrics and Gynecology: School of Medicine
Aristotle University of Thessaloniki, Greece
Lecturer, Obstetrics and Gynecology: School of Medicine
Aristotle University of Thessaloniki, Greece
Assistant Professor, Obstetrics and Gynecology: School of Medicine
Aristotle University of Thessaloniki, Greece
Associate Professor, Obstetrics, Gynecology and Reproductive Medicine: School of
Medicine, Aristotle University of Thessaloniki, Greece
Professor, Obstetrics, Gynecology and Reproductive Medicine: School of Medicine
Aristotle University of Thessaloniki, Greece
2
Basil C. Tarlatzis, M.D., Ph.D.
HOSPITAL APPOINTMENTS:
1975-1976
Dept. of Surgery, Naval Hospitals of Athens and Pireaus.
1976-1977
Dept. of Internal Medicine, Naval Hospital of Pireaus.
1977-1982
2nd Dept. of Obstetrics & Gynecology, School of Medicine, Aristotle University of Thessaloniki,
Hippokrateion General Hospital, Thessaloniki.
1982 - 1985
Dept. of Obstetrics & Gynecology, Yale University, School of Medicine, New Haven, CT, U.S.A.
1986-present
1st Dept. of Obstetrics & Gynecology, School of Medicine, Aristotle University of Thessaloniki,
Papageorgiou General Hospital, Thessaloniki.
VISITING PROFESSOR:
June 1985
Dec. 1986
Aug. 1990
Sep. 1998
2001-2005
2004
Obstetrics and Gynecology Clinic (Klinikum Grosshadern), Ludwig-Maximillian University,
Munich, Germany
Dept. of Obstetrics and Gynecology, Yale University, New Haven, U.S.A.
Centre for Reproductive Medicine, Dutch-speaking Brussels Free University, Belgium
Dept. of Obstetrics and Gynecology, Medical School, UCLA, Los Angeles, U.S.A.
Faculty of Medicine and Pharmacy, Dutch-speaking Brussels Free University, Class
Reproductive Biology, Master and Ph.D. Program in Medical and Pharmaceutical Research
School of Medicine, University of Belgrade, Belgrade, Serbia
SELECTED HONORS AND AWARDS:
1972-1973 Honorary Scholarship of the Greek Ministry of Education
1984-1985 Lalor Foundation Fellow
1988
“N.K. Kerameos” Award of the Medical Society of Thessaloniki for the paper
“Gamete intrafallopian transfer in the treatment of female and male infertility”
1991
1st Award “N. Louros” of the Hellenic Obstetrics and Gynecology Society for the paper
“Factors affecting the achievement of pregnancy in assisted reproduction techniques”
1992
Clinical Paper Award of the 7th Medical Congress of Northern Greece for the paper
“Sperm quality parameters affecting the fertilization of human oocytes in vitro”
1999
Honorary Member, Society Obstetriciorum-Ginecologiae Romaniae
1999
Honorary Member, Societas Romana Humanae Assistentis Propagationis
2000
Honorary Award, Municipality of Thessaloniki
2000
Honorary Member, Societae de Ginecologie Endocrinologica din Romania
2005
Doctor Honoris Causa, Ovidius University, Romania
2005
Honorary Member, Middle East Fertility Soceity
RESEARCH SUPPORT:
1984
1991
2000
2003
2005
Lalor Foundation Fellowship. Research on follicle culture in vitro.
Greek Ministry of Public Health and Social Welfare. Research on follicle and oocyte development.
European Commission. International Collaborative Study of ICSI: Child and Family Outcome.
Greek Ministry of National Education and Religion, “PYTHAGORAS” Program: Research on the
effect of stress on the results of assisted reproduction.
Aristotle University of Thessaloniki, Network on “Current Medical Practice, Biomedicine and Law”.
MOST SIGNIFICANT NATIONAL AND INTERNATIONAL OFFICES:
European Society of Human Reproduction and Embryology (ESHRE), President, 1997-1999
International Federation of Fertility Societies (IFFS), President-elect, 2004-2007
Independent National Authority for Medically Assisted Reproduction – Deputy Chairman (2005-present)
3
Basil C. Tarlatzis, M.D., Ph.D.
International Federation of Fertility Societies (IFFS), President, 2007-present
SCIENTIFIC SOCIETIES:
Member of 22 national and 17 international scientific societies.
National:
1. Medical Society of Thessaloniki (Member of the Executive Committee)
2. Obstetrics and Gynecology Society of Thessaloniki
3. Obstetrics and Gynecology Society of Northern Greece
4. Hellenic Society of Chemotherapy
5. Hellenic Endocrine Society
6. Hellenic Society for the Study of Reproduction (Member of Executive Committee)
7. Hellenic Society of Physiopathology of Reproduction & Artificial Insemination (Secretary General and
Member of Executive Committee)
8. Hellenic Society of Pediatric and Adolescent Gynecology
9. Hellenic Society for the Research and Treatment of Gynecological Cancer
10. Hellenic Society of Gynecological Endocrinology
11. Hellenic Obstetrics and Gynecology Society (Member of Executive Committee)
12. Hellenic Fertility and Sterility Society (Treasurer, Secretary General)
13. Hellenic Andrology Society (Member Executive Committee)
14. Hellenic Society of In Vitro Fertilization (Member Executive Committee)
15. Hellenic Society of Climacterium and Menopause
16. Hellenic Sexology Society
17. Union of Obstetricians and Gynecologists of Macedonia-Thrace
18. Union of Obstetricians and Gynecologists of Greece
19. Panhellenic Union of Specialists in Assisted Reproduction (President, Vice President)
20. Hellenic Endometriosis Society
21. Society for the Study of Medical Law and Bioethics
22. Hellenic Society for Mental Health in Assisted Reproduction
International:
1. American Society for Reproductive Medicine [former American Fertility Society]
(Member of the International Affairs Committee)
2. American Society of Andrology
3. Society for the Study of Reproduction
4. Union Medicale Balkanique
5. Society for the Advancement of Contraception
6. American Association for the Advancement of Science
7. New York Academy of Sciences
8. Endocrine Society
9. European Society of Contraception
10. European Team Early Pregnancy
11. Societe Latin de Biologie et Medicine de la Reproduction “SOLAMER”
12. European Association of Gynecologists and Obstetricians (EAGO)
13. International Federation of Fertility Societies (IFFS – Assistant Treasurer 1998-2001, Secretary General
2001-2004 and President-elect 2004-2007)
14. Society for Gynecological Investigation
15. European Society of Human Reproduction and Embryology (ESHRE)
Member of the Ethics and Law Committee
Coordinator Special Interest Group of Reproductive Endocrinology
Editor of the ESHRE Newsletter “Focus on Reproduction”
Member Advisory Committee 1988-1992
Treasurer 1991-1995
Chairman 1997-1999
Past Chairman 1999-2001
16. European Board and College of Obstetrics and Gynaecology (EBCOG - Executive Committee Member,
representing the Subspecialty “Reproductive Medicine”)
17. International Society of Gynecological Endocrinology (Member of Executive Committee)
4
Basil C. Tarlatzis, M.D., Ph.D.
COMMITTEES:
Aristotle University of Thessaloniki
1. General Assembly Member (1990-1993).
2. Educational Program Committee (1995).
3. Library Committee (1995).
4. Doctoral Theses and Postgraduate Studies Committee (1997-2001).
5. Member of the Bioethics Committee (2002-present).
6. Member of the Evaluation of the Educational Process Committee (2003-present).
7. Member of the International Collaboration Committee (2003-present).
National
1.
2.
3.
4.
5.
Committee for In Vitro Fertilization, Greek Ministry of Health and Social Welfare (1991).
Committee for Artificial Fertilization, Greek Ministry of Health and Social Welfare (1996).
Committee for In Vitro Fertilization and Assisted Reproduction Units, Greek Ministry of Health and Social
Welfare (1996-2001).
Working group for the preparation of the law on medically assisted reproduction, Greek Ministry of Health
and Social Welfare (2002).
Independent National Authority for Medically Assisted Reproduction – Deputy Chairman (2005-present).
International
1. Ethics/Good Clinical and Laboratory Practice Committee, European Society of Human Reproduction and
Embryology (1989 - present).
2. International Working Group on Results of Assisted Reproduction (1989 -present).
3. International Affairs Committee of the American Fertility Society/ American Society for Reproductive
Medicine (1994 - present)
4. Expert Group on Ovarian Cancer and Infertility Agents of the IFFS (1993).
5. International Working Group on Oocyte Donation (1995).
6. Expert Group on Assisted Reproduction Techniques of the IFFS (1995).
7. Task Force on Intracytoplasmic Sperm Injection of the European Society of Human Reproduction and
Embryology (1996).
8. Task Force on Ethics and Law of the European Society of Human Reproduction and Embryology (1998present).
9. FIGO Advisory Panel on Reproductive Medicine (1999-2003).
REVIEW COMMITTEES:
Scientific Papers
Abstract Review Committees for 13 national and international congresses.
Ph.D. Theses:
Examining Committee of 9 international and 23 national Ph.D. Theses.
Research Projects;
Review of 5 international grant applications.
5
Basil C. Tarlatzis, M.D., Ph.D.
Overall Scientific Work:
Evaluation of the scientific work of 8 colleagues from universities worldwide.
SCIENTIFIC JOURNAL EDITORIAL RESPONSIBILITIES:
National:
1.
2.
3.
4.
5.
6.
7.
Hellenic Obstetrics and Gynecology (Deputy Editor-in-Chief)
Adolescent Gynecology, Reproduction and Menopause (Special Collaborator)
Deltio of Physiopathology of Reproduction and Artificial Insemination (Editor-in-Chief)
Epistimoniki Epetirida of the Medical School of the Aristotle University Thessaloniki
Galinos
Hellenic Journal of Gynaecology & Obstetrics (Deputy Editor)
Aristotle University Medical Journal
International:
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
Human Reproduction
Human Reproduction Update (Associate Editor)
Fertility and Sterility
Journal of IVF/ET, currently the Journal of Assisted Reproduction and Genetics
Gynecological Endocrinology
Assisted Reproduction Reviews (Associate Editor)
Middle East Fertility Society Journal
The Egyptian Journal of Fertility and Sterility
Polish Journal of Gynecological Investigations
Assisted Reproductive Technology/Andrology
Fertility Digest
Focus on Reproduction (Past Editor)
European Journal of Obstetrics, Gynecology and Reproductive Biology
European Clinics in Obstetrics & Gynecology (Associate Editor)
BOOK EDITOR:
1. Ovarian Hyperstimulation Syndrome, Editors: A.P. Ferraretti, L. Gianaroli, B.C. Tarlatzis. Serono Fertility
Series, vol. 1, 1997.
2. Current Theory and Practice of ICSI, Editors: P. Devroey, B.C. Tarlatzis, A. Van Steirteghem, Human
Reproduction Supplement 1, vol. 13, 1998.
3. Ovulation Induction, Editor: B.C. Tarlatzis, Elsevier, 2002.
4. Current Topics in Assisted Reproduction, Editors: B.C. Tarlatzis (Chief Editor) and D. Loutradis, T.
Mantzavinos, M. Mastrominas, I. Messinis, M. Tsirigotis, Athens, 2006.
ORGANIZING/SCIENTIFIC COMMITTEE OF NATIONAL AND INTERNATIONAL
CONGRESSES
Member of the Organizing/Scientific Committee of 84 national and 54 international congresses.
PARTICIPATION IN NATIONAL AND INTERNATIONAL CONGRESSES
Participation in 232 national and 271 international congresses.
6
Basil C. Tarlatzis, M.D., Ph.D.
INVITED LECTURES IN NATIONAL AND INTERNATIONAL CONGRESSES
National:
Total of 227 lectures in national congresses.
International:
1. “Germ Cell Development, Metabolism and Function”, Yale University, New Haven, U.S.A.
2. “Human in Vitro Fertilization”, University of Connecticut, Connecticut, U.S.A., 1984.
3. “Human In Vitro Fertilization”, Postgraduate Course on Microsurgery, New Haven, U.S.A., April 1984.
4. “Male Infertility”, St. Rafael Obstetrics & Gynecology Clinic, Postgraduate Course, New Haven, U.S.A., June
1984.
5. “Human In Vitro Fertilization: Fears, Fantasies and Facts”, Yale University, Postgraduate Course, May 1985.
6. “Human In Vitro Fertilization - The Yale Experience”, Obstetrics & Gynecology Clinic (Klinikum
Grosshadern), Ludwig - Maximilians University, Munich, Germany, June 1985.
7. “Ovarian stimulation for in vitro fertilization with special respect to different types of stimulation”. Workshop
“In Vivo Versus In Vitro Fertilization”, Hamburg, Germany, September 1985.
8. “Social and psychological aspects of IVF”, Round Table “New Concepts in IVF and ET”, Fifth World
Congress on Human Reproduction, Athens, September 1985.
9. “In Vitro Follicle Growth”, Symposium on “The Control of Follicle Development, Ovulation and Luteal
Function: Lessons from In Vitro Fertilization”, Paris, France, April 1986.
10. “The renin-angiotensin system in the human ovary”, Symposium on “The Control of Folicle Development,
Ovulation and Luteal Function: Lessons from In Vitro Fertilization”, Paris, France, April 1986.
11. “Ovarian Stimulation for IVF/ET and GIFT: Problems and Prospects”, Workshop on In Vitro Fertilization
Embryo Transfer and G.I.F.T., Rhodes, October 1988.
12. “Ovarian Stimulation for In-Vitro-Fertilization with Clomiphene, HMG and Pure FSH”, III Workshop on
Reproductive Medicine, In-Vitro-Fertilization and Microsurgery, Bonn, Germany, January 1989.
13. “The use of GnRH analogues in ovarian stimulation for assisted reproductive techniques”, Yale University,
New Haven, U.S.A., December 1989.
14. “Patient selection and preparation for assisted procreation”, ESHRE Campus, Brussels, Belgium, February
1990.
15. “Ovarian Stimulation with Gonadotropins”, Centre for Reproductive Medicine, Dutch-speaking Brussels Free
University, Belgium, August 1990.
16. “Modern trends in assisted reproductive technology”, 2nd International Symposium “In Vitro Fertilization and
Alternate Assisted Reproduction”, Cavtat-Dubrovnik, Yugoslavia, October 1990.
17. “Serum estradiol, progesterone and β-hCG levels in early conceptions after assisted reproduction
techniques”, Workshop Early Pregnancy, Granada, Spain, November 1990.
18. “Gonadotrophin stimulation with and without agonists for assisted procreation”, ESHRE Campus Workshop
on Reproductive Medicine, Bonn, Germany, March 1991.
19. “The short and long protocols of ovarian hyperstimulation in IVF”, Round Table Discussion “New Aspects in
Ovarian Hyperstimulation”, ESHRE Campus Workshop on Reproductive Medicine, Tel-Aviv, Israel,
September 1991.
20. “Ethics in assisted procreation - a summary of the Ethical Committee, ESHRE”, Round Table “Ethics in
Assisted Reproduction”, ESHRE Campus Workshop on Reproductive Medicine, Tel-Aviv, Israel, September
1991.
21. “Different stimulation protocols for IVF”, Symposium on Assisted Procreation, Cairo, Egypt, November 1991.
22. “Modern techniques of assisted procreation”, International Symposium «Organon - from Menarche to
Menopause», Moscow, Russia, December 1991.
23. “Ethical guidelines of the ESHRE”, ESHRE Campus Workshop on Reproductive Medicine, Brussels,
Belgium, March 1992.
24. “Assisted reproduction techniques in PCOS”, Round Table “Treatment of Infertile Women with PCOS Therapeutic Perspectives”, Satellite Symposium to the 9th International Congress of Endocrinology
7
Basil C. Tarlatzis, M.D., Ph.D.
“Intraovarian Regulators and Polycystic Ovarian Syndrome: Recent Progress on Clinical and Therapeutic
Aspects”, Athens, August 1992.
25. “Pathophysiology of Ovarian Hyperstimulation”, ESHRE Campus Workshop on Basic and Clinical Aspects of
Ovarian Stimulation, Fertilization, and Implantation in Humans, Valencia, Spain, October 1992.
26. “Infertility: Epidemiology and Causes”, Organon International Workshop on Modern Methods of Infertility
Treatment, Warsaw, Poland, March 1993.
27. “Different techniques of assisted reproduction”, Organon International Workshop on Modern Methods of
Infertility Treatment, Warsaw, Poland, March 1993.
28. “Sperm preparation and insemination techniques”, International Congress on “Recent Advances in Assisted
Reproductive Technologies, Reproductive Endocrinology and Infertility”, Cappadocia, Turkey, May 1993.
29. “ART for PCOD”, International Congress on “Recent Advances in Assisted Reproductive Technologies,
Reproductive Endocrinology and Infertility”, Cappadocia, Turkey, May 1993.
30. “Ethical considerations in IVF”, International Congress on “Recent Advances in Assisted Reproductive
Technologies, Reproductive Endocrinology and Infertility”, Cappadocia, Turkey, May 1993.
31. “Current aspects of bromocriptine treatment”, Round Table “Bromocriptine in Prolactin Related Disorders,
Past, Present and Future”, International Congress on “Recent Advances in Assisted Reproductive
Technologies, Reproductive Endocrinology and Infertility”, Cappadocia, Turkey, May 1993.
32. “Pregnancy outcome in women with PCO-syndrome”, 2nd Euro-Team Early Pregnancy Meeting, Porto,
Portugal, June 1993.
33. “Clinical experiences with recombinant FSH”, Round Table “Current Topics in Gonadotropin Therapy”, 9th
Annual Meeting of the European Society of Human Reproduction and Embryology, Thessaloniki, June 1993.
34. “Semen analysis”, ESHRE Workshop “Male Sterility and Subfertility: Guidelines for Management”, Capri,
Italy, August 1993.
35. “Prospective evaluation of the short and long GnRH -analogue protocols in ovarian stimulation for IVF/ET”,
Round Table “Clinical Application of GnRH Analogues for IVF-ET”, VIIIth World Congress on In Vitro
Fertilization and Alternate Assisted Reproduction, Kyoto, Japan, September 1993.
36. “Unexplained Infertility: Explained”, International Conference on Infertility for the Patient and the Medical
Team, Washington, U.S.A., October 1993.
37. “Results of Assisted Procreation using Recombinant FSH for Ovarian Stimulation”, Organon Symposium on
Gonadotrophin Therapy, Budapest, Hungary, October 1993.
38. “The Role of LH: Ovulation, Endometrium and Implantation”, “International Expert Meeting on Infertility”,
Marbella, Spain, October 1993.
39. “Is there an upper age limit for the treated couple”, ESHRE Campus Workshop on Reproductive Medicine,
Tel-Aviv, Israel, November 1993.
40. “Sperm donation in Greece”, Workshop “Sperm Donation, Ethical and Medical Questions”, Paris, France,
November 1993.
41. “Short versus long protocol for IVF”, VIII ESHRE Campus Workshop “New Developments in Reproductive
Medicine”, Luebeck, Germany, March 1994.
42. “IVF & ΕΤ, an Overall Review”, Workshop on “Update in Reproductive Technology and Gynaecologic
Operative Endoscopy”, Cairo, Egypt, March 1994.
43. “Short Versus Long Protocol for IVF”, “Update in Reproductive Technology and Gynaecologic Operative
Endoscopy”, Cairo, Egypt, March 1994.
44. “Intraovarian markers of follicle and oocyte development”, 1st ESHRE International Symposium on Frontiers
in Reproductive Medicine and Assisted Reproductive Technology, London, Great Britain, June 1994.
45. “Estrogen Replacement Therapy (ERT)”, AFS-ESHRE Conjoint Postgraduate Course “Advances in
Reproductive Medicine and Surgery”, Brussels, Belgium, June 1994.
46. “The difficult cases: PCO and poor responders”, ESHRE Workshop “Anovulatory Infertility”, Anacapri, Italy,
August 1994.
47. “Embryo reduction in the prevention of multiple births”, 9th International Workshop on Multiple Pregnancy,
Tel-Aviv, Israel, October 1994.
8
Basil C. Tarlatzis, M.D., Ph.D.
48. “Novel aspects of ovarian stimulation for assisted procreation”, International Symposium on Assisted
Reproduction, Bled, Slovenia, October 1994.
49. “Gonadotropin Releasing Hormone Agonists and Antagonists in Assisted Reproduction Techniques”,
Postgraduate Course on “New Frontiers in Reproductive Medicine”, 27th Annual Postgraduate Program of
the American Fertility Society, San Antonio, U.S.A., November 1994.
50. Round Table “ART in Older Women», Postgraduate Course on “New Frontiers in Reproductive Medicine”,
27th Annual Postgraduate Program of the American Fertility Society, San Antonio, U.S.A., November 1994.
51. “The Association Between Ovarian Stimulation and Ovarian Cancer: Fears, Fantasies and Facts”,
Postgraduate Course on “New Frontiers in Reproductive Medicine”, 27th Annual Postgraduate Program of
the American Fertility Society, San Antonio, U.S.A., November 1994.
52. “Ovarian Stimulation with Recombinant Follicle Stimulating Hormone for Assisted Procreation”, “New
Frontiers in Reproductive Medicine”, 27th Annual Postgraduate Program of the American Fertility Society,
San Antonio, U.S.A., November 1994.
53. Round Table “Evaluation and Selection of Patients for ICSI”, Postgraduate Course on “New Frontiers in
Reproductive Medicine”, 27th Annual Postgraduate Program of the American Fertility Society, San Antonio,
U.S.A., November 1994.
54. “Intraovarian markers of follicle and oocyte development”, 4th World Congress of Gynecological
Endocrinology, Madona di Campiglio, Italy, February 1995.
55. “Complications of Ovarian Stimulation”, Postgraduate Course “Diagnosis and Treatment of Infertility: A
Euro-American Dialogue”, Hamburg, Germany, June 1995.
56. Round Table “ICSI: Indications, Limitations, Implications”, Postgraduate Course “Diagnosis and Treatment
of Infertility: A Euro-American Dialogue”, Hamburg, Germany, June 1995.
57. “The use of GnRH agonists in IVF”, Symposium on “New Frontiers in Reproductive Endocrinology and
Assisted Reproductive Technology”, Tel-Aviv, Israel, July 1995.
58. “Tubal factor: testing and treatment”, ESHRE Workshop on “Infertility Revisited: The State of the Art Today
and Tomorrow”, Anacapri, Italy, August 1995.
59. “Prevention of the ovarian hyperstimulation syndrome”, 15th World Congress on Fertility and Sterility,
Montpellier, France, September 1995.
60. “Ovarian stimulation with recombinant gonadotropins”, 1st International Annual Conference of the Egyptian
Fertility and Sterility Society, Cairo, Egypt, September 1995.
61. “New gonadotropin preparations in ovarian stimulation for ART”, Postgraduate Course on “Recent
Advances in the Diagnosis and Treatment of Infertility”, 28th Annual Postgraduate Program of the
American Society for Reproductive Medicine, Seattle, U.S.A., October 1995.
62. Round Table “ICSI”, Postgraduate Course on “Recent Advances in the Diagnosis and Treatment of
Infertility”, 28th Annual Postgraduate Program of the American Society for Reproductive Medicine, Seattle,
U.S.A., October 1995.
63. “Complications of ovarian stimulation: I. Ovarian hyperstimulation syndrome”, Postgraduate Course on
“Recent Advances in the Diagnosis and Treatment of Infertility”, 28th Annual Postgraduate Program of the
American Society for Reproductive Medicine, Seattle, U.S.A., October 1995.
64. “Complications of ovarian stimulation: II. Multiple pregnancies”, Postgraduate Course on “Recent Advances
in the Diagnosis and Treatment of Infertility”, 28th Annual Postgraduate Program of the American Society
for Reproductive Medicine, Seattle, U.S.A., October 1995.
65. Round Table “Complications of Ovarian Stimulation”, Postgraduate Course on “Recent Advances in the
Diagnosis and Treatment of Infertility”, 28th Annual Postgraduate Program of the American Society for
Reproductive Medicine, Seattle, U.S.A., October 1995.
66. “Ovarian stimulation and ovarian cancer: fears, fantasies and facts”, 2nd Annual Meeting of the Middle East
Fertility Society, Alexandria, Egypt, October 1995.
67. “Treatment of OHSS: Management of the Patient”, ESHRE Workshop on “Ovarian Hyperstimulation
Syndrome”, Bologna, Italy, October 1995.
68. “The sperm odyssey in the female genital tract”, 3rd ESHRE Campus Symposium “Recent Advances in
9
Basil C. Tarlatzis, M.D., Ph.D.
Assisted Reproductive Technologies”, Thessaloniki, November 1995.
69. “Report on the activities of the ESHRE Task Force in intracytoplasmic sperm injection”, International
Symposium on Genetics and Outcome of Assisted Reproductive Technology, Brussels, Belgium,
December 1995.
70. “Uterotubal defects”, International Meeting “The Sterile Couple: Diagnosis and Treatment”, Roma, Italy,
March 1996.
71. “Strategy for prevention and therapy of the ovarian hyperstimulation syndrome”, IXth ESHRE Campus Workshop
“Ovarian Stimulation and ART”, Luebeck, Germany, April 1996.
72. “Report on ICSI from the ESHRE Task Force”, IXth ESHRE Campus Workshop “Ovarian Stimulation and
ART”, Luebeck, Germany, April 1996.
73. “Ovulation induction protocols in ART: A critical analysis”, International Congress on “Recent Advances and
Controversies in Reproductive Endocrinology, Infertility, Assisted Reproductive Technologies, Gynecologic
Endoscopy, and New Diagnostic Techniques in Gynecology”, Istanbul, Turkey, May 1996.
74. “Recombinant gonadotropins: new frontiers in ovulation induction”, International Congress on “Recent
Advances and Controversies in Reproductive Endocrinology, Infertility, Assisted Reproductive
Technologies, Gynecologic Endoscopy, and New Diagnostic Techniques in Gynecology”, Istanbul, Turkey,
May 1996.
75. “OHSS in ART: prevention and treatment”, International Congress on “Recent Advances and Controversies
in Reproductive Endocrinology, Infertility, Assisted Reproductive Technologies, Gynecologic Endoscopy,
and New Diagnostic Techniques in Gynecology”, Istanbul, Turkey, May 1996.
76. “Risk and management of ovarian hyperstimulation syndrome”, European Meeting on Medically Assisted
Procreation, Siena, Italy, May 1996.
77. “Recombinant FSH and IVF”, Round Table “Recombinant Gonadotropins and their Role in Treatment”, IXth
World Congress on Human Reproduction and Vth World Conference on Fallopian Tube in Health and
Disease, Philadelphia, U.S.A., May 1996.
78. “Pregnancy outcome in PCO patients treated by ART”, Workshop “Early Pregnancy”, Maastricht, The
Netherlands, June 1996.
79. “Follicular phase and pregnancy loss”, Postgraduate Course on “Early Pregnancy Loss”, Maastricht, The
Netherlands, June 1996.
80. “ART in severe endometriosis”, ESHRE Workshop on “Female Infertility: Treatment Options for Complicated
Cases”, Anacapri, Italy, August 1996.
81. “Ovarian hyperstimulation syndrome”, 2nd International Annual Conference of the Egyptian Fertility &
Sterility Society, Cairo, Egypt, September 1996.
82. “ESHRE ICSI Task Force”, International Conference on Intracytoplasmic Sperm Injection: Basic and Clinical
Aspects, Thessaloniki, September 1996.
83. “Pregnancies with oocyte donation in older women”, 5th World Congress of Gynecological Endocrinology,
Barcelona, Spain, October 1996.
84. “Ovarian stimulation in the era of recombinant technology”, ESHRE Campus “Novel Trends in Reproductive
Medicine”, Budapest, Hungary, October 1996.
85. “The ovarian hyperstimulation syndrome”, ESHRE Campus “Novel Trends in Reproductive Medicine”,
Budapest, Hungary, October 1996.
86. “Is there an association between ovarian stimulation and ovarian cancer?”, ESHRE Campus “Novel Trends
in Reproductive Medicine”, Budapest, Hungary, October 1996.
87. “Treatment of tubal infertility: Current concepts”, Postgraduate Course “Reproductive Medicine Toward
2000”, 29th Annual Postgraduate Program of the American Society for Reproductive Medicine, Boston,
U.S.A., November 1996.
88. Round Table “Evaluation of the Diagnostic and Therapeutic Modalities for Infertility”, Postgraduate Course
“Reproductive Medicine Toward 2000”, 29th Annual Postgraduate Program of the American Society for
Reproductive Medicine, Boston, U.S.A., November 1996.
89. “Novel aspects of ovarian stimulation for assisted reproduction techniques”, Postgraduate Course “Reproductive
10
Basil C. Tarlatzis, M.D., Ph.D.
Medicine Toward 2000”, 29th Annual Postgraduate Program of the American Society for Reproductive Medicine,
Boston, U.S.A., November 1996.
90. “Ovarian cancer and ovulatory agents: an update”, Postgraduate Course “Reproductive Medicine Toward
2000”, 29th Annual Postgraduate Program of the American Society for Reproductive Medicine, Boston,
U.S.A., November 1996.
91. Round Table “Management of Multiple Gestations after ART”, Postgraduate Course “Reproductive Medicine
Toward 2000”, 29th Annual Postgraduate Program of the American Society for Reproductive Medicine,
Boston, U.S.A., November 1996.
92. “Ovarian Hyperstimulation Syndrome”, “Distinguished Professor Round Table Discussion”, 52nd Annual
Meeting of the American Society for Reproductive Medicine, Boston, U.S.A., November 1996.
93. “Ectopic Pregnancy and IVF”, ESHRE Campus Workshop on Operative Video-Laser Laparoscopy and
Hysteroscopy, Thessaloniki, November 1996.
94. “Luteal function following hyperstimulation for in vitro fertilization”, 1st Annual ESHRE Winter Training Course in
Reproductive Endocrinology, Rotterdam, The Netherlands, January 1997.
95. “Should pregnant patients after ICSI have prenatal diagnosis?”, ESHRE Campus on “A Round-up of
Selected Topics in Reproductive Endocrinology & Andrology”, Brussels, Belgium, January 1997.
96. “The PCO syndrome: Diagnosis”, ESHRE Campus on “Revisiting Infertility”, Milan, Italy, February 1997.
97. “Survey of ICSI: the results of the ESHRE Task Force on ICSI (1993-1995)”, 3rd Congress of the European
Society for Gynecologic & Obstetric Investigation, Madona di Campiglio, Italy, March 1997.
98. “Recombinant FSH”, International Conference “Human Oocytes: From Physiology to IVF”, Bologna, Italy,
April 1997.
99. “Sons of manipulated oocytes”, International Conference “Human Oocytes: From Physiology to IVF”,
Bologna, Italy, April 1997.
100. “ICSI results: The ESHRE ICSI Task Force”, Workshop “ICSI and Azoospermia”, Roma, Italy, April 1997.
101. “Unexplained Infertility and Assisted Procreation”, International Meeting on Infertility and Assisted
Reproductive Technology, Sardinia, Italy, June 1997.
102. “Clinical Experience in Ovulation Induction with Puregon”, Organon Puregon Symposium, Buenos Aires,
Argentina, August 1997.
103. “Ovarian cancer and ovarian stimulation”, Turkish-Hellenic Scientific Meeting on Maternal-Fetal Medicine
and Obstetrics & Reproductive Sciences, Nevsehir (Antalya), Turkey, October 1997.
104. “Recombinant gonadrotropins in the treatment of infertility”, Turkish-Hellenic Scientific Meeting on
Maternal-Fetal Medicine and Obstetrics & Reproductive Sciences, Nevsehir (Antalya), Turkey, October
1997.
105. “Ectopic pregnancy and IVF”, ESHRE Workshop on “Controversies in Gynecological Endoscopy” Luebeck,
Germany, October 1997.
106. “ESHRE survey on ICSI results”, 13th Meeting of the Austrian Society on in Vitro Fertilization and Assisted
Reproduction, Shift Melk, Austria, October 1997.
107. “Review of 1995 ICSI data using ejaculated, epididymal and testicular spermatozoa from the ESHRE ICSI
Task Force”, Postgraduate Course “Update on Reproductive Medicine”, 30th Annual Postgraduate
Program of the American Fertility Society, Cincinnati, U.S.A., November 1997.
108. “Diagnostic approach of polycystic ovary syndrome”, Postgraduate Course “Update on Reproductive
Medicine”, 30th Annual Postgraduate Program of the American Fertility Society, Cincinnati, U.S.A.,
November 1997.
109. “National Responses: ESHRE”, Workshop on “Societal, Medical and Ethical Implications of Animal
Cloning”, London, Great Britain, November 1997.
110. “Clinical outcome of ICSI: results of the ESHRE Task Force”, Conference on “Treatment of Infertility: The
New Frontiers”, Boca Raton, Florida, U.S.A., January 1998.
111. “Pregnancy and children outcome after assisted reproduction techniques”, ESHRE Campus Workshop
“ART in the Year 2000”, Hamburg, Germany, March 1998.
112. “Clinical protocols of ovarian stimulation”, Joint ESHRE/ MEFS Meeting “20 Years of IVF”, Marrakech, Morocco,
11
Basil C. Tarlatzis, M.D., Ph.D.
March 1998.
113. “What was learned from the european registry of ICSI”, Annual Meeting of the Israel Fertility Association
(IFA), Tel-Aviv, Israel, April 1998.
114. “Overview of ICSI results based on the ESHRE Task Force on ICSI”, Meeting of the Norwegian IVF
Specialists, Athens, May 1998.
115. “In vitro fertilization in PCOS”, Congress on “Ovulation Induction and Menopause 1998”, Antalya, Turkey,
May 1998.
116. “Recombinant FSH in ART results”, Congress on “Ovulation Induction and Menopause 1998”, Antalya,
Turkey, May 1998.
117. “Assisted reproduction techniques: medical dilemmas”, Symposium of the Greek Committee for Applied
Ethics on “Psychological and Ethical Problems of Assisted Reproduction Technology”, Santorini, June
1998.
118. “Luteal function and support”, Precongress Course on “Early Pregnancy”, 14th Annual Meeting of the
European Society of Human Reproduction and Embryology, Goteborg, Sweden, June 1998.
119. “Pregnancy outcome after assisted reproduction techniques”, 4th ETEP Conference, 14th Annual Meeting
of the European Society of Human Reproduction and Embryology, Goteborg, Sweden, June 1998.
120. “Oocyte quality and controlled ovarian hyperstimulation”, International Congress on “The Uterus”, Capri,
Italy, July 1998.
121. “Optimal Use of Infertility Diagnostic Tests and Treatments”, Capri, Italy, August 1998.
122. “Overview of the efficacy and safety of intracytoplasmic sperm injection”, Annual Meeting of the Chinese
Fertility Society, Taipei, Taiwan, September 1998.
123. “Perinatal outcome of children of assisted reproductive technologies (ART)”, ESHRE Campus Symposium
of the Israel Fertility Society, Tel-Aviv, Israel, September 1998.
124. “New Aspects of Ovulation Induction”, Grand Rounds, Dept. of Ob/Gyn, UCLA Medical Center, Los
Angeles, U.S.A., September 1998.
125. “Complications of ovarian stimulation”, Postgraduate Course “Reproductive Medicine: Between Hope and
Hype”, 31th Annual Postgraduate Program of the American Fertility Society, San Francisco, U.S.A.,
October 1998.
126. “Analysis of ICSI results (1993-1995) collected by the ESHRE ICSI Task Force”, Postgraduate Course
“Reproductive Medicine: Between Hope and Hype”, 31th Annual Postgraduate Program of the American Fertility
Society, San Francisco, U.S.A., October 1998.
127. “Impact of the use of recombinant follicle stimulating hormone”, 54th Annual Conference of the American
Society for Reproductive Medicine & 16th International Congress on Fertility and Sterility (IFFS), San
Francisco, U.S.A., October 1998.
128. “Risks of ovarian stimulation”, International Serono Symposium “Gonadotropins and Fertility in the
Woman”, Madrid, Spain, October 1998.
129. “Risks of ovarian stimulation”, European Conference on Reproductive and Fetal Medicine, London, Great
Britain, November 1998.
130. “Diagnostic dilemmas in polycystic ovary syndrome”, 2nd Annual Scientific Meeting of the Saudi Arabian
Fertility Society, Jeddah, Saudi Arabia, November 1998.
131. “Cancer risk following COH: What evidence?”, 2nd Annual Scientific Meeting of the Saudi Arabian Fertility
Society, Jeddah, Saudi Arabia, November 1998.
132. “Intracytoplasmic sperm injection: survey of the world results”, Symposium on “Selected topics in PCOS”,
Athens, November 1998.
133. “Ovulation Induction”, Conference on “The Polycystic Ovary Syndrom”, Athens, November 1998.
134. “Intracytoplasmic sperm injection: survey of world results”, 4th International Congress “The Young Woman
at the Rise of the 21st Century: Gynecological and Reproductive Issues in Health and Disease”, Athens,
November 1998.
135. “Survey of ICSI results based on the ESHRE ICSI Task Force”, 5th Annual Scientific Meeting of the Middle
East Fertility Society in collaboration with the Jordanian Society of Obstetrics and Gynaecology, Amman,
12
Basil C. Tarlatzis, M.D., Ph.D.
Jordan, November 1998.
136. “Overview of the efficacy and safety of ICSI”, Meeting of the Assisted Reproductive Technology Society,
Bangkok, Thailand, November 1998.
137. “Clinical experiences with recombinant FSH”, Meeting of the Assisted Reproductive Technology Society,
Bangkok, Thailand, November 1998.
138. “Advances in Assisted Reproductive Technologies”, 42nd All India Congress of Obstetrics & Gynaecology,
Hyderabad, India, December 1998.
139. “Assisted hatching and related technologies in ART”, Symposium on “ART 2000 - New Horizons”, Aschau,
Germany, January 1999.
140. “Clinical outcome of a multicentre trial of ganirelix (Org 37462) in women undergoing controlled ovarian
hyperstimulation for ART”, 5th International Symposium on GnRH Analogues in Cancer and Human
Reproduction, Geneva, Switzerland, February 1999.
141. “Ovarian hyperstimulation-complications and treatment”, IFFS -Bulgarian Fertility Association Workshop,
Bansko, Bulgaria, February 1999.
142. “Contribution of the endocrinologic status in predicting ART outcome”, IV CERInternational Symposium on
“Human Reproduction and Embryology”, Punta del Este, Uruguay, March 1999.
143. “The use of recombinant gonadotropins in ART”, IV CER International Symposium on “Human
Reproduction and Embryology”, Punta del Este, Uruguay, March 1999.
144. “ICSI clinical results: incidence of genetic problems”, IV CER International Symposium on “Human
Reproduction and Embryology”, Punta del Este, Uruguay, March 1999.
145. “Assisted Reproduction Techniques: the Greek Approach”, 2nd TRAC Workshop on “Assisted Conception:
Research and Regulation”, Athens, April 1999.
146. “Assisted Reproduction in Europe”, Opening Ceremony for the new AZ-VUB Center for Reproductive
Medicine, Brussels Free University, Brussels, Belgium, May 1999.
147. “The use of GnRH antagonist Orgalutran; a new approach in ovarian stimulation”, 11th World Congress on
In Vitro Fertilization and Human Reproductive Genetics, Sydney, Australia, May 1999.
149. “Benefits and risks of ICSI in the treatment of male infertility”, 1st National Congress on Human Assisted
Reproduction, Timisoara, Romania, May 1999.
150. “Survey of the World ICSI Results”, XXV National Congress of Gynaecology and Obstetrics, Zaragoza,
Spain, June 1999.
151. “ Workshop on Clinical Evaluation “Multiple gestation pregnancy”, Capri, Italy, August 1999.
152. “Oocyte donation: clinical and practical aspects”, International Serono Symposium “Gonadal Failure: New
Perspectives”, Cortina d’ Ampezzo, Italy, September 1999.
153. Round Table “HMG vs recFSH in infertility treatment - pros & cons”, Ferring Symposium on “Assisted
Reproduction at the Borderline to the New Millenium”, Hamburg, Germany, September 1999.
154. “Overview of intracytoplasmic sperm injection (ICSI) applications”, Postgraduate Course on “Assisted
Reproductive Techniques in the 21st Century”, 32nd Annual Postgraduate Program of the American
Fertility Society, Toronto, Canada, September 1999.
155. “Pregnancy and children outcome after assisted reproduction techniques”, Postgraduate Course on
“Assisted Reproductive Techniques in the 21st Century”, 32nd Annual Postgraduate Program of the
American Fertility Society, Toronto, Canada, September 1999.
156. “The situation in Greece”, Round Table “The ethical, legal, moral and religious aspects of storing
reproduction”, International Symposium “Storing Reproduction: Cryopreservation of Human Gametes,
Embryos and Gonadal Tissue”, Bologna, Italy, October 1999.
157. “The use of GnRH antagonists in ovarian stimulation for assisted reproduction techniques”, 2nd
International Symposium on Assisted Reproduction, Bled, Slovenia, October 1999.
158. “Pregnancy and child outcome after assisted reproduction techniques”, 6th Annual Scientific Meeting of
the Middle East Fertility Society, Sharm El Sheikh, Egypt, September 1999.
159. “Benefits of embryo freezing”, ESHRE Symposium on “Cryopreservation on Human Embryos”, Brussels,
Belgium, December 1999.
13
Basil C. Tarlatzis, M.D., Ph.D.
160. “Results of ESHRE ICSI Task Force”, Joint Meeting of the Johns Hopkins University and the University of
Athens on “Reproductive and Health Issues”, Athens, December 1999.
161. “GnRH antagonists in ovarian stimulation for assisted reproduction techniques”, ESHRE Winter Course in
Reproductive Endocrinology, Helsinki, Finland, February 2000.
162. “European experience of ICSI: success and failures”, International Congress on Reproductive Medicine,
Obstetrics & Gynaecology: Challenges in the 3rd Millenium, Tel-Aviv, Israel, April 2000.
163. “The use of GnRH antagonists in ART cycles”, Congress on “Reproductive Medicine and Endoscopic
Surgery in the 21st Century: Controversies and New Trends”, Kusadasi, Turkey, September 2000.
164. “An overview of ICSI”, Congress on “Reproductive Medicine and Endoscopic Surgery in the 21st Century:
Controversies and New Trends”, Kusadasi, Turkey, September 2000.
165. “The Role of LH in follicular development”, Congress on “Reproductive Medicine and Endoscopic Surgery
in the 21st Century: Controversies and New Trends”, Kusadasi, Turkey, September 2000.
166. “Actual indications for ICSI”, National Congress of Obstetrics and Gynaecology, Bucharest, Rumania,
September 2000.
167. “GnRH antagonists: novel compound, novel concepts?”, Organon Roundtable Fertility Expert Meeting,
Lisbon, Portugal, September 2000.
168. “Medically assisted reproduction: the practice around Europe. Past and future, differences between
regulation and practice”, 2nd Tempe Workshop on “Teaching Ethics: Materials for Practitioner’s Education”,
Athens, October 2000.
169. “State of the art: agonists versus antagonists”, VIIth Annual Meeting of the Middle East Fertility Society
“Creating Perspectives in ART”, Beirut, Lebanon, November 2000.
170. “ICSI: the ESHRE study”, 5th ESHRE Campus “Advanced Reproductive Medicine, Cancer and Infertility”, Milan,
Italy, November 2000.
171. “Ovulation induction in polycystic ovary syndrome patients”, 8th World Congress of Gynecological
Endocrinology, Florence, Italy, December 2000.
172. “Comparison of the efficacy of gonadotropin-releasing hormone analog buserelin given intranasally and
subcutaneously at different doses for IVF”, 6th International Symposium on GnRH Analogues in Cancer
and Human Reproduction, Geneva, Switzerland, February 2001.
173. “Protocols of gonadotropins-GnRH analogs in COH”, 5th ESHRE Course in Reproductive Endocrinology,
Athens, May 2001.
174. “Old and new friends in ovulation induction (rFSH, rLH, HMG, GnRH analogs, anti-E2)”, 5th ESHRE
Course in Reproductive Endocrinology, Athens, May 2001.
175. “Endometrial dysfunction”, ESHRE Workshop on “Physiopathological determinants of human infertility”,
Capri, Italy, September 2001.
176. “Luteal phase characteristics and pregnancy chances”, 6th ESHRE Winter Course on Infertility,
Conception and Miscarriage, Amsterdam, The Netherlands, December 2001.
177. “Direct ovarian effects and safety aspects of GnRHagonists and antagonists”, ESHRE Campus Workshop
on “GnRHantagonists from basic science to clinical application”, Luebeck, Germany, January 2002.
178. “Infertility and commorbidities”, International Congress on “Quality of Life in Clinical Practice”, Sani Beach
Hotel, Chalkidiki, April 2002.
179. “GnRH agonists”, 17th European Congress of Obstetrics and Gynaecology (EAGO/EBCOG), Prague,
Czech Republic, May 2002.
180. “Puregon Solution andPuregon Pen”, Korean Symposium, Prague, Czech Republic, July 2002.
181. “Metformin”, ESHRE Workshop on “Induction of monoovulatory cycles in profertility programs”, Capri, Italy,
September 2002.
182. “GnRH-antagonists: from research to clinical practice”, 10th World Congress of the International Society of
Gynecological Endocrinology (ISGE), Wroclaw, Poland, September 2002.
183. “Perimenopausal Conception”, The Fifth Athens Congress on Woman’s Health and Disease: Gynecologic
& Reproductive Issues, Athens, September 2002.
184. “Βenefits-drawbacks and results of ART in Europe: Greece”, Sixiemes Journees Europeennes de la
Societe Francaise de Gynecologie, Paris, France, October 2002.
14
Basil C. Tarlatzis, M.D., Ph.D.
185. “The syndrome of polycystic ovaries: diagnostic attitudes and therapeutics in Europe: Greece”, Sixiemes
Journees Europeennes de la Societe Francaise de Gynecologie, Paris, France, October 2002.
186. “Ηοw to express success rates”, Μeeting on Ethical issues in ART : The central european dimension,
ESHRE Special Interest Group in Law and Ethics, Prague, Czech Republic, October 2002.
187. “Risks of ovarian stimulation”, Infertility, Gynecology and Obstetrics Congress, Rotterdam, The
Netherlands, February 2003.
188. “Perimenopausal Conception”, 4th National Congress of Sterility, Contraception and Hormonal
Replacement Therapy, Bulgarian Association of Sterility and Reproductive Health, Borovetz, Bulgaria,
March 2003.
189. “Τhe luteal phase in stimulated cycles for ART”, Symposium of Endocrinology on Ovarian Stimulation,
Budapest, Hungary, May 2003.
190. “Persistent infertility after conventional treatment: is it unexplained?”, ΕSHRE Meeting on the diagnosis
and management of infertile couple: missing information, Capri, Italy, September 2003.
191. “PCOS: Where are we today?”, Round Table “Ovarian stimulation”, 4th Symposium of Gynecologic
Endocrinology and 12th Annual Meeting of the German IVF Centers, Luebeck, Germany, November 2003.
192. “Persistent infertility after conventional treatment”, Daily Seminar of the Siena University, Siena, Italy,
February 2004.
193. “Ovarian stimulation and carcinogeneity”, 11th World Congress of Gynecological Endocrinology, Florence,
Italy, February 2004.
194. “Management of poor responders”, 3rd Annual Congress of the Mediterranean Society for Reproductive
Medicine, Limassol, Cyprus, March 2004.
195. “Diagnostic criteria of PCO Syndromme”, International Conference for the European Union Accession
Countries on Reproductive Endocrinology and Infertility, Bratislava, Slovakia, April 2004.
196. “Long-term health consequences for women with PCOS: report from the consensus ESHRE/ASRM
Meeting, Rotterdam 2003”, Joint RCOG/ESHRE Meeting on “Evidence-based management of
anovulation”, London, Great Britain, April 2004.
197. “Risks of ovarian stimulation”, XVIIIth European Congress of Obstetrics and Gynecology, European Board
and College of Obstetrics and Gynaecology (ΕΒCOG), Athens, May 2004.
198. “Persistent infertility after conventional ART”, ESHRE/ASRM Pre-Congress Course, 20th Annual Meeting of
the European Society of Human Reproduction and Embryology (ESHRE), Berlin, Germany, June 2004.
199. “Oral contraceptives in the treatment of hyperandrogenism”, Round Table “Androgen Excess Disorders”,
Ιnternational Meeting of the Androgen Excess Society, Lisbon, Portugal, August 2004.
200. “ICSI techniques for the therapeutic management of male infertility”, Αnnual Meeting of the Special Interest
Group in Andrology of the European Society of Urological Andrology, Athens, September 2004.
201. “Malformations and genetic defects of children born after assisted reproduction techniques”, 32nd
Conference of the European Teratology Society, Thessaloniki, September 2004.
202. “The Balkan Situation”, 2nd ΕSHRE Campus Symposium on Data Collection & ART Monitoring (EIM),
Thessaloniki, September 2004.
203. “Recurrent ART failure: Common sense management”, 1st Balkan Congress of Reproductive Medicine,
Thessaloniki, September 2004.
204. “The Polycystic Ovary Syndrome”, 1st Balkan Congress of Reproductive Medicine, Thessaloniki,
September 2004.
205. “IVF/ICSI children follow-up”, 1st Balkan Congress of Reproductive Medicine, Thessaloniki, September
2004.
206. “The polycystic ovary syndrome: an update», 2nd Portuguese Congress of Reproductive Medicine, Porto,
Portugal, October 2004.
207. “Limits to medically assisted procreation in Europe: up to what age is it reasonable to consider it?”,
Septiemes Journees Europeennes de la Societe Francaise de Gynecologie, Paris, France, October 2004.
208. “Ovary and oocyte cryopreservation: where do we stand?”, Roundtable Luncheon, 60th Annual Meeting of
the American Society for Reproductive Medicine (ASRM). Philadelphia, Pennsylvania, October 2004.
209. “Pregnancy and children outcome after ART”, 16th International Symposium on Fertility and Sterility, of the
Fertility and Sterility Society of Serbia and Montenegro, Βelgrade, December 2004.
210. “GnRH – agonists and antagonists: hidden benefits and unexpected burden”, New Trends in Ovarian
Stimulation Protocols with and without IVF, Geneva, Switzerland, April 2005.
211. “What to do after ART failure?”, 13th World Congress on In Vitro Fertilization, Assisted Reproduction &
Genetics, Istanbul, Turkey, May 2005.
212. “ART babies and congenital abnormalities: increasing?”, 13th World Congress on In Vitro Fertilization,
Assisted Reproduction & Genetics, Istanbul, Turkey, May 2005.
213. “IVF outcome in PCOS patients”, The 6th Athens Congress on Women’s Health & Disease, Athens,
September 2005.
214. “Recombinant gonadotroprins”, 1st Course Molecular Biology for Reproductive Medicine Specialists:
15
Basil C. Tarlatzis, M.D., Ph.D.
Molecular Reproductive Endocrinology, Siena, Italy, September 2005.
215. “Ottimizzare I risultati della PMA: aspetti clinici”, Workshop: Procreazione medicalmente assistita –
ottimizzare I risultati, Bari, Italy, September 2005.
216. “Pregnancy and children outcome after IVF and ICSI”, 12TH World Congress of Gynecological
Endocrinology, Florence, Italy, March 2006.
217. “ART in patients over 40: may we improve results?”, The 19th European Congress of Obstetrics and
Gynaecology, Torino, Italy, April 2006.
218. “Take home messages and future perspectives”, The 19th European Congress of Obstetrics and
Gynaecology, Torino, Italy, April 2006.
219. “Long-term health risks of PCOS”, PCOS Meeting, Taipei, Taiwan, April 2006.
220. “IVF outcome in PCOS patients”, PCOS Meeting, Taipei, Taiwan, April 2006.
221. “Long-term health risks of PCOS”, Asian Fertility Expert Meeting 2006, Ho Chi Minh City, Vietnam, April
2006.
222. “Laparoscopic ovarian drilling in PCOS”, Asian Fertility Expert Meeting 2006, Ho Chi Minh City, Vietnam,
April 2006.
223. “Epidemiology of malformations after ART”, 5th Annual Meeting of the Mediterranean Society for
Reproductive Medicine, Iraklio, Crete, April 2006.
224. “Improving quality in continuous medical education in RH”, 5 th Annual Meeting of the Mediterranean
Society for Reproductive Medicine, Iraklio, Crete, April 2006.
225. “ESHRE/EBCOG accreditation”, 22nd Annual Meeting of the European Society of Human Reproduction
and Endocrinology, Prague, Czech Republic, June 2006.
226. “Ovarian stimulation and IVF & cancer”, 12th International Congress on Hormonal Steroids and Hormones
& Cancer, Athens, September 2006.
227. “Induction of ovulation”, 2nd Course Molecular Biology for Reproductive Medicine Specialists: Molecular
Reproductive Endocrinology, Siena, Italy, September 2006.
228. "Therapies for PMA and carcinogenesis", 82 nd National SIGO Congress, Rome, Italy, October 2006.
229. "PMA and neo-natal outcome", 82nd National SIGO Congress, Rome, Italy, October 2006.
230. “Diagnosing PCOS: still controversial?”, Reproduktionsmedizin und Endokrinologie, Linz. Austria,
October 2006.
231. “Prediction of response to gonadotrophins”, 2 nd Expert Meeting on Predictors of Ovarian Response to
Stimulation, Evian, France, February 2007.
232. “Ovarian stimulation with GnRH antagonists for ART”, 2007 Hacettepe Congress of Obstetrics and
Gynecology, Ankara, Turkey, April 2007.
233. “Treatment strategies of polycystic ovary syndrome”, 19th IFFS World Congress on Fertility & Sterility,
Durban, South Africa, April – May 2007.
234. “Management of poor response – facts or myths”, 19th IFFS World Congress on Fertility & Sterility,
Durban, South Africa, April – May 2007.
235. “EBCOG/ESHRE Collaboration”, 23rd Annual Meeting of the European Society of Human Reproduction
and Endocrinology, Lyon, France, July 2007.
236. “Update on PCOS”, 23rd Annual Meeting of the European Society of Human Reproduction and
Endocrinology, Lyon, France, July 2007.
237. “Recombinant gonadotropins”, 3rd Course on Molecular Basis and Translational Studies in Reproductive
Medicine, Utrecht, The Netherlands, September 2007.
238. “ASRM/ESHRE Consensus on Treatment of PCOS for Infertility”, 63rd Annual Meeting of the American
Society of Reproductive Medicine, Washington D.C., United States of America, October 2007.
239. “Infertility treatment in women with PCOS”, 63rd Annual Meeting of the American Society of Reproductive
Medicine, Washington D.C., United States of America, October 2007.
240. “Summary of ESHRE/ASRM Meeting on Management of PCOS”, Joint RCOG/ESHRE Conference,
London, United Kingdon, November 2007.
241. “Subspecialization in reproductive medicine in the EU: the ESHRE-EBCOG program”, 30 Years of
Reproductive Medicine in Leuven: The Integrated Approach of Reproductive Surgery and IVF, Leuven,
Belgium, November 2007.
242. “Infertility treatment of PCOS: an evidence based approach”, 2nd Symposium on Recent Advances in
Human Reproduction 2007, Belgrade, Serbia, November 2007.
243. “Evidence-based management of poor ovarian response”, Premature Ovarian Failure and Poor Ovarian
Response Symposium, Sofia, Bulgaria, December 2007.
244. “Current and potential benefits of LH activity”, Updates in Infertility Treatment 2008, Cape Town, South
Africa, January 2008.
245. “The use of GnRH antagonists in ovarian stimulation for IVF”, 13th World Congress of Gynecological
Endocrinology, Florence, Italy, February 2008.
246. “The European concept of accreditation in Reproductive Medicine”, 18th Portuguese Congress of
16
Basil C. Tarlatzis, M.D., Ph.D.
Obstetrics and Gynecology, Lisbon, Portugal, March 2008.
247. “Treatment strategies”, 20th European Congress of Obstetrics and Gynecology, Lisbon, Portugal, March
2008.
248. “Ethical dilemmas in PGD”, Basic genetics for ART practitioners, Athens, Greece, April 2008.
249. “New developments in GnRH antagonist co-treatment”, The Second World Congress on Mild Approaches
in Assisted Reproduction: Embracing Mild IVF and IVM, London, UK, April 2008.
250. “New legal frame for the IVF in Greece: still an issue!”, Mediterranean Conferences for Reproductive
Medicine Workshop, Satellite Symposium Merck Serono: IVF Treatment Targets and Challenges,
Heraklion Crete, Greece, May 2008.
251. “The new law’s perspectives in reproduction”, Mediterranean Conferences for Reproductive Medicine
Workshop: New Trends on Controlled Ovarian Stimulation and Ovulation Induction, Heraklion Crete,
Greece, May 2008.
252. ESHRE, 24th Annual Meeting of the European Society of Human Reproduction and Embryology,
Barcelona Spain, July 2008.
253. “The 7th Athens Congress on Women’s Health & Disease”, Gynecologic, Endocrine & Reproductive
Issues, Athens Greece, September 2008.
254. “Recombinant Gonadotropins”, 4th Course on Molecular Basis and Translational Studies in Reproductive
Medicine, Thessaloniki Greece, October 2008.
255. “Reproductive Health: Lessons from the past and hopes for the future”, 13th International Annual, Cairo,
Egypt October 2008.
256. “The Use of GnRH Antagonists in Ovarian Stimulation for ART”, Roundtable Luncheon, 64th Annual
Meeting of the American Society for Reproductive Medicine (ASRM). San Francisco, California,
November 2008.
257. “Diagnosis and treatment of diminished ovarian reserve in an IVF setting”, Plenary Session, 13th World
Congress on Human Reproduction, Venezia, Italy, March 2009.
258. “Past experience and Future Trends in ART”, Plenary Session, 1st National Reproductive Medicine
Congress, Kuala Lumpur, Malaisia, April 2009.
259. ESHRE, 25th Annual Meeting of the European Society of Human Reproduction and Embryology,
Amsterdam Holland, June-July 2009.
260. SGI Forum” Probiotics in Human Reproduction” Siena, Italy, June-July 2009
261. “How to improve theProbability of Pregnacy in Poor Responders Undergoing in VitroFertilization: A
systematic Review and Meta-analysis”, Roundtable Lucheon, 65th Annual Meeting of the American
Society for Reproductive Medicine (ASRM). Atlanta, Georgia, October 2009
262. “Surgical and ART treatment”, School of Gynecological & Reproductive Endocrinology, 14th World
Congress of Gynecological Endocrinology, Firenze, Italia, March 2010.
263. “Chances for fertility preservation and ovulation induction in POF patients”, Pleanry Session, 14 th World
Congress of Gynecological Endocrinology, Firenze, Italia, March 2010.
264. “Should there be an interantional limit on the number of fertilized oocytes that are implated in a woman at
one time?” (Debate), 14th World Congress of Gynecological Endocrinology, Firenze, Italia, March 2010.
265. “Gonadotropin stimulation for ART: from urinary hMG to “pure” recombinant human (FSH-LH)
preparations” Jubilee Session in honor of Bruno Lunenfeld, 14 th World Congress of Gynecological
Endocrinology, Firenze, Italia, March 2010.
SOCIAL SERVICE:
Lectures to high school students and the public on different aspects of reproductive health.
17
Basil C. Tarlatzis, M.D., Ph.D.
SCIENTIFIC PAPERS
I. DOCTORAL THESIS:
Doctoral Thesis (Ph.D.): The Effect of Aminoglycoside Antibiotics on the Contractility of the Isolated Rat Uterus
(1982).
II. INTERNATIONAL PUBLICATIONS:
A. JOURNALS
1. Objective evaluation of spermatozoal motility in fertile males with the multiple exposure photography (MEP)
method
D. Panidis, B.C. Tarlatzis, A. Papaloucas
Acta Endocrinologica, Suppl. 248: 19-20, 1982
2. Effect of uremic serum on sperm motility: Evaluation by multiple exposure photography
D.K. Panidis, B.C. Tarlatzis, G.K. Vayonas, J.S. Tsouras, A.C. Papaloucas
Archives of Andrology, 8: 307-310, 1982
3. Objective evaluation of spermatozoa motility as influenced by fresh blood serum and normal saline
D. Panidis, B.C. Tarlatzis, J.S. Tsouras, A. Papaloucas
European Journal of Obstetrics Gynecology and Reproductive Biology, 14: 23-30, 1982
4. Effect of aminoglycoside antibiotics on the contractility of the uterus
A.G. Paradelis, B.C. Tarlatzis, C.J. Triantaphyllidis, M.M. El-Messidi, A.C. Papaloucas
Methods and Findings in Experimental and Clinical Pharmacology, 4: 337-341, 1982
5. Interaction of aminoglycoside antibiotics with oxytocin and prostaglandin E2 on uterine contractility
A.G. Paradelis, C.J. Triantaphyllidis, B.C. Tarlatzis, J.S. Tsouras, M.M. El-Messidi, A.C. Papaloucas
Methods and Findings in Experimental and Clinical Pharmacology, 4: 343-345, 1982
6. Continuous culture of the postimplantation rat conceptus
B.C. Tarlatzis, M.K. Sanyal, W.J. Biggers, F. Naftolin
Biology of Reproduction, 31: 415-426, 1984
7. Improved techniques for collecting motile spermatozoa from human semen. I. A self-migratory method
A. Makler, O. Murillo, G. Huszar, B.C. Tarlatzis, A. DeCherney, F. Naftolin
International Journal of Andrology 7: 61-70, 1984
8. Improved techniques for separating motile spermatozoa from human semen. II. An atraumatic
centrifugation method
A. Makler, O. Murillo, G. Huszar, B.C. Tarlatzis, A. DeCherney, F. Naftolin
International Journal of Andrology, 7: 71-78, 1984
9. Human in vitro fertilization employing individualized ovulation induction by human menopausal
gonadotropins
N. Laufer, Α.Η. DeCherney, F.P. Haseltine, M.L. Polan, B.C. Tarlatzis, A.M. Dlugi, F. Naftolin
Journal of In Vitro Fertilization and Embryo Transfer, 1: 56-62, 1984
10. The periovulatory and luteal phase of conception cycles following in vitro fertilization and embryo transfer
18
Basil C. Tarlatzis, M.D., Ph.D.
A.M. Dlugi, N. Laufer, Α.Η. DeCherney, N.J. MacLusky, F.P. Haseltine, M.L. Polan, H.C. Mezer, B.C.
Tarlatzis, F. Naftolin
Fertility and Sterility, 41: 530-537, 1984
11. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin induced cycles
decreases successful in vitro fertilization of human oocytes
N. Laufer, Α.Η. DeCherney, B.C. Tarlatzis, A.L. Zuckerman, M.L. Polan, A.M. Dlugi, R. Graebe, E.R.
Barnea, F. Naftolin
Fertility and Sterility, 42: 198-203, 1984
12. Asynchrony between the cumulus-corona-cell complex and oocyte maturation after human menopausal
gonadotropin treatment for in vitro fertilization
N. Laufer, B.C. Tarlatzis, Α.Η. DeChemey, J.T. Masters, F.P. Haseltine, N. MacLusky, F. Naftolin
Fertility and Sterility, 42: 366-372, 1984
13. In vitro fertilization: State of the art
N. Laufer, B.C. Tarlatzis, F. Naftolin
Seminars in Reproductive Endocrinology, 2(2): 197-219, 1984
14. Human chorionic gonadotropin and prolactin modulation of early luteal function and LH receptor binding
activity in cultured human granulosa-luteal cells
M.L. Polan, N. Laufer, W. Botero-Ruiz, B.C. Tarlatzis, F.P. Haseltine, Α.Η. DeCherney, H.R. Behrman
Journal of Clinical Endocrinology and Metabolism, 59: 773-779, 1984
15. The use of ovarian ultrasonography in monitoring ovulation induction
B.C. Tarlatzis, N. Laufer, Α.Η. DeCherney
Journal of In Vitro Fertilization and Embryo Transfer, 1: 226-232,1984
16. 17β-estradiol and progesterone production by human granulosa-luteal cells isolated from human
menopausal gonadotropin - stimulated cycles for in vitro fertilization
A.M. Dlugi, N. Laufer, M.L. Polan, Α.Η. DeCherney, B.C. Tarlatzis, N.J. MacLusky, H.R. Behrman
Journal of Clinical Endocrinology and Metabolism; 59: 986-992, 1984
17. Reproductive outcome following two ectopic pregnancies
Α.Η. De Cherney, J.S. Silidker, H.C. Mezer, B.C. Tarlatzis
a) Fertility, Sterility, 43: 82-85, 1984
b) Contraception, Fertilité, Sexualité, 12(5): 701-704, 1984
18. cAMP levels in human follicular fluid: Relationship to oocyte maturation and achievement of pregnancy
after in vitro fertilization
B.C. Tarlatzis, N. Laufer, A.H. DeCherney, M.L. Polan, F.P. Haseltine, H.R. Behrman
Journal of Clinical Endocrinology and Metabolism, 60:1111-1115, 1985
19. Steroid secretion by human oocyte-corona-cumulus complexes associated with conceptions following in
vitro fertilization
N. Laufer, B.C. Tarlatzis, A.H. DeCherney, H.R. Behrman
Journal of In Vitro Fertilization and Embryo Transfer, 2:156-161,1985
20. A simple technique of ovarian suspension in preparation for in vitro fertilization
Α.Η. DeCherney, B.C. Tarlatzis, N. Laufer, F. Naftolin
Fertility and Sterility, 43: 659-661, 1985
19
Basil C. Tarlatzis, M.D., Ph.D.
21. The day of initiation of human menopausal gonadotropin stimulation affects follicular growth in in vitro
fertilization cycles
A.M. Dlugi, N. Laufer, Α.Η. DeCherney, M.L. Polan, B.C. Tarlatzis, R.A. Graebe, E.R. Barnea, F. Naftolin
Journal of In Vitro Fertilization and Embryo Transfer, 2: 33-40, 1985
22. Psychological interviews in screening couples undergoing in vitro fertilization
F.P. Haseltine, C. Mazure, W. de L’Aune, D. Greenfeld, N. Laufer, B.C. Tarlatzis, M.L. Polan, E.E. Jones,
R. Graebe, F. Nero, A. Dlugi, D. Fazo, J. Masters, Α.Η. DeCherney
Annals of the New York Academy of Sciences, 442: 504-522, 1985
23. Follicular development: Lessons learned from human in vitro fertilization
Α.Η. DeCherney, B.C. Tarlatzis, N. Laufer
American Journal of Obstetrics and Gynecology, 153: 911-923, 1985
24. Renin-like activity in ovarian follicular fluid
L.A. Fernandez, B.C. Tarlatzis, P.J. Rzasa, V.J. Caride, N. Laufer, A.F. Negro-Vilar, Α.Η. DeCherney, F.
Naftolin
Fertility Sterility, 44: 219-223, 1985
25. Semen evaluation following preparation for human in vitro fertilization (IVF)
B.C. Tarlatzis, N. Laufer, O. Murillo, A. Makler, F. Naftolin, Α.Η. DeCherney
Archives of Andrology 17: 215-222, 1986
26. The association between preovulatory serum 17β-estradiol pattern and conception in human menopausal
gonadotropin - human chorionic gonadotropin stimulation
N. Laufer, Α.Η. DeCherney, B.C. Tarlatzis, F. Naftolin
Fertility Sterility, 46: 73-76, 1986
27. Glycosaminoglycans in follicular fluid from women undergoing in vitro fertilization and their relationship to
cumulus expansion, fertilization, and development
M.E. Bellin, R.L. Ax, N. Laufer, B.C. Tarlatzis, Α.Η. DeCherney, D. Feldberg, F.P. Haseltine
Fertility Sterility, 45: 244-248, 1986
28. Human chorionic gonadotropin (hCG) stimulation of estradiol production and androgen antagonism of
gonadotropin-stimulated responses in cultured human granulosa-luteal cells
M.L. Polan, D. Seu, B.C. Tarlatzis
Journal of Clinical Endocrinology and Metabolism, 62: 628-633, 1986
29. Angiotensin II-like immunoreactivity in human ovarian follicular fluid
M.D. Culler, B.C. Tarlatzis, A. Lightman, L.A. Fernandez, Α.Η. DeCherney, A. Negro-Vilar, F. Naftolin
Journal of Clinical Endocrinology and Metabolism, 62: 613-615, 1986
30. The value of the cervical score in monitoring ovulation induction for in vitro fertilization: A prospective
double-blind study
G. Oelsner, S.B. Pan, E.R. Barnea, S.P. Boyers, B.C. Tarlatzis, Α.Η. DeCherney
Journal of In Vitro Fertilization and Embryo Transfer, 3:366-369,1986
31. In vitro fertilization and embryo transfer: The legal status in Europe
B.C. Tarlatzis, Α.Η. DeCherney
Journal of In Vitro Fertilization and Embryo Transfer, 3: 343-344,1986
20
Basil C. Tarlatzis, M.D., Ph.D.
32. Recruitment of multiple follicular development for in vitro fertilization in the presence of a viable intrauterine
pregnancy
M.P. Diamond, B.C. Tarlatzis, Α.Η. DeCherney
Obstetrics and Gynecology, 70: 498-499, 1987
33. Fertilization and cleavage rates of heparin-exposed human oocytes in vitro, and their effect on the
acrosome reaction rate of coincubated human sperm
S.P. Boyers, B.C. Tarlatzis, F.P. Haseltine, Α.Η. DeCherney
Fertility Sterility, 48: 628-632, 1987
34. The ovarian renin-angiotensin system: Renin-like activity and angiotensin II/III immunoreactivity in
gonadotropin-stimulated and unstimulated human follicular fluid
A. Lightman, B.C. Tarlatzis, P.J. Rzasa, M.D. Culler, V.J. Caride, A.F. Negro-Vilar, D. Lennard, Α.Η.
DeCherney, F. Naftolin
American Journal of Obstetrics and Gynecology, 156: 808-816, 1987
35. Les années 1980: La décade des techniques de reproduction assistée
B.C. Tarlatzis, Α.Η. DeCherney
La lettre du gynecologue, 126: 2-7, 1990
36. Evaluation of intrauterine insemination with washed spermatozoa from the husband in the treatment of
infertility
B.C. Tarlatzis, J. Bontis, E.M. Kolibianakis, T. Sanopoulou, J. Papadimas, S. Lagos, S. Mantalenakis
Human Reproduction, 6: 1241-1246, 1991
37. Seminal plasma transferin in infertile men
J. Papadimas, F. Papadopoulou, S. loannidis, P. Katsaveli, B.C. Tarlatzis, I. Bontis, S. Mantalenakis
a) Archives of Andrology, 28: 125-133, 1992
b) Materia Medica Greca, 18(4): 349-360, 1990
38. Evaluation of Hamilton-Thorn automated semen analysis system
E.M. Kolibianakis, B.C. Tarlatzis, J. Bontis, J. Papadimas, E. Spanos, S. Mantalenakis
Archives of Andrology, 28: 213-222, 1992
39. Oocyte collection and quality
B.C. Tarlatzis
Assisted Reproduction Reviews, 2(1): 16-22, 1992
40. β-N-acetylhexosaminidase activity in human oocytes and preimplantation embryos
K. Sermon, W. Lissens, B.C. Tarlatzis, P.R. Braude, P. Devroey, A. Van Steirteghem, I. Liebaers
Human Reproduction, 7: 1278-1280, 1992
41. The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation
techniques: Experience from three centers
J. Smitz, R. Ron-El, B.C. Tarlatzis
Human Reproduction, 7 (Suppl. I): 49-66, 1992
42. Preimplantation diagnosis
I. Liebaers, Κ. Sermon, W. Lissens, J. Liu, P. Devroey, B.C. Tarlatzis, A. Van Steirteghem
Human Reproduction, 7 (Suppl. I): 107-110, 1992
43. LHRH analogues and follicular fluid in IVF cycles
21
Basil C. Tarlatzis, M.D., Ph.D.
B.C. Tarlatzis, H. Bili
The Releaser, Vol. 7(2): 3-7, 1992
44. Unexplained infertility
P.G. Crosignani, J. Collins, I.D. Cooke, E. Diczfalusy, B. on behalf of J. Cohen, J. Collins, I.D. Cooke, P.G.
Crosignani, E. Diczfalusy, T. Farley, T.Β. Hargreave, S. Jager, E. Walters and G. Benagiano, B.C.
Tarlatzis, A. Van Steirteghem
Human Reproduction, 8: 977-980, 1993
45a. IFFS Expert Group Report on the Whittemore study related to the risk of ovarian cancer associated with the
use of infertility agents
J. Cohen, R. Forman, S. Harlap, E. Johannisson, B. Lunenfeld, J. de Mouzon, R. Pepperell, B.C. Tarlatzis,
A. Templeton
Human Reproduction, 8: 996-999, 1993
45b. Fertility drugs and ovarian cancer
Fertility Sterility, 60: 406-408, 1993
46. Psychosocial impacts of infertility on Greek couples
I. Tarlatzis, B.C. Tarlatzis, I. Diakogiannis, J. Bontis, S. Lagos, D. Gavriilidou, S. Mantalenakis
Human Reproduction, 8: 396-401, 1993
47. Effect of follicular fluid on the kinetics of human sperm acrosome reaction in vitro
B.C. Tarlatzis, J. Danglis, E.M. Kolibianakis, J. Papadimas, J. Bontis, S. Lagos, S. Mantalenakis
Archives of Andrology, 31: 167-175, 1993
48. Ovarian stimulation with Buserelin/HMG/HCG: Prospective randomized study of short versus long protocol
B.C. Tarlatzis, G. Pados, J. Bontis, S. Lagos, G. Grimbizis, E. Spanos, S. Mantalenakis
Human Reproduction, 8: 807-812, 1993
49. Growth hormone, estradiol, progesterone and testosterone concentrations in follicular fluid after ovarian
stimulation with various regimes for assisted reproduction
B.C. Tarlatzis, K. Pazaitou, H. Bili, J. Bontis, J. Papadimas, S. Lagos, E. Spanos, S. Mantalenakis
Human Reproduction, 8: 1612-1616, 1993
50. Assisted reproduction techniques in polycystic ovarian syndrome
B.C. Tarlatzis, G. Grimbizis
Annals of the New York Academy of Sciences, 687: 280-287, 1993
51. Follicle cyst formation after administration of different GnRH analogues for assisted reproduction
B.C. Tarlatzis, H. Bili, J. Bontis, S. Lagos, I. Vatev, S. Mantalenakis
Human Reproduction, 9(11): 1983-1986, 1994
52. Evaluation of two GnRH-analogues (Leuprolide and Buserelin) in the short and long protocols for assisted
reproduction techniques
B.C. Tarlatzis, G. Grimbizis, F. Pournaropoulos, J. Bontis, S. Lagos, G. Pados, S. Mantalenakis
Journal of Assisted Reproduction and Genetics, 11(2): 85-90, 1994
53. Clinical pregnancy and male subfertility: the ESHRE multicentre trial on the treatment of male subfertility
P.G. Crosignani, D.E. Walters (εκ μέρους των ερευνητών)
Human Reproduction, 9(6): 1112-1118, 1994
54. Male sterility and subfertility: Guidelines for management
22
Basil C. Tarlatzis, M.D., Ph.D.
P.G. Crosignani, B. Rubin on behalf of the speakers (Α. Acosta, G. Benagiano, J. Collins, E. Diczfalusy, T.
Farley, Τ. Hargreave, Β.C. Tarlatzis, A. Van Steirteghem, E. Walters) and the discussants (Κ. Diedrich, G.
Ragni)
Human Reproduction, 9(7): 1260-1264, 1994
55. Evaluation of different ovarian stimulation protocols for in vitro fertilization
G. Pados, B.C. Tarlatzis, J. Bontis, S. Lagos, J. Papadimas, E. Spanos, S. Mantalenakis
Gynecological Endocrinology, 9: 103-112, 1995
56. The effect of pentoxifylline on human sperm motility and fertilizing capacity
B.C. Tarlatzis, E.M. Kolibianakis, J. Bontis, M. Tousiou, S. Lagos, S. Mantalenakis
Archives of Andrology, 34: 33-42, 1995
57. Ovarian stimulation and ovarian tumors: A critical reappraisal
B.C. Tarlatzis, G. Grimbizis, J. Bontis, S. Mantalenakis
Human Reproduction Update, 1(3): 284-301, 1995
58. The prognostic value of basal luteinizing hormone: follicle-stimulating hormone ratio in the treatment of
patients with polycystic ovarian syndrome by assisted reproduction techniques
B.C. Tarlatzis, G. Grimbizis, F. Pournaropoulos, J. Bontis, S. Lagos, E. Spanos, S. Mantalenakis
Human Reproduction, 10(10): 2545-2549, 1995
59. Two cases of ovarian tumours in women with multiple ovarian stimulation attempts
G. Grimbizis, B.C. Tarlatzis, J. Bontis, D. Miliaras, S. Lagos, F. Pournaropoulos, S. Mantalenakis
Human Reproduction, 10(3): 520-523, 1995
60. Anovulatory infertility
The ESHRE Capri Workshop Group (D.T. Baird, I. Cooke, G. Benagiano, J. Cohen, P.G. Crosignani, E.
Diczfalusy, K. Diedrich, R.G. Edwards, T. Farley, M. Filicori, D. Mishell, G.Ragni, B.C. Tarlatzis, A. Van
Steirteghem,B.L. Rubin)
Human Reproduction, 10: 1549-1553, 1995
61. The relationship between ovarian stimulation and ovarian tumours
B.C. Tarlatzis, G. Grimbizis, J. Bontis, S. Mantalenakis
Human Reproduction Update, 1(4): 428,1995 (Letter to the Editor)
62. ESHRE guidelines for good clinical and laboratory practice for investigation and treatment of infertile
couples
ESHRE Committee on Good Clinical and Laboratory Practice (B. Kjessler, H.M. Beier, P. Devroey, M.
Germond, A. McLaren, J. Montagut, E. Muller-Tyl, B.C. Tarlatzis, D. Whittingham, A.C. Van Steirteghem,
P.G. Crosignani, K. Diedrich, H. Evers, J.R. Zorn)
a) Human Reproduction, 10: 1246-1271, 1995
b) Human Reproduction, 10: 1880, 1995
63. The Euro-Team Early Pregnancy (ETEP) protocol for recurrent miscarriage
C.W. Berry, B. Brambati, T.K.A.B. Eskes, N. Exalto, H. Fox, J.P.M. Geraedts, I. Gerhard, F. Gonzales
Gomes, J.G. Grudzinskas, J. Hustin, P. Jouppila, B.K.A. Lindblom, M. Mantoni, N. Montenegro, F. Nogales
Fernandes, R. O’Rahilly, J.F. Pedersen, P.W.J. Peters, L. Regan, D.L. Rushton, H.W.M. van Straaten, B.C.
Tarlatzis, M. Wells
Human Reproduction, 10(6): 1516-1520, 1995
23
Basil C. Tarlatzis, M.D., Ph.D.
64. A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle
stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization
H.J. Out, B.M.J.L. Mannaerts, S.G.A.J. Driessen, H.J.T. Coelingh Bennink (on behalf of the researchers)
Human Reproduction, 10(10): 2534-2540, 1995
65. Application of image analysis cytometry in follicular fluid cells obtained from in-vitro fertilization cycles:
relationships to patients age, oocyte maturity, fertilizability and in-vitro fertilization outcome
T. Agorastos, J. Bontis, B.C. Tarlatzis, H. Bili, T. Constantinidis, S. Mantalenakis
Human Reproduction, 11(10): 2200-2207, 1996
66. Αzoospermia - Clinical, hormone and biochemical investigation
J. Papadimas, F. Papadopoulou, S. Ioannidis, E. Spanos, B.C. Tarlatzis, J. Bontis, S. Mantalenakis
Archives of Andrology, 37: 97-102, 1996
67. Microsurgical and laparoscopic management of tubal infertility: Report of 763 cases
J. Bontis, B.C. Tarlatzis, G. Grimbizis, J. Papadimas, G. Pados, F. Pournaropoulos, S. Mantalenakis
Middle East Fertility Society Journal, 1(1): 17-29, 1996
68. Guidelines to the prevalence, diagnosis, treatment and management of infertility, 1996
The ESHRE Capri Workshop (P.G. Crosignani, B. Rubin, A. Acosta, D.T. Baird, G. Benagiano, J. Cohen, J.
Collins, I. Cooke, E. Diczfalusy, K. Diedrich, R.G. Edwards, T. Farley, M. Fillicori, A. Glasier, T. Hargreave,
S. Jager, D.R. Mishell, E. Nieschlag, G. Ragni, B.C. Tarlatzis, A. Van Steirteghem, W. Walters, L. Weström
Human Reproduction, 11(8): 1775-1807, 1996
69a) Cystic fibrosis and infertility caused by congenital bilateral absence of the vas deference and related
clinical entities: Discussion
D. Page, W. Lissens, B.C. Tarlatzis, S. Silber, M. Merdad
Human Reproduction, 11 (Suppl. 4): 79-80, 1996
69b) Registers of in ivtro fertilization and assisted conception: Discussion
K. Nygren, A. Van Steirteghem, J.L. Simpson, P. Lancaster, R.G. Edwards, B.C. Tarlatzis, S. Silber
Human Reproduction, 11 (Suppl. 4): 105-109, 1996
70. Report on the activities of the ESHRE Task Force on Intracytoplasmic Sperm Injection
B.C. Tarlatzis
Human Reproduction, 11 (Suppl 4): 160-186, 1996
71. Pregnancies with oocyte donations in older women
B.C. Tarlatzis
Gynecological Endocrinology, 10 (Suppl. 4); 51-52, 1996
72. Testosterone undecanoate versus mesterolone in hypogonadal male patients
J. Papadimas, E. Bili, F. Papadopoulou, E. Spanos, B.C. Tarlatzis, B. Kokkas, G. Pangalos, J. Bontis, S.
Mantalenakis
Epitheorese Klinikes Farmakologias - Farmakokinetikes, International Edition, 10:3-8, 1996
73. Pituitary-testicular axis in men with β-thalassaemia major
J. Papadimas, E. Mandala, G. Pados, B. Kokkas, G. Georgiadis, B.C. Tarlatzis, J. Bontis, Z. Sinakos, S.
Mantalenakis
Human Reproduction, 11(9): 1900-1904, 1996
24
Basil C. Tarlatzis, M.D., Ph.D.
74. The significance of high follicular-phase luteinizing hormone levels in the treatment of women with
polycystic ovarian syndrome by in vitro fertilization
B.C. Tarlatzis, G. Grimbizis
Journal of Assisted Reproduction and Genetics, 14(1): 1-4, 1997
75. Development and clinical applications of new gonadotropin preparations in assisted reproduction
techniques
B.C. Tarlatzis, H. Bili
Assisted Reproduction Reviews, 7(1): 2-6, 1997
76. A prospective, randomized study to assess the tolerance and efficacy of intramuscular and subcutaneous
administration of recombinant follicle-stimulating hormone (Puregon)
H.J. Out, Ρ.E. Reimitz, H.J.T. Coelingh Bennink (on behalf of the researchers)
Fertility Sterility, 67:278-283, 1997
77. Laparoscopic management of polycystic ovarian syndrome: A review
H. Saravelos, T.C. Li, J. Bontis, B.C. Tarlatzis, I.D. Cooke
Gynaecological Endoscopy, 6: 331-340, 1997
78. Female infertility: Treatment options for complicated cases
The ESHRE Capri Workshop (K. Diedrich, J. Collins, D.T. Baird, J.L.H. Evers, P.G. Crosignani, B.C.
Tarlatzis, I. Cooke, A. Glasier, P. Devroey, A. Van Steirteghem, G. Benagiano, J. Cohen, E. Diczfalusy, G.
Ragni)
Human Reproduction, 12(6): 1191-1196, 1997
79. Ovarian hyperstimulation syndrome
B.C. Tarlatzis, G. Grimbizis
The Egyptian Journal of Fertility and Sterility, 1: 21-30, 1997
80. Intrafollicular ovarian pregnancy after ovulation induction/intrauterine insemination: pathophysiological
aspects and diagnostic problems (Case report)
J. Bontis, G. Grimbizis, B.C. Tarlatzis, D. Miliaras, H. Bili
Human Reproduction, 12(2); 376-378, 1997
81. Therapeutic approach of immotile cilia syndrome by intracytoplasmic sperm injection: a case report
J. Papadimas, B.C. Tarlatzis, H. Bili, T. Sotiriadis, K. Koliakou, J. Bontis, S. Mantalenakis
Fertility Sterility, 67(3): 562-565, 1997
82. Gonadotropin releasing hormone agonists in controlled ovarian hyperstimulation (Les Agonistes des GnRH
dans l’hyperstimulation ovarienne)
B.C. Tarlatzis, G. Grimbizis
References en Gynecologie Obstetrique, 5, 181-190, 1997
83. Pregnancy outcome after assisted fertilization-a short survey
W. Kupker, B.C. Tarlatzis, K. Diedrich
International Journal of Andrology, 20(Suppl. 3): 65-68, 1997
84. Tubal factor infertility: treatment in the era of in vitro fertilization
B.C. Tarlatzis, G. Grimbizis
Middle East Fertility Society Journal, 2: 177-184, 1997
85. Survey on intracytoplasmic sperm injection: Report from the ESHRE ICSI Task Force
25
Basil C. Tarlatzis, M.D., Ph.D.
B.C. Tarlatzis, H. Bili
Human Reproduction, 13(Suppl. 1): 165-177, 1998
86. Cytokines in the human ovary: presence in follicular fluid and correlation with leukotriene B 4
H. Bili, B.C. Tarlatzis, M. Daniilidis, A. Fleva, J. Bontis, A. Tourkantonis, S. Mantalenakis
Journal of Assisted Reproduction and Genetics, 15: 93-98, 1998
87. Will clomiphene persist in the 21 century? (Debate)
B.C. Tarlatzis, G. Grimbizis
Human Reproduction, 13: 2356-2358, 1998
88. A double-blind randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing
hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women
undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon R).
The ganirelix dose-finding study group (B. Mannaerts, P. Devroey, T. Abyholm, K. Diedrich, T.Hillensjo, B.
Hedon, J. Itskovitz-Eldor, J. Kahn, O. Naether, F. Olivennes, S. Pavlou, B.C. Tarlatzis, L. Westergaard, B.
Vander Heijden, H. Coelingh Bennink)
Human Reproduction, 13: 3023-3031, 1998
89. Micro- and macro-consequences of ooplasmic injections of early haploid male gametes
N. Sofikitis, I. Miyagawa, Y. Yamamoto, D. Loutradis, T. Mantzavinos, B.C. Tarlatzis
Human Reproduction Update, 4: 197-212, 1998
90. Ooplasmic injections of secondary spermatocytes for non-obstructive azoospermia
N. Sofikitis, Th. Mantzavinos, D. Loutradis, Y. Yamamoto, B.C. Tarlatzis, I. Miyagawa
The Lancet, 351: 1177-1178, 1998
91. Male infertility update
The ESHRE Capri Workshop Group (J. Collins, A. Van Steirteghem, J. Cohen, S.A. Davis, E. Diczfalusy, K.
Diedrich, R. Edwards, J. Egozcue, J.L.H. Evers, D. Mishell, B.C. Tarlatzis, P.G. Crosignani, B. Rubin)
Human Reproduction, 13: 2025-2032, 1998
92a. Discussion: Semen characteristics and fertility required for storage of spermatozoa
P. Jouannet, Ch. Barratt, L. Bassas, B.C. Tarlatzis, F. Thepot, J. Critser, Y. Englert, E. Baldock, Ch.
Bardoux, C. Gotllieb
Human Reproduction, 13(Suppl. 2): 8-11, 1998
92b. Discussion: Screening for infectious diseases
P. Jouannet, Ch. Barratt, C. Liesnard, Y. Englert, B.C. Tarlatzis, L. Bassas, L. Gunning
Human Reproduction, 13(Suppl. 2): 32-34, 1998
93a. Discussion: Structural biology of the gonadotrophin hormone receptor
B.C. Tarlatzis, S. Chappel, H. Jones, B. Fauser, P. Devroey, A. Trounson, L. Hamberger, K. Diedrich, J.
Tesarik, C. Warner, R.G. Edwards, C. Howles, S. Oehninger
Human Reproduction, 13 (Suppl. 3): 47-51, 1998
93b. Discussion: Oocyte maturation as a source of human embryos
B. Fauser, A. Trounson, D. Gardner, H. Jones, B. Lessey, J. Mandelbaum, J. Tesarik, A. Chandley, C.
Warner, S. Oehninger, S. Chappel, B.C. Tarlatzis, J. Cohen, J. Russell
Human Reproduction, 13 (Suppl. 3): 71-75, 1998
93c. Discussion: Genetic contribution to male infertility
26
Basil C. Tarlatzis, M.D., Ph.D.
C. Warner, A. Chandley, R.G. Edwards, J. Tesarik, P. Devroey, J. Mandelbaum, L. Hamberger, A.
Trounson, M. Plachot, H. Jones, B.C. Tarlatzis
Human Reproduction, 13 (Suppl. 3): 84-88, 1998
93d. Discussion: Spermatids as gametes
L. Hamberger, J. Tesarik, M. Plachot, R.G. Edwards, J. Cohen, A. Chandley, B.C. Tarlatzis, A. Trounson
Human Reproduction, 13 (Suppl 3): 108-111, 1998
93e. Discussion: New treatments for men
L. Hamberger, P. Devroey, B. Fauser, A. Chandley, J. Tesarik, J. Mandelbaum, M. Plachot, B.C. Tarlatzis
Human Reproduction, 13 (Suppl. 3): 123-126, 1998
93f. Discussion: Molecular interactions between embryo and uterus
C. Simon, J. Mandelbaum, S. Chappel, E. Loumaye, M. Plachot, B. Fauser, B.C. Tarlatzis, R. Franchin
Human Reproduction, 13 (Suppl. 3): 233-236, 1998
94. The presence of white blood cells in semen
J. Papadimas, Th. Zeginiadou, B.C. Tarlatzis, S. Mantalenakis
Middle East Fertility Society Journal, 4: 188-194, 1999
95. Spontaneous pregnancy following therapeutic approach of an intertile man with aspermia/obstructive
azoospermia
J. Papadimas, S. Ioannidis, S. Kiouras, B.C. Tarlatzis, A. Papanicolaou, J. Bontis, A. Kalinderis, S.
Mantalenakis
Archives of Andrology, 42 (2): 105-108, 1999
96. Growth hormone response to oral glucose tolerance and insulin tolerance tests in patients with PCOS
V. Zournatzi, G. Koios, D. Vavilis, H. Saravelos, B.C. Tarlatzis, J. Bontis
Clin. Exp. Obstet. & Gynec. XXVI (2): 109-111, 1999
97. Pregnancy and child outcome after assisted reproduction techniques
B.C. Tarlatzis, G. Grimbizis
Human Reproduction, 14 (Suppl. 1): 231-234, 1999
98. High doses of gonadotrophin-releasing hormone antagonist in in vitro fertilization cycles do not adversely
affect the outcome of subsequent freeze-thaw cycles
S. Kol, A. Lightman, T. Hillensjo, P. Devroey, B. Fauser, B.C. Tarlatzis, B. Mannaerts, J. Itskovitz-Eldor
Human Reproduction, 14: 2242-2244, 1999
99a. IFFS Surveillance 1998
H.W. Jones, J. Cohen, H.J.Out (on behalf of the researchers)
Fertility and Sterility, 71 (Suppl. 2): 1S-34S, 1999
99b. IFFS Surveillance 2001
H.W. Jones, J. Cohen, J.W.M. Maas (on behalf of the researchers)
Fertility and Sterility, 76 (Suppl. 2): S1-S36, 2001
100. Optimal use of infertility diagnostic tests and treatments
The ESHRE Capri Workshop Group (D.T. Baird, J. Collins, I. Cooke, J. Cohen, J.L.H. Evers, A. Glasier, E.
Nieschlag, A. Van Steirteghem, P. Vercellini, D.R. Mishell, P. Devroey, E. Diszfalusy, K. Diedrich, R.G.
Edwards, S. Engels, I. Liebaers, A. Lindner, G. Ragni, B.C. Tarlatzis, P.G. Crosignani, B.L. Rubin
Human Reproduction, 15: 723-732, 2000
27
Basil C. Tarlatzis, M.D., Ph.D.
101. Significance of chromosomal aberrations of the unsuccesful procedures of assisted reproduction
B.C. Tarlatzis, D.I. Toncheva, I.Ts. Vatev
European Journal of Obstetrics & Gynecology and Reproductive Biology, 88: 181-7, 2000
102. Oocyte donation: clinical and practical aspects
B.C. Tarlatzis, G. Pados
Molecular and Cellular Endocrinology, 161: 99-102, 2000
103. Intracytoplasmic sperm injection. Survey of world results
B.C. Tarlatzis, H. Bili
Annals of the New York Academy of Sciences, 900: 336-44, 2000
104. Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the
GnRH antagonist Cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III
study
R.E. Felberbaum, C. Albano, M. Ludwig, H. Riethmuller-Winzen, M. Grigat, P. Devroey, K. Diedrich, on
behalf of the European Cetrorelix Study Group
Human Reproduction, 15(5):1015-1020, 2000
105. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian
stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a
controlled, randomized, multicentre trial
The European Orgalutran(R) Study Group, G. Borm and B. Mannaerts
Human Reproduction, 15: 1490-1498, 2000
106. Multiple gestation pregnancy
The ESHRE Capri Workshop Group (D.T. Baird, P. Barri, E. Bryan, J. Collins, K. Diedrich, R.G. Edwards,
H. Evers, L. Fraser, U. Nikolini, L. Gianaroli, A. Glasier, I. Liebaers, A. Lindner, J.P. Quartarolo, B.C.
Tarlatzis, A. Van Steirteghem, P.G. Crosignani, B. Rubin)
Human Reproduction, 15: 1856-1864, 2000
107.Continuation rates for oral contraceptives and hormone replacement therapy
The ESHRE Capri Workshop Group (D.T. Baird, M.H. Birkhauser, J. Collins, P.G. Crosignani, E.
Diczfalusy, A. Glasier, U. Habenicht, P. Kenemans, C. La Vecchia, M. Meschia, D.R. Mishell, L. Puglisi,
B.L. Rubin, S.O. Skouby, J.C. Stevenson, B.C. Tarlatzis)
Human Reproduction, 15: 1865-1871, 2000
108. Dose-finding agonists and antagonists
G.F. Grimbizis, B.C. Tarlatzis
Infertility and Reproductive Medicine Clinics of North America, 12(1): 57-73, 2001
109. Clinical implications of uterine malformations and hysteroscopic treatment results
G. Grimbizis, M. Camus, B.C. Tarlatzis, J.N. Bontis, P. Devroey
Human Reproduction Update, 7: 161-174, 2001
110. The moral status of the pre-implantation embryo
The ESHRE Task Force on Ethics and Law (F. Shenfield, G. Pennings, C. Sureau, J. Cohen, P. Devroey,
B.C. Tarlatzis)
Human Reproduction, 16: 1046-1048, 2001
111. The cryopreservation of human embryos
28
Basil C. Tarlatzis, M.D., Ph.D.
The ESHRE Task Force on Ethics and Law (F. Shenfield, G. Pennings, C. Sureau, J. Cohen, P. Devroey,
B.C. Tarlatzis, Y. Englert, A. Van Steirteghem)
Human Reproduction, 16: 1049-1050, 2001
112. Overview of the current applications of intracytoplasmic sperm injection (ICSI)
B.C. Tarlatzis, H. Bili
Polish Journal of Gynaecological Investigation, 3: 1-5, 2001
113. Social determinants of human reproduction
The ESHRE Capri Workshop Group (J. Collins, H. Evers, S. Golombok, C. La Vecchia, D.J. Macunovich,
P.G. Crosignani, P. Devroey, K. Diedrich, T. Farley, L. Gianaroli, I. Liebaers, J. Persson, J.P. Quartarolo,
G. Ragni, B.C. Tarlatzis, A. Van Steirteghem, E. Diczfalusy, B.L. Rubin)
Human Reproduction, 16: 1518-1526, 2001
114. Ovarian and endometrial function during hormonal contraception
The ESHRE Capri Workshop Group (D.T. Baird, J. Collins, I. Cooke, A. Glasier, H.S. Jacobs, C. La
Vecchia, G. Stock, P. Vercellini, J. Cohen, P.G. Crosignani, E. Diczfalusy, J.L.H. Evers, S. Skouby, B.C.
Tarlatzis, B.L. Rubin)
Human Reproduction, 16: 1527-1535, 2001
115. Ambiguous genitalia, 45,X/46,XY mosaic karyotype, and Y chromosome microdeletions in a 17-year-old
man
J. Papadimas, D.G. Goulis, Ch. Giannouli, A. Papanikolaou, B.C. Tarlatzis, J.N. Bontis
Fertility Sterility, 76 (6): 1261-1263, 2001
116. Congenital obstructive azoospermia in a man with Marfan syndrome: coincidence or association?
A. Kukuvitis, I. Georgiou, S. Ioannidis, B.C. Tarlatzis, J. Bontis, J. Papadimas
Fertility Sterility, 76(6): 1256-1257, 2001
117. Alternative approaches in IVF
B.C.J.M. Fauser, P. Bouchard, H.J. T. Coelingh Bennink, J.A. Collins, P. Devroey, J.L.H. Evers, A. Van
Steirteghem (on behalf of the speakers: A.G. Byskov, A.J. Hsueh, M.M. Matzuk, D.T. Baird, I. Boime, B.C.
Tarlatzis, P. Barri, K. Diedrich, B.A. Lessey, J.A. Collins, J. Smitz, B. Behr, M. Plachot, M.H.E.C. Pieters, L.
Hamberger, J. Shaw)
Human Reproduction Update, 8(1): 1-9, 2002
118. Increased monozygotic twinning rate after intracytoplasmic sperm injection and blastocyst stage embryo
transfer
B.C. Tarlatzis, H.S. Qublan, Th. Sanopoulou, L. Zepiridis, G. Grimbizis, J. Bontis
Fertility and Sterility, 77:196-198, 2002
119. Association of oestrogen receptor α polymorphisms and androgen receptor CAG trinucleotide repeats with
male infertility: a study in 109 Greek infertility men
A. Kukuvitis, I. Georgiou, I. Bouba, A. Tsirka, Ch. Giannouli, C. Yapijakis, B.C. Tarlatzis, J. Bontis, D. Lolis,
N. Sofikitis, J. Papadimas
International Journal of Andrology, 25:149-152, 2002
120. III. Gamete and embryo donation.
ESHRE Task Force on Ethics and Law (F. Shenfield, G. Pennings, C. Sureau, J. Cohen, P. Devroey, B.C.
Tarlatzis)
Human Reproduction, 17(5): 1407-1408, 2002
29
Basil C. Tarlatzis, M.D., Ph.D.
121. IV.Stem cells
ESHRE Task Force on Ethics and Law (F. Shenfield, G. Pennings, C. Sureau, J. Cohen, P. Devroey, B.C.
Tarlatzis)
Human Reproduction, 17(5): 1409-1410, 2002
122. β-thalassemia and gonadal axis: a cross-sectional, clinical study in a Greek population
J. Papadimas, D.G. Goulis, E. Mandala, G. Georgiadis, V. Zournatzi, B.C.Tarlatzis, J.N. Bontis
Hormones, 1 (3): 179-187, 2002
123. How many embryos should be transferred?
S.F. Marcus, K. Jaroudi, B.C. Tarlatzis, H.N. Bili
Middle East Fertility Society Journal, 7(2): 81-87, 2002
124.Direct ovarian effects and safety aspects of GnRH agonists and antagonists
B.C. Tarlatzis, E.M. Kolibianakis
Reproductive Biomedicine Online, 5, Suppl. 1(3): 8-13, 2002
125.Germ cell transplantation: a review and progress report on ICSI from spermatozoa generated in
xenogeneic testes
N. Sofikitis, A. Kaponis, Y. Mio, D. Makredimas, D. Giannakis, Y. Yama-moto, N. Kanakas, H. Kawamura,
J. Georgiou, M. Schrader, E. Lolis, X. Giannakopoulos, D. Loutradis, B.C. Tarlatzis, I. Miyagawa
Human Reproduction Update, 9 (3): 291-307, 2003
126.Taskforce 5: Preimplantation Genetic Diagnosis
The ESHRE Task Force on Ethics and Law (F. Shenfield, G. Pennings, P. Devroey, C. Sureau, B.C.
Tarlatzis, and J. Cohen)
Human Reproduction, 18 (3): 649-51, 2003
127.Mono-ovulatory cycles: A key goal in profertility programmes.
D.T. Baird, J. Collins, P.G. Crosignani, J.L.H. Evers, R. Fanchin, B.C. Fauser, M. Filicori, H. Jacobs, B.C.
Tarlatzis, J. Cohen, E. Diczfalusy, K. Diedrich, L. Fraser, G.C. Frigerio, L. Gianaroli, J. Harlin, J. Persson,
A. Rojas-Rios, A. Sunde, A. Van Steirteghem, P. Crosignani
Human Reproduction Update, 9 (3): 263-74, 2003
128.Safety and efficacy of a 3 mg dose of the GnRH antagonist cetrorelix in preventing premature LH surges:
Report of two large multicentre, multinational, phase IIIb clinical experiences.
F. Oliveness, K. Diedrich, R. Frydman, R.E. Felberbaum, C.M. Howles, P. de Albuquerque, R.A. Ferriani,
J. B. Soares, Z.G. Lun, T. Mardesic, D.M. Egan, R.F. Harrison,M. Aboulghar, E. Khalifa, M. Yehia, J.P.
Allart, J.M. Antoine, A. Audebert, C. Avril, J. Belaisch-Allart,M. Commenges, J.C. Emperaire, R. Frydman,
P. Giacomini, A. Hazout, B. Hedon, C. Hocke, J.N. Hugues, V. Isnard, H. Letur-Konirsch, P. Lopes, J.
Montagut, B. Nicollet, I. Nisand, J. Parinaud, J.L. Pouly, B. Rossin-Amar, R. Roulier, D. Royere, J.C. Sage,
A. Thebault, J.R. Zorn, H. Alexander, I.T. Backert, T. Bauer, H.M. Behre, F.D. Berg, G. Bispink,K.
Brandenburg, C. Bruckner, K. Diedrich, S. Dieterle, W. Distler, K.U. Ebner, R. Fischer, C. Haberle, M.
Hamori, B. Hinney, F.A. Hmeidan, P. Kaltwasser, T. Katzorske, C. Keck, H. Kentenich, J. Kleinstein, J.S.
Krussel, M. Lehnert, W. Maletz-Kehry, D.B. Mayer-Eichberger, L. Mettler, J. Neulen, U. Noss, S. Palm, I.
Putz, T. Rabe, H.K. Rjosk, P. Rosenbaum, H.W. Schlosser, E.H. Schmidt, B. Seifert, E.R. Siebzehnrubl, T.
Steck, K. Sterzik, T. Strowitzki, R. Sudik, P. Sydow, M. Thaele, H.R. Tinneberg, H.H. van der Ven, H.C.
Verhoeven, A. von Sutterheim, H. Weigel, W. Wurfel, K.D. Giatras, N.I. Kanakas, M.I. Mastrominas, I.
Prapas, B.C. Tarlatzis, M. Tsirigotis, E.N. Hung Yu, and others
Reproductive Biomedicine Online, 6 (4): 432-8, 2003
129.Clinical management of low ovarian response to stimulation for IVF: a systematic review
B.C. Tarlatzis, L. Zepiridis, G. Grimbizis and J. Bontis
30
Basil C. Tarlatzis, M.D., Ph.D.
Human Reproduction Update, 9 (1): 61-76, 2003
130.Gonadotropin-releasing hormone antagonists: impact on IVF practice and potential non-assisted
reproductive technology applications. Review.
B.C. Tarlatzis, and H. Bili
Current Opinion in Obstetrics and Gynecology, 15 (3): 259-264, 2003
131.Taskforce 6: Ethical issues related to multiple pregnancies in medically assisted procreation
The ESHRE Task Force on Ethics and Law (F. Shenfield, G. Pennings, J. Cohen, P. Devroey, C. Sureau
and B.C. Tarlatzis)
Human Reproduction, 18 (9): 1976-79, 2003
132.Perimenopausal conception
B.C. Tarlatzis and L. Zepiridis
Annals of the New York Academy of Sciences, 997: 93-104, 2003
133.Safety of GnRH agonists and antagonists. Review.
B.C. Tarlatzis and H. Bili
Expert Opinion on Drug Safety, 3 (1): 39-46, 2004
134.Idiopathic non-obstructive azoospermia or severe oligozoospermia: a cross-sectional study in 61 Greek
men
C. Giannouli, D.G.Goulis, A. Lambropoulos, W. Lissens, B.C. Tarlatzis, J.N. Bontis, J. Papadimas
International Journal of Andrology, 27 (2): 101-7, 2004
135.Taskforce 7: Ethical considerations for the cryopreservation of gametes and reproductive tissues for self
use
The ESHRE Task Force on Ethics and Law (F. Shenfield, G. Pennings, J. Cohen, P. Devroey, C. Sureau
and B.C. Tarlatzis)
Human Reproduction, 19 (2): 460-62, 2004
136.Taskforce 8: Ethics of medically assisted fertility treatment for HIV positive men and women
The ESHRE Ethics and Law Task Force (F. Shenfield, G. Pennings, J. Cohen, P. Devroey, B.C. Tarlatzis
and C. Sureau)
Human Reproduction, 19 (11): 2454-56, 2004
137.Case report: Laparoscopic treatment of a ruptured interstitial pregnancy.
G.F. Grimbizis, T. Tsalikis, T. Mikos, L. Zepiridis, A. Athanasiadis, B.C. Tarlatzis, J.N. Bontis
Reproductive Biomedicine Online, 9 (4): 447-51, 2004
138.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary
syndrome (PCOS)
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (J. Chang, R. Azziz, R.
Legro, D. Dewailly, S. Franks, B.C. Tarlatzis, B.C.J.M. Fauser, A. Balen, P. Bouchard, E. Dahlgren, L.
Devoto, Diamanti, A. Dunaif, M. Filicori, R. Homburg, L. Ibanzez, B.A. Laven, D.A. Magoffin, J.E. Nestler,
R.J. Norman, R. Pasquali, M. Pugeat, J.F. Strauss, S.L. Tan, H.S. Taylor, M.D. Wild, R.A. Wild)
a) Human Reproduction, 19 (1): 41-7, 2004
b) Fertility and Sterility, 81 (1): 19-25, 2004
139.Successful end-to-end cervico-cervical anastomosis in a patient with conge-nital cervical fragmentation:
case report
G. Grimbizis, T. Tsalikis, T. Mikos, N. Papadopoulos, B.C. Tarlatzis, J. N. Bontis
Human Reproduction, 19 (5): 1204-10, 2004
31
Basil C. Tarlatzis, M.D., Ph.D.
140.The influence of assisted reproduction on family functioning and children’s socio-emotional development:
results from a European study
J. Barnes, A.G. Sutcliffe, I. Kristoffersen, A. Loft, U. Wennerholm, B.C. Tarlatzis, X. Kantaris, J.
Nekkebroeck, B.S. Hagberg, S.V. Madsen and M. Bonduelle
Human Reproduction, 19 (6): 1480-87, 2004
141.Ovarian hyperstimulation syndrome: Are preventative measures effective?
B.C. Tarlatzis, L. Zepiridis, G. Grimbizis, K.H.I. Abd-El-Maeboud, M.A. Kamel
Middle East Fertility Society Journal, 9 (2): 107-17, 2004
142.Evaluation of GnRH antagonists in ovarian stimulation protocols for IVF cycles compared to GnRH
agonists.
F. Pournarolopoulos, B.C. Tarlatzis, G. Grimbizis, M. Zafrakas, H. Bili, L. Zepiridis, G. Pados, J.
Papadimas, J. Bontis
Review of Clinical Pharmacology & Pharmacokinetics, International Edition, 18 (1): 70-2, 2004
143.Assisted reproductive technology in Europe, 2000. Results genetrated from European register by ESHRE.
K.G. Nygren, N. Andersen, L. Gianaroli, P. De Sutter, P. Ventruba, K. Erb, M. Gissler, J. De Mouzon, R.
Felberbaum, B.C. Tarlatzis, J. Urbancsek, H. Bjorgvinsson, R.F. Harrison, A.P. Ferraretti, J.A.M. Kremer,
J.T. Hazehamp, W. Kuczynsk,C. Clahaz-Jorge, V.S. Korsak, I.V. Klun, J. Hernandez, P.O. Karlstrom, C.
Limoni, A. McNam, V. Veselovsky
Human Reproduction, 19 (3): 490-503, 2004
144.Diagnosis and management of the infertile couple: Missing information.
D.T. Baird, J. Cohen, J. Collins, K. Diedrich, J.L.H. Evers, S. Irvine, E. Nieschlag, B.C. Tarlatzis, A.
Templeton, A. Van Steirteghem, H. Andersen, P.G. Crosignani, E. Diczfalusy, B.C.J.M. Fauser, L. Fraser,
A. Glasier, E. Weis
Human Reproduction Update, 10 (4): 295-307, 2004
145.A multi-centre cohort study of the physical health of five-year-old children conceived after intracytoplasmic
sperm injection, in vitro fertilization and natural conception.
M. Bonduelle, U.-B. Wennerholm, A. Loft, B.C. Tarlatzis, C. Peters, S. Henriet, C. Mau, A. VictorinDederquist, A. Van Steirteghem, A. Balaska, J.R. Emberson, A.G. Sutcliffe
Human Reproduction, 20 (2): 413-9, 2005
146.Assisted reproductive technology in Europe, 2001. Results genetrated from European registers by
ESHRE.
A. N. Andersen, L. Gianaroli, R. Felberbaum, J. de Mouzon, K.G. Nygren, B. Van den Eede, P. de Sutter,
S. Kyurkchiev, K. Erb, M. Gissler, J. de Mouzon, R, Felberbaum, B.C. Tarlatzis, J. Urbancsek, H.
Bjorgvinsson, R. Harrison, A.P. Ferraretti, J.A.M. Kremer, J.T. Hazehamp, W. Kuczynski, C. Calhaz-Jorge,
V.S. Korsak, I.V. Klun, J. Hernandez, P.O. Karlstroem, C. Limoni, R. Baranowski, V. Veselovsky, K.M.
Grunwald, J. Neulen, R. Rau, Warnecke, K.F. Hiller, T.H. Bauer, H. Kraus, S. Todorow, E. Schwarz, D.
Struller, B. Pfuller, A. Jankte, H. Schmiady, M. Bloechle, S. Marr, M.Z.A. Dakah, H. Kentenich, G. Stief, A.
Tandler-Schneider, A. Haase, D.H.G. Temme, R. Metzger, D.J. Peet, P. Sydow, C. Sydow, R. Hannen, B.
Pfuller, I. Scheiber, K. Volklein, B. Harms, H.H. van der Ven, G. Prietl, E.H. Schmidt, O. Drost, A. von
Stutterheim, C. Clasing, H.H. Riedel, G. Leyendecker, A. Dieterle, A. Neuer, H. J. Held, W. Distler, G.
Keck, H. Verhoeven, M. Scholtes, M. Behler, M. Schulte, G. Freundl, C. Gnoth, H.G. Bender, J. van Uem,
K.G. Bregulla, M. Hamori, R. Behrens, L. Wildt, T. Katzorke, D. Propping, S. Wohlers, J.E. Costea, E.
Merz, M. Amroni, S. Schuh, C. Keck, Weitzell, M. Thiemann, F. Geisthovel, U. Czeromin, I. Walter-Gobel,
W. Kunzel, W. Weidner, Gips, M. Tobler, and others
Human Reproduction, 20 (5): 1158-76, 2005
147.Multifetal pregnancy reduction in pregnancies with a monochorionic component
A.P. Αthanasiadis, M. Zafrakas, B.C. Tarlatzis, V. Vaitsi, T. Mikos and J. Bontis
Fertility and Sterility, 83 (2): 474-6, 2005
148.Identifying the public’s knowledge and intention to use human cloning in greek urban areas
G. Tzamalouka, P. Soultatou, M. Papadakaki, S. Chatzifotiou, B.C. Tarlatzis, J. Chliaoutakis
Journal of Assisted Reproduction and Genetics, 22 (2): 47-56, 2005
149.International collaborative study of intracytoplasmic sperm injection-conceived, in vitro-fertilization-
32
Basil C. Tarlatzis, M.D., Ph.D.
conceived, and naturally conceived 5-year-old child outcomes: congnitive and motor assessment
I. Ponjaert-Kristoffersen, M. Bonduelle, J. Barnes, J. Nekkebroeck, A. Loft, U-B. Wennerholm, B.C.
Tarlatzis, C. Peters, B.S. Hagberg, A. Berner, and A.G. Sutcliffe
Pediatrics, 115 (3): 283-9, 2005
150.Taskforce 9: the application of preimplantation genetic diagnosis for human leukocyte antigen typing of
embryos
The ESHRE Task Force on Ethics and Law (F. Shenfield, G. Pennings, J. Cohen, P. Devroey, and B.C.
Tarlatzis)
Human Reproduction, 20 (4): 845-7, 2005
151.Efforts to create an artificial testis: culture systems of male germ cells underbiochemical conditions
resembling the seminiferous tubular biochemical environment
N. Sofikitis, E. Pappas, A. Kawatani, D. Baltogiannis, D. Loutradis, N. Kanakas, D. Giannakis, F.
Dimitriadis, K. Tsoukanelis, I. Georgiou, G. Makrydimas, Y. Mio, B.C. Tarlatzis, M. Melekos, I. Miyagawa.
Human Reproduction Update, 11 (3): 229-59, 2005
152.Fertility and ageing
The ESHRE Capri Workshop Group (D.T. Baird, J. Collins, J. Egozcue, L.H. Evers, L. Gianaroli, H.
Leridon, A. Sunde, A. Templeton, A. Van Steirteghem, J. Cohen, P.G. Crosignani, P. Devroey, K. Diedrich,
B.C. Fauser, L. Fraser, A. Glasier, I. Liebaers, G. Mautone, G. Penney, B.C. Tarlatzis)
Human Reproduction Update, 11 (3): 261-76, 2005
153.GnRH antagonists in IVF
E.M. Kolibianakis, B.C. Tarlatzis, P. Devroey
Reproductive Biomedicine Online 11 (2): 271, 2005
154.Fetal reduction in a nontuplet pregnancy: technical and ethical consideration
A. Athanasiadis, A. Karavida, S. Tzitzimikas, D. Vavilis, G. Grimbizis, B.C. Tarlatzis, J. Bontis
European Journal of Οbstetrics Gynecology and Reproductive Biology, 120 (2): 227-9, 2005
155.Predicting human cloning acceptability: a national Greek survey on the beliefs of the public
G.S. Tzamalouka, M. Papadakaki, P. Soutatou, S. Chatzifotiou, B.C. Tarlatzis, J. El Chliaoutakis
Journal of Assisted Reproduction and Genetics, 22 (9-10): 315-22, 2005
156.ESHRE Tasforce on Ethics and Law 10: surrogacy
The ESHRE Task Force on Ethics and Law (F. Shenfield, G. Pennings, J. Cohen, P. Devroey, G. de Wert,
and B.C. Tarlatzis)
Human Reproduction, 20 (10): 2705-7, 2005
157.Laterality in five-year-olds conceived by intracytoplasmic sperm injection, standard in vitro fertilization and
natural conception: a European study
A.G. Sutcliffe, J. Barnes, U.B. Wennerholm, A. Loft, B.C. Tarlatzis, I. Ponjaert-Kristoferson, M. Bonduelle
British Journal of Obstetrics and Gynaecology, 112 (10): 1397-401, 2005
158.Role of GnRH agonists prior to endoscopic surgical treatment of fibroids
T.D. Theodoridis, B.C. Tarlatzis, J.N. Bontis
European Clinics of Obstetrics and Gynaecology, 1: 12-18, 2005
159.Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the
probability of ongoing pregnancy? A systematic review
E.M. Kolibianakis, J. Collins, B.C. Tarlatzis, E. Papanikolaou, P. Devroey
Human Reproduction Update, 12 (1): 3-12, 2006
160.Reply: Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated
with the probability of ongoing pregnancy? A systematic review [2]
E.M. Kolibianakis, J. Collins, B.C. Tarlatzis, E. Papanikolaou, P. Devroey
Human Reproduction Update, 12 (3): 326-7, 2006
161.The use of recombinant huma LH (lutropin alfa) in the late stimulation phase of assisted reproduction
cycles: a double-blind, randomized, prospective study
33
Basil C. Tarlatzis, M.D., Ph.D.
B.C. Tarlatzis, E. Tavmergen, M. Szamatowicz, A. Barash, A. Amit, E. Levitas, Z. Shoham
Human Reproduction, 21 (1): 90-4, 2006
162.The effects of sperm quality on embry development after intracytoplasmic sperm injection
K.E. Loutradi, B.C. Tarlatzis, D.G. Goulis, L. Zepiridis, T. Pagou, E. Chatziioannou, G.F. Grimbizis, I.
Papadimas, I. Bontis
Journal of Assisted Reproduction and Genetics, 23 (2): 69-74, 2006
163.Characterization of a de novo balanced 1; Y translocation in a phenotypically normal twin male infant
H. Hatzissevastou-Loukidou, T.G. Kalemi, A.F. Lambropoulos, M. Nikita, E. Sotiridou, B.C. Tarlatzis, A.
Kotsis
Fertility and Sterility, 85 (4): 1059.e5-7, 2006
164.Paternal sperm concentration and growth and cognitive development in children born with a gestational
age more than 32 weeks after assisted reproductive therapy
U.B. Wennderholm, M. Bonduelle, A. Sutcliffe, C. Bergh, A. Niklasson, B.C. Tarlatzis, C.M. Kai, C. Peters,
A. Victorin Cederqvist, A. Loft
Human Reproduction, 21 (6): 1514-20, 2006
165.GnRH antagonists in ovarian stimulation for IVF
B.C. Tarlatzis, B.C. Fauser, E.M. Kolibianakis, K. Diedrich, P. Devroey, M. Aboulghar, J. Collins, P.G.
Crosignani, G. Griesinger, S. Kol, V.N. Lan, W. Ledger, N. Macklon, R. Millar, F. Oliveness, L.J.F.
Rombauts, D. Shapiro, C. Simon, A. Tavaniotou, H. Tournaye
Human Reproduction Update, 12 (4): 333-40, 2006
166.Emotionally expressive coping reduces pregnancy rates in patients undergoing in vitro fertilization
E. Panagopoulou, K. Vedhara, C. Gaintarzti, B.C. Tarlatzis
Fertility and Sterility, 86 (3): 672-7, 2006
167.Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth
dependent on the type of analogue used? A systematic review and meta-analysis
E.M. Kolibianakis, J. Collins, B.C. Tarlatzis, P. Devroey, K. Diedrich, G. Griesinger
Human Reproduction Update, 12 (6): 651-71, 2006
168.ESHRE Tasforce on Ethics and Law 11: Posthumous assisted reproduction
The ESHRE Task Force on Ethics and Law (G. Pennings, G. de Wert, F. Shenfield, J. Cohen, P. Devroey,
and B.C. Tarlatzis)
Human Reproduction, 21 (12): 3050-3, 2006
169.Is it of value to treat endometriosis prior to IVF?
E.M. Kolibianakis, B.C. Tarlatzis, J. Awwad, C.W. Lipari, S.J. Muasher
Middle East Fertility Society Journal, 11 (1): 24-34, 2006
170.Nutrition and reproduction in women
D.T. Baird, S. Cnattingius, J. Collins, J.L.H. Evers, A. Glasier, B.L. Heitmann, R. Norman, K.K. Ong, A.
Sunde, J. Cohen, B. Cometti, P.G. Crosignani, P. Devroey, E. Diczfalusy,K. Diedrich, L. Fraser, L.
Gianaroli, I. Liebaers, G. Mautone, B.C. Tarlatzis, G. Ragni, A. Van Steirteghem
Human Reproduction Update, 12 (3): 193-207, 2006
171.GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins,
polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis
G. Griesinger, K. Diedrich, B.C. Tarlatzis, E.M. Kolibianakis
Reproductive Biomedicine Online 13 (5): 271, 2006
172.Exposure time to cryoprotectants influences oocyte survival rate
N. Tsagias, B.C. Tarlatzis, E. Paggou, T. Sanopoulou, E. Chatziiioannou, A. Tokmakidou, M. Arsenakis, I.
Bontis
Journal of Biological Research 5: 55-60, 2006
173.GnRH agonists vs antagonists
B.C. Tarlatzis, E.M. Kolibianakis
34
Basil C. Tarlatzis, M.D., Ph.D.
Best Practice & Research Clinical Obstetrics & Gynaecology 21 (1): 57-65, 2007
174.Evaluation of a transfer medium containing high concentration of hyaluronan in human in vitro fertilization
K.E. Loutradi, I. Prassas, E. Bili, T. Sanopoulou, I. Bontis, B.C. Tarlatzis
Fertility and Sterility, 87 (1): 48-52, 2007
175.The effect of oral contraceptives on assisted reproductive technology cycles
E.M. Kolibianakis, C.A. Venetis,, B.C. Tarlatzis
Current Opinion in Obstetrics and Gynecology, 19: 244-247, 2007
176.Laparoscopic excision of uterine adenomyomas
G.F. Grimbizis, T. Mikos, L. Zepiridis, T. Theodoridis, D. Miliaras, B.C. Tarlatzis, I. Bontis
Fertility and Sterility, 89 (4): 953-961, 2008
177.Cryopreservation of human embryos by vitrification or slow freezing: a systematic review and metaanalysis
K.E. Loutradi, E.M. Kolibianakis, C.A. Venetis, E.G. Papanikolaou, G. Pados, I. Bontis, B.C. Tarlatzis
Fertility and Sterility, in press, 2007
178.Multifollicular ovarian stimulation for IVF: more may not be better
B.C. Tarlatzis, E.G. Papanikolaou
Gynecological Endocrinology, 23 (6): 307-308, 2007
179.Intracytoplasmic sperm injection (ICSI) in 2006: Evidence and Evolution
The ESHRE Capri Workshop
Human Reproduction Update, 13 (6): 515-526, 2007
180.ThinPrep are superior to conventional smears in the cytological diagnosis of subfertile men by testicular
fine-needle aspiration
G. Grimbizis, T. Mikos, K. Pantazis, E. Athanassiou, P. Sevastiadou, A. Papanicolaou, P. Polychronou, D.
Goulis, B.C. Tarlatzis, J.N. Bontis
Diagnostic Cytopathology, 36 (1): 1-7, 2007
181.Serum anti-Müllerian hormone levels differentiate control from subfertile men but not men with different
causes of subfertility
D. Goulis, P.K. Iliadou, C. Tsametis, S. Gerou, B.C. Tarlatzis, J.N. Bontis, I. Papadimas
Gynecological Endocrinology, 23 (9): 1-3, 2007
182.Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the
probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis
C.A. Venetis, E.M. Kolibianakis, E. Papanikolaou, J. Bontis, P. Devroey, B.C. Tarlatzis
Human Reproduction Update, 13 (4): 343-355, 2007
183.Serum inhibin B and antimüllerian hormone are not superior to follecile-stimulating hormone as predictors
of the presence of sperm in testicular fine-needle aspiration in men with azoospermia
D.G. Goulis, C. Tsametis, P.K. Iliadou, P. Polychronou, P.D. Kantartzi, B.C. Tarlatzis, J.N. Bontis, I.
Papadimas
Fertility and Sterility, in press, 2008
184.Metabolic syndrome and reproduction: I. Testicular function
D.G. Goulis, B.C. Tarlatzis
Gynecological Endocrinology, 14 (1): 33-39, 2008
185.Genome-wide microarray gene expression, array-CGH analysis, and telomerase activity in advanced
ovarian endometriosis: A high dedgree of differentiation rather than malignant potential
M. Zafrakas, B.C. Tarlatzis, T. Streichert, F. Pournaropoulos, U Wölfe, S.J. Smeets, B. Wittek, G.
Grimbizis, R.H. Brakenhoff, K. Pantel, J. Bontis, C. Günes
International Journal of Molecular Medicine, 21 (3): 335-344, 2008
186.Consensus on infertility treatment related to polycystic ovary syndrome
The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, March 2-3 2007,
35
Basil C. Tarlatzis, M.D., Ph.D.
Thessaloniki, Greece
a). Fertility and Sterility, 89 (3): 505-522, 2008
b). Human Reprodcution, 23 (3): 462-477, 2008
187.How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization:
systematic review and meta-analysis
D. Kyrou, E.M. Kolibianakis, C.A. Venetis, E.G. Papanikolaou, J. Bontis, B.C. Tarlatzis
Fertility and Sterility, in press, 2008
a
188.Reply: Comment on: Is progesterone elevation on the day of human chorionic gonadotrophin
administration associated with the probability of pregnancy in in vitro ferlization? A systematic review and
meta-analysis.
C.A. Venetis, E.M. Kolibianakis, B.C. Tarlatzis
Human Reproduction Update, 14 (2): 195-196, 2008
189.Serum anti-Müllerian hormone levels differentiate control from subfertile men but no men with different
causes of subfertility
D. Goulis, P.K. Iliadou, C. Tsametis, S. Gerou, B.C. Tarlatzis, I.N. Bontis, I. Papadimas
Gynecological Endocrinology, 24 (3): 158-160, 2008
190.Serum inhibin-B and FSH as predictors of the presence of sperm in testicular Fine Needle Aspirate in men
with azoospermia
D. Goulis, P. Polchronou, T. Mikos, G. Grimbizis, S. Gerou, V. Pavlidou, A. Papanikolaou, B.C. Tarlatzis,
I.N. Bontis, I. Papadimas
Hormones, 7 (2): 140-147, 2008
191.Does hyaluronan improve embryo implantation?
K.E. Loutradi, T.B. Tarlatzi, E.M. Kolibianakis, B.C. Tarlatzis
Current Opinion in Obstetrics and Gynecology, 20: 305-307, 2008
192.Predictors of ovarian response: progress towards individualized treatment in ovulation induction and
ovarian stimulation
B.C.J.M. Fauser, K. Diedrich, P. Devroey on behalf of the Evian Annual Reproduction (EVAR) Workshop
Group 2007
Human Reproduction Update, 14 (1): 1-14, 2008
193.Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic
review and meta-analysis.
G. Griesinger, C. A. Venetis, T. Marx, K Diedrich, B.C. Tarlatzis, M. Kolibianakis
Fertility and Sterility, 90 (4): 1055-1063, 2008
194.The effect of leptin on the tonic secretion of gonadotropins in the female rats.
C. Arnaoutoglou, A. Keivanidou, M. Arnaoutoglou, E. Kastrouni, V. Samaras, A. Kaiki- Astara, G. A.
Kazdaglis, E. Spandou, B.C. Tarlatzis, O. Guiba- Tziampiri
Neuroendocrinology Letters, 29 (6): 999-1006, 2008
195.Genetic aspects of female reproduction.
The ESHRE Capri Workshop
Human Reproduction Update, 14 (4): 293-307, 2008
196.How to improve the probability of pregnacy in poor responders undergoing in vitro fertillization: a systematic
review and meta-analysis.
D. Kyroy, E. M. Kolibianakis, C. A. Venetis, E. G. Papanikolaou, J. Bontis, B.C. Tarlatzis,
Fertility and Sterility, 91 (3): 749-766, 2009
197.Serum inhibin B and anti-Müllerian hormone are not superior to follicle-stimulating hormone as predictors of
the presence of sperm in testicular fine-needle aspiration in men with azoospermia.
D. G Goulis, C. Tsametis, P. K Iliadou, P. Polychronou, P Kantartzi, B.C. Tarlatzis, J. Bontis, I.Papadimas
Fertility and Sterility, 91 (4): 1279-1284, 2009
36
Basil C. Tarlatzis, M.D., Ph.D.
198.Intrauterine insemination
The ESHRE Capri Workshop Group,
Human Reproduction Update, 15 (3): 265-277, 2009
199.Adiponectin levels in women with polycystic ovary syndrome: a systematic review and meta-analysis.
K. A Toulis, D. G Goulis, D. Farmakiotis, N. A Georgopoulos, I. Katsikis, B.C. Tarlatzis, I. Papadimas, D.
Panidis
Human Reproduction Update, 15 (3): 297-307, 2009
200. Role of the endocrine profile for the achievement of pregnacy with IVF.
E.M Kolibianakis, C.A Venetis, B.C. Tarlatzis
Reproductive BioMedicine Online, 18 (2): 37-43, 2009
201. Benefits of luteinizing hormone activity in ovarian stimulation for IVF.
C.A Venetis, E.M Kolibianakis, T. B Tarlatzi, B.C. Tarlatzis
Reproductive BioMedicine Online, 18 (2): 31-36, 2009
37
Basil C. Tarlatzis, M.D., Ph.D.
B. BOOKS
1. Luteolytic hormones are calcium-mediated, guanine nucleotide antagonists of gonadotropin-sensitive
adenylate cyclase
H.R. Behrman, J.L. Luborsky, R.F. Aten, M.L. Pοlan, B.C. Tarlatzis, F.P. Haseltine, S.L. Preston, L.K.
Soodak, G.F. Mattson, A.S.Y. Chi
Advances in Prostaglandin, Thromboxane and Leukotriene Research, Vol. 15. Eds. 0. Hayaishi and S.
Yamamoto, Raven Press, New York, pp. 601-604, 1985
2. Radical Surgical Management of Ectopic Pregnancy
G. Oelsner, B.C. Tarlatzis
Ectopic Pregnancy, Ed. A.H. DeChereny, Aspen Publishers Inc., pp. 125-132, 1986
3. Anatomy and Physiology of the Fallopian Tube
B.C. Tarlatzis
Reproductive Surgery, Eds: A.H. DeCherney and M.L. Polan, Year Book Medical Publishers, pp. 3-18,
1987
4. Semen Preparation for IVF
B.C. Tarlatzis, A.H. DeCherney
Foundations of In Vitro Fertilization, Eds: C.M. Fredericks, J. Paulson, A.H. DeCherney, Hemisphere Publ.
Corp., pp. 60-69, 1987
5. In vitro culture of isolated human ovarian follicles
B.C. Tarlatzis, J.M. Jimenez, A. Lightman, A. DelValle, Α.Η. DeCherney, F. Naftolin
The Control of Follicle Development, Ovulation and Luteal Function: Lessons from In Vitro Fertilization,
Eds. F. Naftolin, A.H. DeCherney, Raven Press, New York, Vol. 35: 45-55, 1987
6. The renin-angiotensin system in the human ovary
B.C. Tarlatzis, A. Lightman, P.J. Rzasa, M.D. Culler, L.A. Fernandez, V.J. Caride, A.F. Negro-Vilar, Α.Η.
DeCherney, F. Naftolin
The Control of Follicle Development, Ovulation and Luteal Function: Lessons from In Vitro Fertilization,
Eds. F. Naftolin, Α.Η. DeCherney. Raven Press, New York, Vol. 35: 57-63, 1987
7. Prospective evaluation of the short and long GnRH-Analogue protocols in ovarian stimulation for IVF/ET
B.C. Tarlatzis, G. Grimbizis, F. Pournaropoulos
Perspectives on Assisted Reproduction, Serono Symposia Series «Frontiers in Endocrinology», vol. 4, Eds.
T. Mori, T. Aono, T. Tominaga, H. Hiroi. Ares-Serono Symposia, Christengraf s.r.L, Rome, Italy, p. 415421, 1994
8. Intraovarian markers of follicle and oocyte development
B.C. Tarlatzis, H. Bili
Recent Developments in Gynecology and Obstetrics, Eds. A.R. Ganazzani, F. Petraglia, G. D’Ambrogio,
A.D. Genazzani, P.G. Artini. The Parthenon Publishing Group, Lancs, United Kingdom, p. 39-42, 1995
9. Prevention of the ovarian hyperstimulation syndrome
B.C. Tarlatzis, G. Grimbizis
Fertility and Sterility: A Current Overview, Eds. B. Hedon, J. Bringer, P. Mares. The Parthenon Publishing
Group, Lancs, United Kingdom, p. 205-209, 1995
10. Hysteroscopic metroplasty of septate uterus: a report of 31 cases
G. Pados, J. Bontis, B.C. Tarlatzis
38
Basil C. Tarlatzis, M.D., Ph.D.
The Uterus Throughout the Woman’s Life, Eds. J. Donnez, I. Brosens. Monduzzi Editore, Bologna, p. 269272,1995
11. Risks and management of ovarian hyperstimulation syndrome
B.C. Tarlatzis, G. Grimbizis
Medically Assisted Procreation, Eds. N. D’Antona, P. Inaudi. CIC Edizioni Internazionali, Roma, p. 209-214,
1996
12. Recombinant follicle stimulating hormone and in vitro fertilization
B.C. Tarlatzis, H. Bili
New Horizons in Reproductive Medicine, Eds. C. Coutifaris and L. Mastroianni. The Parthenon Publishing
Group, New York, p. 295-299, 1996
13. IFFS International consensus on assisted procreation
The IFFS Expert Group on Assisted Reproduction Techniques (P. Barri, J. Cohen, L. Hamberger, A.
Handyside, J. Mandelbaum, D. Royere, J. Shenker, R. Schoysman, A. Speirs, A. Van Steirteghem, G.H.
Zeilmaker, I. Belaisch-Allart, B. Bodnar, K. Diedrich, H. Jones, J. Nisker, R. Palermo, M. Plachot, Soon
Chye Ng, M. Stamatowicz, B.C. Tarlatzis, J. Wiczyk, M. Wikland)
a) GnRH Analogues. The State of the Art 1996, Eds. B. Lunenfeld, V. Insler. Parthenon Publishing, Lancs,
Appendix, p. 149-178, 1996
b) IFFS Newsletter, p. 6-17, Spring 1996
14. Treatment of ovarian hyperstimulation syndrome: management of the patient
B.C. Tarlatzis, G. Grimbizis
Ovarian Hyperstimulation Syndrome, Eds. A.P. Ferrarretti, L. Gianaroli, B.C. Tarlatzis. Serono Fertility
Series, 1:71-82, 1997
15. Steroid and cytokine production by human cumulus cells
B.C. Tarlatzis, H. Bili
Microscopy of Reproduction and Development. A Dynamic Approach, Ed. P.M. Motta. Antonio Delfino
Editore, Rome, p. 151-153, 1997
16. Examination of the Woman: Evaluation of Ovulation, Tubes and Other Functions
B.C. Tarlatzis
Inferitlity and Contraception: A Textbook for Clinical Practice, Eds. O. Rodriguez-Armas, B. Hedon and S.
Daya. The Parthenon Publishing Group, Lancs, UK, p. 17-21, 1998
17. Clinical outcome of ICSI: Results of the ESHRE Task Force
B.C. Tarlatzis, H. Bili
Treatment of Infertility: The New Frontiers, Eds. M. Filicori and C. Flamigni. Communications Media for
Education, New Jersey, p. 301-308, 1998
18. Impact of the use of recombinant follicle stimulating hormone
B.C. Tarlatzis, H. Bili
Fertility and Reproductive Medicine, Eds. R.D. Kempers, J. Cohen, A.F. Haney, J.B. Younger. Elsevier
Science, Amsterdam, p. 103-112, 1998
19. Tumors of the Female Reproductive System
Th. Agorastos, B.C. Tarlatzis
Encyclopedia of Reproduction, Eds. E. Knobil and J.D. Neill. Academic Press, San Diego, vol. 4, p. 860871, 1998
20. Risks of ovarian stimulation
39
Basil C. Tarlatzis, M.D., Ph.D.
B.C. Tarlatzis, G. Grimbizis
Gonadotrophins and Fertility in the Woman, Eds. E.Y. Adashi, D.T. Baird, P.G. Crosignani. Serono Fertility
Series, Rome, vol. 3, p. 159-169, 1999
21. Antagonistic analogs of GnRH: Preferable stimulating protocol
B.C. Tarlatzis, H. Bili
Textbook of Assisted Reproductive Techniques: Laboratory and Clinical Perspectives, Eds. D.K. Gardner,
A. Weissman, C.M. Howles and Z. Shoham. Martin Dunitz Publishers, London, p. 493-500, 2001
22. Ovulation induction in polycystic ovary syndrome patients
B.C. Tarlatzis, H. Bili
Advances in Gynecological Endocrinology, Eds. A.R. Genazzani, F. Petraglia. Parthenon Publishing,
Lancs, UK, p. 79-81, 2002
23. Introduction
B.C. Tarlatzis
Ovulation Induction, Ed. B.C. Tarlatzis. Elsevier, Amsterdam, p. 13-14, 2002
24. GnRH agonists
B.C. Tarlatzis, G. Grimbizis
Ovulation Induction, Ed. B.C. Tarlatzis. Elsevier, Amsterdam, p. 155-170, 2002
25. Introduction: The European dream
B.C. Tarlatzis
The European Society of Human Reproduction and Embryology Monographs, Vol. 4, p. ix-xii, 2005
26. Management of poor response: Facts or myths?
B.C. Tarlatzis, D. Kirou, C.A. Venetis
Advances in Fertility Studies and Reproductive Medicine, IFFS 2007, Eds. T.F. Kruger, Z. Van der Spuy,
R.D. Kempers. Juta & Co Publishing, Cape Town, p. 311-318, 2007
27. Polycystic ovary syndrome
B.C.J.M. Fauser, F.J. Broekmans, J.S.E. Laven, N.S. Macklon, B.C. Tarlatzis
Insulin Resistance and Polycystic Ovarian Syndrome, Eds. E. Diamanti-Kandarakis, J.E. Nestler, D.
Panidis, R. Pasquali. Humana Press, New Jersey, p. 3-12, 2007
C. PROCEEDINGS
1. Evaluation of chemoprophylaxis in abdominal hysterectomy
I.G. Kotoulas, B.C. Tarlatzis, A.C. Papaloucas, A.G. Paradelis
Proceedings of the 1st Mediterranean Congress of Chemotherapy, p. 1195-1198, 1978
2. Inhibition of frog’s spermatozoa motility by derivatives of hydrazine in vivo
A.G. Paradelis, B.C. Tarlatzis, G. Salpigidis, A. Papaloucas, G. Logaras
Fertility and Sterility. Proceedings of the Vo European Congress on Sterility and Fertility, Eds. B. Salvadori,
K. Semm, E. Vadora, p. 429-431, 1978.
3. Study on hypothalamic - pituitary - testicular function in chronic renal failure
A. Spiliopoulos, A. Tourkantonis, A. Pharmakiotis, I.G. Kotoulas, B.C. Tarlatzis, A. Papaloucas
Fertility and Sterility. Proceedings of the Vo European Congress on Sterility and Fertility, Eds. B. Salvadori,
K. Semm, E. Vadora, p. 468-470, 1978
40
Basil C. Tarlatzis, M.D., Ph.D.
4. Haemodialysis and hypothalamo - pituitary - testicular axis
A. Tourkantonis, A. Spiliopoulos, A. Pharmakiotis, I.G. Kotoulas, B.C. Tarlatzis, A. Papaloucas
Fertility and Sterility. Proceedings of the Vo European Congress on Sterility and Fertility, Eds. B. Salvadori,
K. Semm, E. Vadora, p. 492-494, 1978
5. Our experience with the application of IVF/ET and GIFT in the treatment of infertility
B.C. Tarlatzis, J. Bontis, S. Lagos, G. Pados, J. Papadimas, G. Papageorgiou, E. Spanos, S. Mantalenakis
Proceedings International Workshop on In Vitro Fertilization Embryo Transfer and G.I.F.T., Eds. D.
Aravantinos, G. Creatsas, D. Loutradis, Rhodos, Greece, p. 131, 1988
6. Ovarian stimulation for IVF/ET and GIFT: Problems and prospects
B.C. Tarlatzis
Proceedings International Workshop on In Vitro Fertilization Embryo Transfer and G.I.F.T., Eds D.
Aravantinos, G. Creatsas, D. Loutradis, Rodos, Greece, p. 5-7, 1988
7. Gonadotropin releasing hormone agonists and antagonists in assisted reproduction techniques
B.C. Tarlatzis, G. Grimbizis
New Frontiers in Reproductive Medicine, The American Fertility Society, p. 57-69, 1994
8. The association between ovarian stimulation and ovarian cancer: fears, fantasies and facts
B.C. Tarlatzis, G. Grimbizis
New Frontiers in Reproductive Medicine, The American Fertility Society, p. 125-135, 1994
9. Ovarian stimulation with recombinant follicle stimulating hormone for assisted procreation
B.C. Tarlatzis, H. Bili
New Frontiers in Reproductive Medicine, The American Fertility Society, p. 149-160, 1994
10. New gonadotropin preparations in ovarian stimulation for ART
B.C. Tarlatzis, H. Bili
Recent Advances in the Diagnosis and Treatment of Infertility, The American Society for Reproductive
Medicine, p. 39-55, 1995
11. Complications of ovarian stimulation: I. Ovarian hyperstimulation syndrome
B.C. Tarlatzis, G. Grimbizis
Recent Advances in the Diagnosis and Treatment of Infertility, The American Society for Reproductive
Medicine, p. 131-151, 1995
12. Complications of ovarian stimulation: II. Multiple pregnancies
B.C. Tarlatzis, G. Grimbizis
Recent Advances in the Diagnosis and Treatment of Infertility, The American Society for Reproductive
Medicine, p. 169-184, 1995
13. The sperm odyssey in the female genital tract
B.C. Tarlatzis
Syllabus, 3rd ESHRE Campus Symposium, «Recent Advances in Assisted Reproductive Technologies», p.
7-8, 1995
14. Follicular phase and pregnancy loss
B.C. Tarlatzis, G. Grimbizis
Syllabus on «Early Pregnancy», 1996
15. Treatment of tubal infertility: Current concepts
B.C. Tarlatzis, G. Grimbizis
41
Basil C. Tarlatzis, M.D., Ph.D.
Reproductive Medicine Toward 2000, The American Society for Reproductive Medicine, p. 39-55, 1996
16. Novel aspects of ovarian stimulation for assisted reproduction techniques
B.C. Tarlatzis, H. Bili
Reproductive Medicine Toward 2000, The American Society for Reproductive Medicine, p. 133-157, 1996
17. Ovarian cancer and ovulatory agents: an update
B.C. Tarlatzis, G. Grimbizis
Reproductive Medicine Toward 2000, The American Society for Reproductive Medicine, p. 211-229, 1996
18. Ectopic pregnancy and in vitro fertilization
B.C. Tarlatzis, G. Grimbizis
Proceedings of the ESHRE Campus Workshop on Operative Video-Laser Laparoscopy and Hysteroscopy,
p. 43-45, 1996
19. Luteal function following hyperstimulation for in vitro fertilization
B.C. Tarlatzis
Syllabus of the 1st Annual ESHRE Winter Training Course in Reproductive Endocrinology, 1997
20. The polycystic ovary syndrome: diagnosis
B.C. Tarlatzis
Syllabus of the ESHRE Campus ‘97: Revisiting Infertility, 1997
21. Review of 1995 ICSI data using ejaculated, epididymal and testicular spermatozoa from the ESHRE ICSI
Task Force
B.C. Tarlatzis, H. Bili
Update on Reproductive Medicine, The American Society for Reproductive Medicine, p. 83-97, 1997
22. Diagnostic approach of polycystic ovary syndrome
B.C. Tarlatzis, H. Bili
Update on Reproductive Medicine, The American Society for Reproductive Medicine, p. 105-119, 1997
23. Pregnancy outcome after assisted reproduction techniques
B.C. Tarlatzis
Proceedings of the 4th ETEP Conference, Göteborg, Sweden, June 1998
24. Luteal function and support
B.C. Tarlatzis, H. Bili
Syllabus on “Endocrinology”. Postgraduate Precongress Course “Endocrinology” in the Annual Meeting of
ESHRE, p. 34-41, Göteborg, Sweden, 1998
25. Complications of ovarian stimulation
B.C. Tarlatzis, G. Grimbizis
Reproductive Medicine: Between Hope and Hype. The American Society for Reproductive Medicine, p.
179-198, 1998
26. Analysis of ICSI results (1993-1995) collected by the ESHRE ICSI Task Force
B.C. Tarlatzis
Reproductive Medicine: Between Hope and Hype, The American Society for Reproductive Medicine, p.
219-237, 1998
27. Assisted Reproduction Techniques: The Greek Approach
42
Basil C. Tarlatzis, M.D., Ph.D.
B.C. Tarlatzis
Proceedings of the 2nd TRAC Workshop Assisted Conception: Research & Regulation, Athens, Greece,
April 1999
28. Overview of intracytoplasmic sperm injection (ICSI) applications
B.C. Tarlatzis, H. Bili
Assisted Reproductive Techniques in the 21st Century, The American Society for Reproductive Medicine,
p. 35-48, 1999
29. Pregnancy and children outcome after assisted reproduction techniques
B.C. Tarlatzis, G. Grimbizis
“Assisted Reproductive Techniques in the 21st Century”, The American Society for Reproductive
Medicine, p. 133-151, 1999
30. Old and new friends in ovulation induction (rFSH, rLH, HMG, GnRH analogs, Anti-E2)
B.C. Tarlatzis, H. Bili
Syllabus on Reproductive Endocrinology, 5th ESHRE Course, p. 109-114, Athens, 2001
31. Protocols of gonadotropins-GnRH analogs in COH
B.C. Tarlatzis, H. Bili
Syllabus on Reproductive Endocrinology, 5th ESHRE Course, p. 125-126, Athens, 2001
32. Risks of ovarian stimulation
B.C. Tarlatzis, G. Grimbizis
Proceedings en test van het Congres: Infertiliteit, Gynaecologie en Obstetrie, p. 133-141, Rotterdam, The
Netherlands, February, 2003
33. Persistent infertility after conventional ART
B.C. Tarlatzis
ESHRE/ASRM Pre-Congress Course Syllabi “Advanves in Reproductive Endocrinology”, 20th Annual
Meeting
of the European Society of Human Reproduction and Embryology, Berlin, Germany, p. 114-117, 2004.
34. The need of exogenous LH administration in ovarian stimulation for ART
B.C. Tarlatzis, E.M. Kolibianakis
12th World Congress: Human Reproduction, Symposium on Advanced Research on LH in Ovarian
Stimulation, p. 546-549, Venice, Italy, March, 2005
35. Do we need insulin sensitizers?
B.C. Tarlatzis
Proceedings of the 7th World Congress on Controversies in Obstetrics Gynecology and Infertility, p. 64-67,
Athens, Greece, April, 2005
36. Recombinant gonadotropins
B.C. Tarlatzis
1st Course Molecular Biology for Reproductive Medicine Specialists:
Molecular Reproductive
Endocrinology, Final Scientific Program – Syllabus and Reviews, p. 67-70, Siena, Italy, September, 2005
37. Hysteroscopy in the workup of female infertility
G. Pados, D. Athanatos, J. Tympanidis, A. Sortsis, B.C. Tarlatzis, J. Bontis
Proceedings of the 14th Annual Congress of the European Society for Gynaecological Endoscopy, p. 61-65,
Athens, Greece, October, 2005
38. Laparoscopic autologous orthotopic and heterotopic ovarian transplantation in rabbits
A. Sortsis, G. Pados, B.C. Tarlatzis, A. Saratsi, I. Savas, P. Skepastianos, V. Tzioufa, G. Kazakos, v.
Sdrani, J. Bontis
43
Basil C. Tarlatzis, M.D., Ph.D.
Proceedings of the 14th Annual Congress of the European Society for Gynaecological Endoscopy, p. 61-65,
Athens, Greece, October, 2005
39. Induction of ovulation
B.C. Tarlatzis, H. Bili
2nd Course Molecular Biology for Reproductive Medicine Specialists:
Molecular Reproductive
Endocrinology, Final Scientific Program – Syllabus and Reviews, Siena, Italy, September, 2006
44
Basil C. Tarlatzis, M.D., Ph.D.
D. ABSTRACTS
1. Pituitary - thyroid axis in pregnancy
A. Tourkantonis, A. Pharmakiotis, A. Spiliopoulos, E. Eriphillides, I.G. Kotoulas, B.C. Tarlatzis, A.C.
Papaloukas
IXth World Congress of Gynecology and Obstetrics, Tokyo, Japan, October 1979, Abstracts, No. 539
2. Coagulation tests for the evaluation of the newborn liver function
A. Manitsa, I.G. Kotoulas, B. Zournatzi, B.C. Tarlatzis, G. Iordanov, A.C. Papaloukas
IXth World Congress of Gynecology and Obstetrics, Tokyo, Japan, October 1979, Abstracts, No. 778
3. Correlation entre le volume du testicle et le nombre des spermatozoides
D. Panidis, B.C. Tarlatzis, I.G. Kotoulas, A. Papaloucas
XVIeme Semaine Medicale Balkanique, Bucharest, Rumania, September 1980, Program, p. 51
4. Evaluation de la coloration selon Papanicolaou pour l’estimation des globules blancs du sperme
D. Panidis, B.C. Tarlatzis, B. Zournatzi, A. Papaloucas
XVIeme Semaine Medicale Balkanique, Bucharest, Rumania, September 1980, Program, p. 51
5. Our experience with the multiple exposure photography method for sperm motility: evaluation in 50 cases
B.C. Tarlatzis, D.K. Panidis, A.C. Papaloucas
III World Congress of Human Reproduction, W. Berlin, Germany, March 1981, Abstracts, p. 134
6. The effect of semen dilution with normal saline on spermatozoal motility
D.K. Panidis, B.C. Tarlatzis, A.C. Papaloucas
III World Congress of Human Reproduction, W. Berlin, Germany, March 1981, Abstracts, p. 139
7. Evaluation of sperm motility and velocity for four hours with the multiple exposure photography (MEP)
method
B.C. Tarlatzis, D.K. Panidis, A.C. Papaloucas
1) II International Congress of Andrology, Tel-Aviv, Israel, July, 1981, Abstract, p. 41
2) Israel Journal of Medical Sciences, 17: 5145, 1981
8. The application of the multiple exposure photography (MEP) method for sperm analysis in our laboratory
D.K. Panidis, B.C. Tarlatzis, A.C. Papaloucas
1) II International Congress of Andrology, Tel-Aviv, Israel, July 1981, Abstracts, p. 41
2) Israel Journal of Medical Sciences, 17: 5145, 1981
9. Psychological factors of abortion and contraception in Greece
I. Diacoyanni-Tarlatzis, B.C. Tarlatzis, G. Kaprinis, C. Fokas, A. Pitsavas
International Symposium on Reproductive Health Care, Maui, U.S.A., October 1982, Abstracts,
Contraceptive Delivery Systems, 3: 557, 1982
10. Effect of serum concentration in culture media on cleavage rate of human oocytes fertilized in vitro
A. DeCherney, N. Laufer, F. Haseltine, M.L. Polan, H. Mezer, A. Dlugi, B.C. Tarlatzis
1) Congress on Recent Progress in Human in Vitro Fertilization, Vienna, Austria, June 1983
2) Archives of Andrology, 11: 186, 1983
11. Treatment of postoperative tubal surgery patients with human menopausal gonadotropin
Α.Η. DeCherney, H.C. Mezer, A.M. Dlugi, M.L. Polan, F.P. Haseltine, B.C. Tarlatzis
XI World Congress on Fertility and Sterility, Dublin, Ireland, June 1983, Abstracts, No. 665
12. The effect of different methods of centrifugation on sperm motility, morphology and acrosome integrity
45
Basil C. Tarlatzis, M.D., Ph.D.
B.C. Tarlatzis, 0. Murillo, N. Laufer, A. Makler, F. Naftolin, Α.Η. DeCherney
1) Annual Meeting of the American Society of Andrology, Los Angeles, U.S.A., March 1984, Abstracts,
Journal of Andrology, 5: 14, 1984
2) Fifth World Congress on Human Reproduction, Athens, September 1985, Abstracts, No. 67
13. The effect of human oocyte-corona-cumulus complex (OCCC) on sperm motility and acrosome reaction
B.C. Tarlatzis, N. Laufer, 0. Murillo, A. Makler, A. DeCherney, F. Naftolin
1) 40th Annual Meeting of the American Fertility Society, New Orleans, U.S.A., 1984, Abstracts, Fertility
and Sterility, 41: 102S, 1984.
2) Third World Congress of In Vitro Fertilization and Embryo Transfer, Helsinki, Finland, 1984, Abstracts,
Journal of In Vitro Fertilization and Embryo Transfer, 1(2): 143, 1984
14. Equal success following the Tompkins procedure or Jones procedure for habitual abortion due to an
intrauterine Mullerian anomaly
Α.Η. DeCherney, B.C. Tarlatzis
40th Annual Meeting of the American Fertility Suciety, New Orleans, U.S.A., April 1984, Abstracts, Fertility
and Sterility, 41: 71S, 1984
15. The value of serum β-HCG, estradiol (E2) and progesterone (P) levels in predicting the pregnancy outcome
in human in vitro fertilization (IVF) cycles
B.C. Tarlatzis, N. Laufer, Α.Η. DeCherney, N.J. MacLusky, M.L. Polan, F.P. Haseltine, F. Naftolin
III World Congress of In Vitro Fertilization and Embryo Transfer, Helsinki, Finland, May 1984, Abstracts,
Journal of In Vitro Fertilization and Embryo Transfer, 1: 143, 1984
16. Relationship between follicular fluid aspirated volume (FFV) and oocyte quality in hMG-induced cycles for
IVF
Α.Η. DeCherney, Y. Sadovsky, N. Laufer, B.C. Tarlatzis, F.P. Haseltine, M.L. Polan
III World Congress of In Vitro Fertilization and Embryo Transfer, Helsinki, Finland, May 1984, Abstracts,
Journal of In Vitro Fertilization and Embryo Transfer, 1: 105, 1984
17. Human follicular and oocyte development after HMG stimulation for in vitro fertilization (IVF)
B.C. Tarlatzis, N. Laufer, Α.Η. DeCherney, A. Dlugi, M.L. Polan, F.P. Haseltine, F. Naftolin
1) VII European Sterility Congress (ESCO), Monte Carlo, Μoνακό, September 1984, Abstracts, No. 147
2) Vth World Congress on In Vitro Fertilization and Embryo Transfer, Norfolk, U.S.A., April 1987, Abstracts,
p. 117
18. Detection of antibodies in some in vitro fertilization patients against sperm and teratocarcinoma cells in the
serum and follicular fluid
F.P. Haseltine, D. Anderson, N. Laufer, B.C. Tarlatzis, M.L. Polan, Α.Η. DeCherney
XIth Annual Conference of the International Embryo Transfer Society, Montreal, Canada, January 1985,
Abstracts, Theriogenology, 23: 195, 1985
19. Testosterone and adenosine modulate steroidogenesis in human periovulatory corona-cumulus cells
(CCC)
B.C. Tarlatzis, M.L. Polan, N. Laufer, H.R. Behrman, Α.Η. DeCherney
1) 32nd Annual Meeting of the Society for Gynecologic Investigation, Phoenix, U.S.A., March 1985,
Abstracts, No. 178 P.
2) 13o Πανελλήνιo Συνέδριo της Ελληνικής Ενδoκρινoλoγικής Εταιρείας, Athens, April 1986, Abstracts, p.
23
20. Asynchrony between oocyte-corona-cumulus complex (OCCC) maturation and mural granulosa-cell
luteinization in HMG-HCG cycles for in vitro fertilization (IVF)
N. Laufer, J. Luborsky, B.C. Tarlatzis, M. Merino, M.L. Polan, Α.Η. DeCherney
46
Basil C. Tarlatzis, M.D., Ph.D.
32nd Annual Meeting of the Society for Gynecologic Investigation, Phoenix, U.S.A., March 1985,
Abstracts, No. 2
21. In vitro fertilization (IVF) in the treatment of idiopathic infertility and male subfertility
Α.Η. DeCherney, B.C. Tarlatzis, S.B. Pan, N. Laufer, M.L. Polan, F.P. Haseltine, N. MacLusky and F.
Naftolin
1) IIIrd International Congress of Andrology, Boston, U.S.A., May 1985, Abstracts, Journal of Andrology, 6
(Suppl): 77P, 1985.
2) Fourth World Conference on In Vitro Fertilization, Melbourne, Australia, November 1985, Abstracts,
Journal of In Vitro Fertilization and Embryo Transfer, 3: 155, 1986
22. Semen characteristics and in vitro fertilization (IVF) of human oocytes
B.C. Tarlatzis, Α.Η. DeCherney, S. Amster, N. Laufer, R.A. Graebe, S. Boyers, G. Huszar, F. Naftolin
1) IIIrd International Congress of Andrology, Boston, U.S.A., May 1985, Abstracts, Journal of Andrology, 6
(Suppl): 76P, 1985.
2) Fifth World Congress on Human Reproduction, Athens, September 1985, Abstracts, No. 180
23. The appearance of serum β-HCG in conceptions after in vitro fertilization and embryo transfer
B.C. Tarlatzis, Α.Η. DeCherney, N.J. MacLusky, F. Naftolin
1) 1st Meeting of the European Society of Human Reproduction and Embryology, Bonn, Germany, June
1985, Abstracts, No. 6.
2) 41st Annual Meeting of the American Fertility Society, Chicago, U.S.A., October 1985, Abstracts, No. p.
80.
3) Fourth World Conference of In Vitro Fertilization, Melbourne, Australia, November 1985, Abstracts,
Journal of In Vitro Fertilization and Embryo Transfer, 3(3): 196-197, 1986
24. The day of embryo transfer (ET) does not affect the achievement of pregmancy after human in vitro
fertilization (IVF)
B.C. Tarlatzis, Α.Η. DeCherney, J.B. Russell, S.P. Boyers, F. Naftolin
XIth World Congress of Gynecology and Obstetrics, W. Berlin, Germany, September 1985, Abstracts,
Archives of Gynecology, 237 (Suppl): 229, 1985
25. In vitro culture of the postimplantation rat conceptus
B.C. Tarlatzis, M.K. Sanyal, W.J. Biggers, E.R. Barnea, Α.Η. DeCherney, F. Naftolin
Fifth World Congress on Human Reproduction, Athens, September 1985, Abstracts, No. 231
26. Isthmic versus ampullary ectopic pregnancy: Histopathologic appearance
Α.Η. DeCherney, S.P. Boyers, B.C. Tarlatzis, E.E. Jones
41st Annual Meeting of the American Fertility Society, Chicago, U.S.A., October 1985, Abstracts, No. 22
27. Human in vitro fertilization and embryo transfer (IVF/ET) at Yale: 1982-1984
Α.Η. DeCherney, B.C. Tarlatzis, N. Laufer, F. Naftolin
1) 41st Annual Meeting of the American Fertility Society, Chicago, U.S.A., October 1985, Abstracts, No. 32
2) Fourth World Conference on In Vitro Fertilization, Melbourne, Australia, November 1985, Abstracts,
Journal of In Vitro Fertilization and Embryo Transfer, 3: 198, 1986
28. Production of glycosaminoglycans by cumulus and granulosa cells from women undergoing in vitro
fertilization following ovarian stimulation
H. Fakih, B.C. Tarlatzis, A. DeCherney, D. Fayo, F. Haseltine
41st Annual Meeting of the American Fertility Society, Chicago, U.S.A., October 1985, Abstracts, No. p. 44
29. Endometrial measurement by ultrasound: A new method to evaluate estrogenic activity and endometrial
responsiveness in ovulation induction
47
Basil C. Tarlatzis, M.D., Ph.D.
S. Yarkoni, W. Schmidt, B.C. Tarlatzis, Α.Η. DeCherney, F. Naftolin, J.C. Hobbins
41st Annual Meeting of the American Fertility Society, Chicago, U.S.A., October 1985, Abstracts, No. p. 63
30. Factors affecting the achievement of pregnancy after in vitro fertilization and embryo transfer (IVF/ET):
Follicular phase serum estradiol (E2) pattern and the day of EΤ
B.C. Tarlatzis, J.B. Russel, S.B. Pan, A. Lightman, Α.Η. DeCherney
1) 41st Annual Meeting of the American Fertility Society, Chicago, U.S.A., October 1985, Abstracts, No. p.
79.
2) Fourth World Conference on In Vitro Fertilization, Melbourne, Australia, November 1985, Abstracts,
Journal of In Vitro Fertilization and Embryo Transfer, 3: 144, 1986
31. Follicular fluid steroid levels in human menopausal gonadotropin/ human chorionic gonadotropin
(HMG/HCG) treatment regimens for in vitro fertilization (IVF)
B.C. Tarlatzis, F.P. Haseltine, E.R. Barnea, H.R. Behrman, Α.Η. DeCherney
1) 41st Annual Meeting of the American Fertility Society, Chicago, U.S.A., October 1985, Abstracts, No. p.
81.
2) Fourth World Conference on In Vitro Fertilization, Melbourne, Australia, November 1985, Abstracts,
Journal of In Vitro Fertilization and Embryo Transfer, 3: 169, 1986
32. The effect of human chorionic gonadotropin (HCG) on intraocular pressure (IOP) in women and rabbits
F. Nero, P.A.D. Rubin, B.C. Tarlatzis, V. Caprioli, A.H. DeCherney
41st Annual Meeting of the American Fertility Society, Chicago, U.S.A., October 1985, Abstracts, No. p. 84
33. The repetitive response of estradiol in normal ovulatory women stimulated with human menopausal
gonadotropin in an in vitro fertilization program
J.B. Russell, B.C. Tarlatzis, A. del Fluente, Α.Η. DeChemey
Fourth World Conference on In Vitro Fertilization, Melbourne, Australia, November 1985, Abstracts,
Journal of In Vitro Fertilization and Embryo Transfer, 3: 144, 1986
34. The incidence of binovular follicles in human ovaries: A possible cause for dizygotic and monozygotic
twinning
B.C. Tarlatzis, Α.Η. DeCherney, J.B. Russel, J. Masters, J.N. Bates and F. Naftolin
4th World Conference on In Vitro Fertilization, Melbourne, Australia, November 1985, Abstracts, Journal of
In Vitro Fertilization and Embryo Transfer, 3: 149, 1986
35. The effect of human follicular fluid from stimulated and unstimulated cycles on the in vitro growth of mouse
embryos
G.Oelsner, S.B. Pan, E.R. Barnea, B.C. Tarlatzis, S.P. Boyers, J.N. Bates, Α.Η. DeCherney, F. Naftolin
Fourth World Conference on In Vitro Fertilization, Melbourne, Australia, November 1985, Abstracts,
Journal of In Vitro Fertilization and Embryo Transfer, 3: 156, 1986
36. Follicular and oocyte development in conception after in vitro fertilization and embryo transfer (IVF/ET)
B.C. Tarlatzis, S.L. Mandelbaum, N. MacLusky, G. Oelsner, Α.Η. DeCherney
Fourth World Conference on In Vitro Fertilization, Melbourne, Australia, November 1985, Abtsracts,
Journal of In Vitro Fertilization and Embryo Transfer, 3: 162, 1986
37. Comparison of granulosa cell aromatase activity and progesterone (P) production and follicular fluid
estradiol (FFE2) and progesterone (FFP) levels in cycles stimulated with human menopausal gonadotropin
(hMG) or pure follicle stimulating hormone (FSH)
M.L. Polan, R. Bayless, B.C. Tarlatzis, S. Boyers, J.B. Russell, A.H. DeCherney
Fourth World Conference on In Vitro Fertilization, Melbourne, Australia, November 1985, Abstracts,
Journal of In Vitro Fertilization and Embryo Transfer, 3: 170, 1986
48
Basil C. Tarlatzis, M.D., Ph.D.
38. β-Endorphin (β-ΕΡ), adrenocorticotropic hormone (ACTH) and corticotropin-releasing factor (CRF) levels in
plasma and follicular fluid from women undergoing in vitro fertilization (IVF)
B.C. Tarlatzis, E.R. Barnea, M.L. Polan, J.B. Russell, Α.Η. DeCherney
Fourth World Conference on In Vitro Fertilization, Melbourne, Australia, November 1985, Abstracts,
Journal of In Vitro Fertilization and Embryo Transfer, 3: 176, 1986
39. Serum LH and E2 pattern in HMG-stimulated cycles for IVF
B.C. Tarlatzis, J. Bontis, J. Papadimas, S. Lagos, E. Spanos, S. Mantalenakis
1) 1o Βoρειoελλαδικό Ιατρικό Συνέδριo, Thessaloniki, May 1986, Abstracts, No 125.
2) 3rd Annual Meeting of the European Society of Human Reproduction and Embryology, Cambridge, Great
Britain, June 1987, Abstracts, Human Reproduction, 2 (Suppl. I): 19, 1987
40. Simultaneous measurements of clomiphene citrate in plasma and follicular fluid in women undergoing IVF
& EΤ
G. Oelsner, E.R. Barnea, M.V. Mullen, T.J. Mikkelson, B.C. Tarlatzis, F. Naftolin, Α.Η. DeCherney
42nd Annual Meeting of the American Fertility Society, Toronto, Canada, September 1986, Abstracts, No.
39
41. Stimulation of follicular development with gonadotropins for IVF/Τ after pituitary desensitization with a
GnRH analogue
B.C. Tarlatzis, J. Bontis, J. Papadimas, S. Lagos, E. Spanos, S. Mantalenakis
Vth World Congress on In Vitro Fertilization and Embryo Transfer, Norfolk, U.S.A., April 1987, Abstracts, p.
31
42. The association between semen quality parameters and the fertilization of human oocytes in vitro
B.C. Tarlatzis, T. Sanopoulou, J. Bontis, J. Papadimas, S. Lagos, S. Mantalenakis
1) 3rd Annual Meeting of the European Society of Human Reproduction and Embryology, Cambridge,
Great Britain, June 1987, Abstracts, Human Reproduction, 2 (Suppl. 1): 42, 1987
2) 2o Βoρειoελλαδικό Ιατρικό Συνέδριo, Thessaloniki, May 1987, Abstracts, p. 42 (Έπαινoς Ιατρικής
Εταιρείας Θεσ/νίκης).
3) 69e Congres de l’Association des Anatomistes, THESSALONIKI, Resumés, p. 183, 1987
43. Ovarian stimulation with HMG for IVF and GIFT
Β.C. Tarlatzis, J. Bontis, S. Lagos, J. Papadimas, S. Mantalenakis
1) 3rd Annual Meeting of the European Society of Human Reproduction and Embryology, Cambridge,
Great Britain, June 1987, Abstracts, Human Reproduction, 2 (Suppl. I): 18, 1987
2) 2o Βoρειoελλαδικό Ιατρικό Συνέδριo, Thessaloniki, May 1987, Abstracts, p. 42.
44. Our experience with the application of GIFT and ZIFT in the treatment of infertility
J. Bontis, B.C. Tarlatzis, G. Pados, S. Lagos, J. Papadimas, E. Spanos, S. Mantalenakis
VI World Congress of in Vitro Fertilization and Alternate Assisted Reproduction, Jerusalem, Israel, April
1989, Abstracts, p. 30
45. The ovarian renin-angiotensin system
F. Naftolin, A. Lightman, A. Palumbo, M. Alam, R. Apa, T. Zreik, A. Pellicer, V. Tarlatzis, M.L. Carcangin, A.
DeCherney
Vl World Congress of In Vitro Fertilization and Alternate Assisted Reproduction, Jerusalem, Israel, April
1989, Abstracts, p. 62
46. Comparative use of Buserelin/HMG or HMG/prednisolone in ovulation induction for IVF and GIFT
B.C. Tarlatzis, J. Bontis, G. Pados, J. Papadimas, S. Lagos, E. Spanos, S. Mantalenakis
1) VI World Congress of in Vitro Fertilization and Alternate Assisted Reproduction, Jerusalem, Israel, April
1989, Abstracts, p. 90
49
Basil C. Tarlatzis, M.D., Ph.D.
2) 16o Πανελλήνιo Συνέδριo της Ελληνικής Ενδoκρινoλoγικής Εταιρείας, Athens, April 1989, Abstracts, p.
37
3) 5th Annual Meeting of the European Society of Human Reproduction and Embryology, Malmo, Sweden,
June 1989
47. Our experience with the application of IVF/ET, GIFT and ZIFT in the treatment of female and male infertility
B.C. Tarlatzis, J. Bontis, G. Pados, S. Lagos, J. Papadimas, E. Spanos, S. Mantalenakis
1) 4ο Βορειοελλαδικό Ιατρικό Συνέδριο, Thessaloniki, May 1989, Abstracts, p. 67
2) XIII World Congress on Fertility and Sterility, Marrakesh, Morocco, October 1989, Abstract No. 258
48. Ethical guidelines of the ESHRE
B.C. Tarlatzis
1) ESHRE Campus Workshop on Reproductive Medicine, In Vitro Fertilization and Microsurgery,
THESSALONIKI, June 1990
2) ESHRE Campus Workshop on Reproductive Medicine, Brussels, Belgium, March 1992
3) Focus on Reproduction, volume I, No 3: 10-38, 1991
49. Ovarian stimulation for IVF/ET and ZIFT with Buserelin/HMG: Analysis of 231 cases
B.C. Tarlatzis, J. Bontis, G. Pados, S. Lagos, E. Spanos, S. Mantalenakis
VII World Congress of Human Reproduction, Helsinki, Finland, June 1990, Abstracts, No. 209
50. Zygote intrafallopian transfer as a successful approach in female and male infertility
J. Bontis, B.C. Tarlatzis, G. Pados, S. Lagos, E. Spanos, G. Papageorgiou, S. Mantalenakis
VII World Congress on Human Reproduction, Helsinki; Finland, June 1990, Abstracts, No. 466
51. Prospective evaluation of zygote intrafallopian transfer and tubal embryo transfer in the treatment of
infertility
B.C. Tarlatzis, J. Bontis, G. Pados, S. Lagos, E. Spanos, S. Mantalenakis
II Joint Meeting of the European Society of Human Reproduction and Embryology and the European
Sterility Congress Organization, Milan, Italy, August 1990, Abstracts, Human Reproduction, p. 119-120,
1990
52. Pregnancies from oocyte and embryo donation
B.C. Tarlatzis, J. Bontis, G. Pados, S. Lagos, V. Palapelas, E. Spanos, S. Mantalenakis
5th Meeting of the European Association of Gynaecologists and Obstetricians, Vouliagmeni, Athens,
October 1990, Abstracts, p. 53
53. SP1, aFP, PRL, β-HCG, SHBG, PROG and E2 in the luteal phase of women undergoing IVF/ET
V. Papameletiou, B.C. Tarlatzis, J. Bontis, G. Grimbizis, H. Bili, S. Lagos, S. Mantalenakis
8th Annual Meeting of the European Society of Human Reproduction and Embryology, The Hague,
Holland, July 1992, Abstracts, Human Reproduction, 7 (Suppl. 2): 152, 1992
54. Clinical experiences with recombinant FSH
B.C. Tarlatzis, H. Bili, H.J. Out, H.J.T. Coelingh-Bennink
1) 9th Annual Meeting of the European Society of Human Reproduction and Embryology, Thessaloniki,
June 1993, Abstracts, Human Reproduction, 8 (Suppl I): 19, 1993
2) 21o Πανελλήνιo Συνέδριo της Ελληνικής Ενδoκρινoλoγικής Εταιρείας, Athens, April 1994, Abstracts, p.
27
55. Evaluation of the GnRH test in women with polycystic ovarian syndrome (PCOS)
E. Sideropoulos, B.C. Tarlatzis, J. Papadimas, J. Giovos, J. Bontis, S. Lagos, S. Mantalenakis
9th Annual Meeting of the European Society of Human Reproduction and Embryology, Thessaloniki, June
1993, Abstracts, Human Reproduction, 8 (Suppl. I): 54, 1993
50
Basil C. Tarlatzis, M.D., Ph.D.
56. Comparison of IVF-ET results in women with polycystic ovarian syndrome treated by HMG or buserelinlong/HMG and in normal ovulatory women
G. Grimbizis, B.C. Tarlatzis, F. Pournaropoulos, J. Bontis, S. Lagos, S. Mantalenakis
1) 9th Annual Meeting of the European Society of Human Reproduction and Embryology, THESSALONIKI,
June 1993, Abstracts, Human Reproduction, 8 (Suppl. I): 104, 1993
2) 2nd Euro-Team Early Pregnancy Meeting, Porto, Portugal, June 1993, Abstracts
57. Concentrations of interleukin-2, interleukin-4 and interleukin-6 in human periovulatory follicular fluid
B.C. Tarlatzis, H. Bili, M. Daniilidis, J. Bontis, F. Pournaropoulos, A. Tourkantonis, S. Mantalenakis
9th Annual Meeting of the European Society of Human Reproduction and Enbryology, Thessaloniki, June
1993, Abstracts, Human Reproduction, 8 (Suppl. I): 104, 1993
58. The place of GnRH-agonists in the treatment of endometrial hyperplasia (preliminary report)
T. Agorastos, M. Vakiani, K. Anagnostou, G. Fraggidis, N. Argiriadis, V. Tarlatzis, J. Bontis
9th Annual Meeting of the European Society of Human Reproduction and Embryology, Thessaloniki, June
1993, Abstracts, Human Reproduction, 8 (Suppl. I): 112, 1993
59. Relationship of follicular phase endocrine parameters with the outcome of pregnancy in spontaneous and
induced cycles
V. Terzidou, B.C. Tarlatzis, G. Pados, F. Pournaropoulos, J. Bontis, S. Lagos, J. Tibanidis, S. Mantalenakis
9th Annual Meeting of the European Society of Human Reproduction and Embryology, Thessaloniki, June
1993, Abstracts, Human Reproduction, 8 (Suppl. I): 113, 1993
60. Human assisted fertilization by micromanipulation
I.Ts. Vatev, B.C. Tarlatzis, Ch. Dukaki, J. Bontis, S. Lagos, S. Mantalenakis
9th Annual Meeting of the European Society of Human Reproduction and Embryology, Thessaloniki, June
1993, Abstracts, Human Reproduction, 8 (Suppl. I): 121, 1993
61. Transabdominal multifetal pregnancy reduction. Our experience
A.P. Athanasiadis, S. Lagos, B.C. Tarlatzis, J. Bontis
9th Annual Meeting of the European Society of Human Reproduction and Embryology, Thessaloniki, June
1993, Abstracts, Human Reproduction, 8 (Suppl. I): 129, 1993
62. Patient recruitment for a multicentre study in a IVF programme
D. Bakratsa, B.C. Tarlatzis, H. Bili, J. Bontis, S. Lagos, D. Gavriilidou, S. Mantalenakis
9th Annual Meeting of the European Society of Human Reproduction and Embryology, Thessaloniki, June
1993, Abstracts, Human Reproduction, 8 (Suppl. I): 133, 1993
63. Gamete antibodies in follicular fluids from women participating in an assisted reproduction programme
B.C. Tarlatzis, D. Klissourska, E. Gateva, M. Ivanova, I. Vatev
9th Annual Meeting of the European Society of Human Reproduction and Embryology, Thessaloniki, June
1993, Abstracts, Human Reproduction, 8 (Suppl. I): 168, 1993
64. Factors affecting the occurrence of ectopic pregnancies following IVF/ET
B.C. Tarlatzis, E.M. Kolibianakis, J. Bontis, S. Lagos, F. Pournaropoulos, S. Mantalenakis
1) VIIIth World Congress on In Vitro Fertilization and Alternate Assisted Reproduction, Kyoto, Japan,
September 1993, Abstracts, Journal of Assisted Reproduction and Genetics, 10 (Suppi); 201, 1993
2) 6ο Πανελλήνιο Συνέδριο Μαιευτικής και Γυναικολογίας, Athens, November 1994, Abstracts, p. 291
65. Factors affecting the achievement of pregnancy after oocyte/embryo donation
B.C. Tarlatzis, J. Bontis, G. Grimbizis, J. Tybanidis, F. Pournaropoulos, S. Lagos, S. Mantalenakis
1) VIIIth World Congress on In Vitro Fertilization and Alternate Assisted Reproduction, Kyoto, Japan,
September 1993, Abstracts, Journal of Assisted Reproduction and Genetics, 10 (Suppl): 235, 1993
51
Basil C. Tarlatzis, M.D., Ph.D.
2) 6ο Πανελλήνιο Συνέδριο Μαιευτικής και Γυναικολογίας, Athens, November 1994, Abstracts, p. 230
66. Sperm donation in Greece
B.C. Tarlatzis, E.M. Kolibianakis
Workshop: Sperm Donation, Ethical and Medical Questions, Paris, France, November 1993, Abstracts
67. Cytokines and leukotriene B4 levels in human periovulatory follicular fluid and in preimplantation embryo
culture media
H. Bili, B.C. Tarlatzis, M. Daniilidis, A. Fleva, J. Bontis, A. Tourkantonis, S. Mantalenakis
10th Annual Meeting of the European Society of Human Reproduction and Embryology, Βrussels, Belgium,
June 1994, Abstracts, Human Reproduction, 9 (Suppl. 4); 11,1994
68. Hysteroscopy in the evaluation of female infertility
G. Pados, J. Bontis, B.C. Tarlatzis
10th Annual Meeting of the European Society of Human Reproduction and Embryology, Βrussels, Belgium,
June 1994, Abstracts, Human Reproduction, 9 (Suppl. 4): 59,1994
69. Semen infection and assisted reproduction results
G. Grimbizis, B.C. Tarlatzis, F. Pournaropoulos, J. Bontis, S. Lagos, S. Mantalenakis
1) 10th Annual Meeting of the European Society of Human Reproduction and Embryology, Βrussels,
Belgium, June 1994, Abstracts, Human Reproduction, 9 (Suppl. 4): 132,1994
2) 1o Πανελλήνιo Ανδρoλoγικό Συνέδριo, Athens, November 1994, Abstracts, p. 46
3) 6o Πανελλήνιo Συνέδριo Μαιευτικής και Γυναικoλoγίας, Athens, November 1994, Abstracts, p. 347
70. Our preliminary experience with the application of ICSI in the treatment of severe male infertility
B.C. Tarlatzis, Ch. Doukaki, J. Bontis, G. Grimbizis, I. Vatev, S. Lagos, S. Mantalenakis
1) 10th Annual Meeting of the European Society of Human Reproduction and Embryology, Βrussels,
Belgium, June 1994, Abstracts, Human Reproduction, 9 (Suppl. 4): 222,1994
2) 1o Πανελλήνιo Ανδρoλoγικό Συνέδριo, Athens, November 1994, Abstracts, p. 45.
3) 6o Πανελλήνιo Συνέδριo Μαιευτικής και Γυναικoλoγίας, Athens, November 1994, Abstracts, p. 231
71. Embryo reduction in the prevention of multiple births
B.C. Tarlatzis, A. Athanasiadis, J. Bontis
9th International Workshop on Multiple Pregnancy, Tel-Aviv, Israel, October 1994, Abstracts, Israel J.
Obstet. Gynecol, 5 (No. 3, Suppl): 19, 1994
72. Novel aspects of ovarian stimulation for assisted procreation
B.C. Tarlatzis
International Symposium on Assisted Reproduction, Bled, Slovenia, October 1994, Abstracts, No. 5
73. Interleukin production by human preimplantation embryos
B.C. Tarlatzis, H. Bili, M. Daniilidis, A. Fleva, J. Bontis, G. Grimbizis, A. Tourkantonis, S. Mantalenakis
1) 50th Annual Meeting of the American Fertility Society, San Antonio, U.S.A., November 1994, Abstracts,
p. S 80-81,1994
2) 6o Πανελλήνιo Συνέδριo Μαιευτικής και Γυναικoλoγίας, Athens, November 1994, Abstracts, p. 290
74. Recombinant FSH in ovarian stimulation for IVF/ET
B.C. Tarlatzis, H. Bili, J. Bontis, S. Lagos, D. Bakratsa, G. Grimbizis, G. Pados, E. Spanos, S. Mantalenakis
IX World Congress on in Vitro Fertilization and Alternate Assisted Reproduction, Vienna, Austria, April
1995, Abstracts, J. Ass. Reprod. Genet., 12 (No. 3, Suppl.):61S, 1995
75. The effect of hydrosalpinges on IVF outcome
G. Pados, B.C. Tarlatzis, F. Pournaropoulos, J. Bontis, S. Lagos, S. Mantalenakis
52
Basil C. Tarlatzis, M.D., Ph.D.
11th Annual Meeting of the European Society of Human Reproduction and Embryology, Hamburg,
Germany, June 1995, Abstracts, Human Reproduction, 10 (Abstract Book 2): 38,1995
76. Hysteroscopic septum resection to patients with recurrent abortion
G. Pados, J. Bontis, B.C. Tarlatzis
11th Annual Meeting of the European Society of Human Reproduction and Embryology, Hamburg,
Germany, June 1995, Abstracts, Human Reproduction, 10 (Abstract Book 2): 67,1995
77. The use of serum oestradiol concentration per follicle developed in predicting IVF results
B.C. Tarlatzis, F. Pournaropoulos, G. Grimbizis, J. Bontis, H. Bili, J. Papadimas, S. Lagos, 5. Mantalenakis
11th Annual Meeting of the European Society of Human Reproduction and Embryology, Hamburg,
Germany, June 1995, Abstracts, Human Reproduction, 10 (Abstract Book 2): 132, 1995
78. Prospective comparison of an intermediate with the long gonadotrophin-releasing hormone analogue
protocol in ovarian stimulation for IVF
G. Grimbizis, B.C. Tarlatzis, V. Terzidou, J. Bontis, H. Bili, F. Pournaropoulos, S. Lagos, S. Mantalenakis
11th Annual Meeting of the European Society of Human Reproduction and Embryology, Hamburg,
Germany, June 1995, Abstracts, Human Reproduction, 10 (Abstract Book 2): 132, 1995
79. Inhibin and steroid concentrations in preovulatory follicular fluid obtained from gonadotrophin-releasing
hormone analogue/human menopausal gonadotrophin-stimulated women for IVF
H. Bili, B.C. Tarlatzis, V. Zournatzi, J. Bontis, G. Grimbizis, J. Papadimas, S. Lagos, S. Mantalenakis
1) 11th Annual Meeting of the European Society of Human Reproduction and Embryology, Hamburg,
Germany, June 1995, Abstracts, Human Reproduction, 10 (Abstract Book 2): 171,1995
2) 15th World Congress on Fertility and Sterility, Montpellier, France, September 1995, Abstracts,
Contraception Fertilite Sexualite, 23 (No. 9 SuppL): S77-S78, 1995
80. Hormonal study of pituitary-gonadal axis in patients with β-thalassaemia major
J. Papadimas, E. Mandala, B.C. Tarlatzis, G. Georgiadis, B. Kokkas, F. Papadopoulou, H. Bili, J. Bontis, Z.
Sinakos, S. Mantalenakis
11th Annual Meeting of the European Society of Human Reproduction and Embryology, Hamburg,
Germany, June 1995, Abstracts, Human Reproduction, 10 (Abstract Book 2): 172,1995
81. Ovarian stimulation with recombinant gonadotropins
B.C. Tarlatzis
1st International Annual Conference of the Egyptian Fertility and Sterility Society, Cairo, Egypt, September
1995, Abstracts, p. 7-8
82. Ovarian stimulation and ovarian cancer: fears, fantasies and facts
B.C. Tarlatzis
2nd International Scientific Meeting of the Middle East Fertility Society, Αlexandria, Egypt, October 1995
83. Preconceptional intravenous immunoglobulin in secondary recurrent spontaneous abortions: switch to
TH0/TH2-type response?
M. Daniilidis, A. Fleva, K. Adam, H. Bili, B.C. Tarlatzis, E. Chatzaki, H. Gianoulis, P. Konstantinou, S.
Mantalenakis, A. Tourkantonis
a) 4th Interlaken’s International Meeting on Ivig Immunotherapy, Interlaken, Switzerland, June 1996 (4th
Award)
b) 1ο Πανελλήνιο Συνέδριο Eλληνικής Eταιρείας Γονιμότητας και Στειρότητας, Athens, November 1997,
Abstract Book, p. 66
84. Pregnancy outcome in PCO patients treated by ART
B.C. Tarlatzis
53
Basil C. Tarlatzis, M.D., Ph.D.
Workshop «Early Pregnancy», Maastricht, Holland, June 1996, Abstracts
85. The number of follicles developed after stimulation can better predict IVF outcome than the woman’s age
B.C. Tarlatzis, G. Grimbizis, J. Bontis, F. Pournaropoulos, H. Bili, S. Lagos, J. Papadimas, S. Mantalenakis
1) 12th Annual Meeting of the European Society of Human Reproduction and Embryology, Maastricht,
Holland, June 1996, Abstracts, Human Reproduction, 11 (Abstract Book I): 146,1996
2) 7o Πανελλήνιo Συνέδριo Μαιευτικής και Γυναικoλoγίας, Ηράκλειo Κρήτης, May 1997, Τόμoς Περιλήψεων
p. 119
3) 10th World Congress on In Vitro Fertilization and Assisted Reproduction, Vancouver, Canada, May
1997, Abstracts, Journal of Assisted Reproduction and Genetics, 14(5): 68S, 1997 (Suppl.)
86. Prospective evaluation of different FSH/LH ratios with GnRH analogues on ovarian stimulation for IVF
G. Grimbizis, B.C. Tarlatzis, J. Bontis, F. Pournaropoulos, H. Bili, S. Lagos, G. Pados, S. Mantatenakis
12th Annual Meeting of the European Society of Human Reproduction and Embryology, Maastricht,
Holland, June 1996, Abstracts, Human Reproduction, 11 (Abstract Book I): 216,1996
87. Polycystic ovarian syndrome (PCOS): Levels of insulin and c-peptide after insulin tolerance test (ΠΤ)
V. Zournatzi, G. Koios, D. Vavilis, B.C. Tarlatzis, V. Alexandri, J. Bontis
5th World Congress of Gynecological Endocrinology, Barcelona, Spain, October 1996, Abstracts,
Gynecological Endocrinology, 10 (Suppl. 4): 148, 1996
88a. Survey of ICSI: The results of the ESHRE Task Force on ICSI (1993-1995)
B.C. Tarlatzis
3rd Congress of the European Society for Gynecologic and Obstetric Investigation, Madona di Campiglio,
Italy, March 1997, Abstracts, PL7
88b. ICSI Results: The ESHRE ICSI Task Force
B.C. Tarlatzis
Workshop on Intracytoplasmic Sperm Injection and Azoospermia, Roma, Italy, April 1997, Abstracts
89. Recombinant FSH
B.C. Tarlatzis
International Conference on «Human Oocytes: from Physiology to IVF», Bologna, Italy, April 1997,
Abstracts
90. Sons of manipulated oocytes
B.C. Tarlatzis
International Conference on «Human Oocytes: from Physiology to IVF», Bologna, Italy, April 1997,
Abstracts
91. Unexplained infertility and assisted procreation
B.C. Tarlatzis
International Meeting on Infertility and Assisted Reproductive Technology, Sardinia, Italy, June 1997,
Abstracts, p. 64
92. Treatment of male infertility caused by spermatogenic arrest at the primary spermatocyte stage with
ooplasmic injections of round spermatids or secondary spermatocytes isolated from foci of early haploid
male gametes
N.V. Sofikitis, T. Mantzavinos, D. Loutradis, S. Antypas, L. Miyagawa, B.C.. Tarlatzis
13th Annual Meeting of the European Society of Human Reproduction and Embryology, Edinburg, Great
Britain, June 1997, Human Reproduction, vol. 12, Abstract Book 1, p. 81-82,1997
93. Analysis of factors influencing early pregnancy loss after IVF
54
Basil C. Tarlatzis, M.D., Ph.D.
H.G. Saravelos, B.C. Tarlatzis, F. Pournaropoulos, J. Bontis, G. Grimbizis, S. Lagos, G. Pados, J.
Papadimas, H. Bili, S. Mantalenakis
13th Annual Meeting of the European Society of Human Reproduction and Embryology, Edinburg, Great
Britain, June 1997, Human Reproduction, Vol. 12, Abstract Book 1, p. 176-177,1997
94. Factors affecting pregnancy outcome after ICSI
E. Pagou, H. Bill, B.C. Tarlatzis, J. Bontis, G. Grimbizis, S. Lagos, G. Pados, J. Papadimas, S.
Mantalenakis
13th Annual Meeting of the European Society of Human Reproduction and Embryology, Edinburg, Great
Britain, June 1997, Human Reproduction, Vol. 12, Abstract Book 1, p. 288-289, 1997
95a. ESHRE survey on ICSI results
B.C. Tarlatzis
13th Meeting of the Austrian Society on in Vitro Fertilization and Assisted Reproduction, Shift Melk, Austria,
Abstracts, October 1997
95b. What was learned from the european registry of ICSI
B.C. Tarlatzis
The Annual Meeting of the Israel Fertility Association (IFA), Tel-Aviv, Israel, Abstracts, April 1998
95c. Overview of the efficacy and safety of intracytoplasmic sperm injection
B.C. Tarlatzis
Annual Meeting of the Chinese Fertility Society, September 1998, Taipei, Taiwan, Abstracts, p. 23, 1998
95d. Benefits and risks of ICSI in the treatment of male infertility
B.C. Tarlatzis
1st National Congress on Human Assisted Reproduction, Timisoara, Rumania, May 1999, Abstracts,
Volum de Rezumate, p. 15, 1999
96. Correlation between testicular histology and wet preparation findings in azoospermic men undergoing
testicular sperm extraction for intracytoplasmic sperm injection
G. Grimbizis, A. Papanicolaou, B.C. Tarlatzis, E. Pagou, J. Papadimas, A. Karanikas, J. Bontis, G. Pados,
I. Vatev, S. Mantalenakis
a) 14th Annual Meeting of the European Society of Human Reproduction and Embryology, Göteborg,
Sweden, June 1998, Human Reproduction, 13 (Abstract Book 1), 9, 1998
b) 1ο Πανελλήνιο Συνέδριο Γονιμότητας και Στειρότητας, Eλληνική Eταιρεία Γονιμότητας και Στειρότητας,
Ξενοδοχείο «DIVANI-CARAVEL», Athens, November 1997, Proceedings, p. 75
97. Immunogenetic profile in patients with repeated unsuccessful IVF
M. Daniilidis, B.C. Tarlatzis, H. Bili, A. Fleva, J. Mytilineos, B. Palapelas, J. Bontis, N. Mamopoulos, S.
Mantalenakis, A. Tourkantonis
14th Annual Meeting of the European Society of Human Reproduction and Embryology, Göteborg,
Sweden, June 1998, Human Reproduction, Vol. 13, Abstract Book 1, p. 25, 1998
98. Interleukin-10 and interleukin-12 in the peritoneal fluid of women with endometriosis
G. Pados, V. Zournatzi, J. Bontis, B.C. Tarlatzis, F. Pournaropoulos, D. Hatzis, A. Mamopoulos
14th Annual Meeting of the European Society of Human Reproduction and Embryology, Göteborg,
Sweden, June 1998, Human Reproduction, 13(Suppl. 1), Abstract Book 1, p. 255, 1998
99. Parameters influencing the outcome of round spermatid injections (ROSI) into oocytes: source of round
spermatids (RSs), round spermatid viability (RS-VL), and capacity to activate oocytes (RS-CAO)
N. Sofikitis, I. Miyagawa, T. Mantzavinos, N. Kanakas, D. Loutradis, K. Kalianidis, Y. Yamamoto, K.
Troukoudes, P. Zavos, B.C. Tarlatzis
55
Basil C. Tarlatzis, M.D., Ph.D.
54th Annual Meeting of the American Society for Reproductive Medicine & 16th International Congress on
Fertility and Sterility, San Francisco, H.Π.A., October 1998, Abstracts, No. 051, 1998
100. The effect of chronological and biological age on the fertility potential of the women
B.C. Tarlatzis, G. Grimbizis
7th World Congress of Gynecological Endocrinology, Buenos Aires, Argentina, April, 1999, Abstracts,
Gynecological Endocrinology, 13, Suppl 2, 67, 1999
101. Hysteroscopic myomectomy after pre-operative administration of the GnRH-a triptorelin: prospective
randomized trial
G. Pados, J. Bontis, D. Miliaras, B.C. Tarlatzis, M. Kafidas
a) 15th Annual Meeting of the European Society of Human Reproduction and Embryology, Tours, France,
June 1999, Human Reproduction 14 (Suppl. 1), Abstract 199, 1999
b) 1o Πανελλήνιο Συνέδριο Γυναικολογικής Eνδοσκόπησης, Athens 1999, Abstract E3
c) 1ο Πανελλήνιο Συνέδριο της Eλληνικής Eταιρείας Γονιμότητας και Στειρότητας, Athens, November 1998,
Abstract Book, p. 37
102. Culture of supernumenary embryos up to blastocyst stage may predict higher chances of implantation
Th. Sanopoulou, G. Grimbizis, B.C. Tarlatzis, J. Bontis, G. Pados, H. Bili, S. Lagos, E. Pagou, S.
Mantalenakis
15th Annual Meeting of the European Society of Human Reproduction and Embryology, Tours, France.
June 1998, Human Reproduction, 14 (Abstract Book 1), 340, 1999
103. Serum CEA, Ca-125, Ca-15.3 and Ca-19.9 levels as a diagnostic test for endometriosis
G. Pados, D. Hatzis, I. Timpanidis, K. Paulitou, S. Hrisohoidou, V. Zournatzi, J. Bontis, B.C. Tarlatzis, E.
Malaka, A. Mamopoulos
a) 15th Annual Meeting of the European Society of Human Reproduction and Embryology, Tours, France,
June 1999, Human Reproduction 14 (Suppl. 1), Abstract R157, 1999
b) 1ο Πανελλήνιο Συνέδριο Γυναικολογικής Eνδοσκόπησης, Athens, October 1999, Abstract Book, p. 54
104. The ethical, legal, moral and religious aspects of storing reproduction: the situation in Greece
B.C. Tarlatzis
International Symposium on: “Storing Reproduction: Cryopreservation of Human Gametes, Embryos and
Gonadal Tissue”, Bologna, Italy, October 1999, Abstracts No. 02
105. State of the art: agonists versus antagonists
B.C. Tarlatzis
VIIth Annual Meeting of the Middle East Fertility Society “Creating Perspectives in ART”, Beirut, Lebanon,
November 2000, Abstracts, p. 5
106. The effect of luteinizing hormone administered during late follicular phase in normo-ovulatory women
undergoing in vitro fertilization
A.F. Ben-Amor, B.C. Tarlatzis, E. Tavmergen, Z. Shoham, M. Szamatowicz, A. Barash, A. Amit, I. Levitas,
E. Geva
a) 16th Annual Meeting of the European Society of Human Reproduction and Embryology, Bologna, Italy,
June 2000, Human Reproduction, 15, Abstracts, No 0116, 2000
b) Congress on “Reproductive Medicine and Endoscopic Surgery in the 21st Century: Controversies and
New Trends”, Kusadasi, Turkey, September 2000
107. Comparison of the efficacy of gonadotropin-releasing hormone analogue buserelin given intranasally and
subcutaneously at different doses for IVF
The Buserelin Dose Finding Study Group: B.C. Tarlatzis, Z. Ben-Rafael, M. Dirnfeld, Y. Gonen, P.
Drakakis, D. Loutradis
56
Basil C. Tarlatzis, M.D., Ph.D.
6th International Symposium on GnRH Analogues in Cancer and Human Reproduction, Geneva,
Switzerland, February, Abstracts, Gynecological Endocrinology, 15 (Suppl. 1): 29, 2001
108. Peritoneal fluid levels of human macrophages and Granulocyte-Macrophage Cology-Stimulating factor
(GM-CSF) as prognostic factors in endometriosis
G. Pados, D. Hatzis, V. Zournatzi, I. Timpanidis, M. Kasapis, M. Tsarouha, H. Agouridaki, B.C. Tarlatzis, J.
Bontis
17th Annual Meeting of the European Society of Human Reproduction and Embryology, Lausanne,
Switzerland, July 2001, Human Reproduction, vol. 16, Abstract Book 1, 2001
109. Perimenopausal conception
B.C. Tarlatzis, L. Zepiridis
5th Athens Congress on Woman’s Health & Disease, Athens, Greece, September 2002, Final Program
110. The syndrome of polycystic ovaries. Diagnostic attitudes and therapeutics in Europe: Greece
B.C. Tarlatzis
Sixièmes Journées Européennes de la Société Française de Gynécologie, Paris, France, October 2002,
Abstracts, p. 25
111. Benefits – drawbacks and results of ART in Europe: Greece
B.C. Tarlatzis
Sixièmes Journées Européennes de la Société Française de Gynécologie, Paris, France, October 2002,
Abstracts, p. 40
112. Family functioning and socio-emotional development
J. Barnes, A. Sutcliffe, I. Ponjaert, A. Loft, U. Wennerholm, B.C. Tarlatzis, M. Bonduelle
19th Annual Meeting of the ESHRE, Madrid, Spain, June 2003, Human Reproduction, Vol. 18, Abstract
Book 1, No 283
113. Cognitive and motor development outcomes of 1523 ICSI/IVF/naturally conceived 5 years old children
A. Sutcliffe, J. Barnes, M. Bonduelle, I. Ponjaert, B.C. Tarlatzis, U.B. Wennerholm, A. Loft
19th Annual Meeting of the ESHRE, Madrid, Spain, June 2003
114. Long term health consequences for women with PCOS: Report from consensus ESHRE/ASRM Meeting,
Rotterdam 2003
B.C. Tarlatzis
Joint RCOG/ESHRE Meeting, London, Great Britain, April 2004, Abstract Book, p. 37
115. Εxposure time to cryoprotectants influence oocytes survival rate
N. Tsagias, B.C. Tarlatzis, E. Paggou, Th. Sanopoulou, A. Tokmakidou, E. Chatziioannou, M. Arsenakis, J.
Bontis
XVIIIth European Congress of Obstetrics and Gynecology, European Board and College of Obstetrics &
Gynaecology-ΕΒCOG, Athens, May 2004, Poster Abstracts, P194, p. 211
116. Prospective, blind, randomized evaluation of exogenous LH supplementation in the long GnRHa/recFSH
stimulation protocol for IVF/ICSI
F. Pournaropoulos, B.C. Tarlatzis, L. Zepiridis, H. Bili, G. Grimbizis, G. Pados, J. Papadimas, J. Bontis
20th Annual Meeting of the ESHRE, Berlin, Germany, June 2004, Human Reproduction, Final Program &
Abstract Book, No 346, p. 189
57
Basil C. Tarlatzis, M.D., Ph.D.
117. Malformations and genetic defects of children born after assisted reproduction techniques
B.C. Tarlatzis
Abstracts, Reproductive Toxicology 18 (5): 715, July 2004
118. IVF outcome of patients with polycystic ovary syndrome
B.C. Tarlatzis
Updates on Polycystic Ovary Syndrome, Hong Kong, March 2005, Abstract Book, p. 14
119. Surgical management of polycystic ovary syndrome
B.C. Tarlatzis
Updates on Polycystic Ovary Syndrome, Hong Kong, March 2005, Abstract Book, p. 16
120. Leptin induces LH secretion in MPOA lesioned female rats
T. Dagklis, B.C. Tarlatzis, K. Kallaras, D. Kouvelas, G. Papazisis, P. Skepastianos, I. Papadimas, J.
Bontis, O. Guiba-Tziampiri
21st Annual Meeting of the European Society of Human Reproduction and Embryology, Copenhagen, Denmark,
June 2005, Abstracts Book, Human Reproduction 20 (Suppl. 1): O-071, i25, 2005
121. Pregnancy and children outcome after IVF and ICSI
B.C. Tarlatzis,
12TH World Congress of the International Society of Gynecological Endocrinology, Florence, Italy, March 2006,
Book of Abstracts, Gynecological Endocrinology 22 (Suppl. 1): PL7, p. 7, 2006
122. IVF outcome in PCOS patients
B.C. Tarlatzis
PCOS Meeting, Taipei, Taiwan, April 2006, Abstracts, p. 9
123. Long-term health risks of PCOS
B.C. Tarlatzis
a) PCOS Meeting, Taipei, Taiwan, April 2006, Abstracts, p. 27
b) Asian Fertility Expert Meeting, Ho Chi Minh City, Vietnam, April 2006, Abstracts
124. The vision of health professionals in assisted reproduction: a brazil-europe cross-cultural perspective
E. Pandolfi Passos, X. Zachia, D. Knauth, J.R. Goldim, F. Freitas, J.S. Cunha-Filho, R. Felberbaum, B.C.
Tarlatzis, P.G. Crosignani
22nd Annual Meeting of the European Society of Human Reproduction and Embryology, Prague, Czech Republic,
June 2006, Abstracts Book, Human Reproduction 21 (Suppl. 1): O-131, i51, 2006
125. Is progesterone elevation on the day of hcG administration associated with the probability of live birth in
IVF? A meta-analysis
C.A. Venetis, E.M. Kolibianakis, E.G. Papanikolaou, J. Bontis, B.C. Tarlatzis, P. Devroey
22nd Annual Meeting of the European Society of Human Reproduction and Embryology, Prague, Czech Republic,
June 2006, Abstracts Book, P-330, Human Reproduction 21 (Suppl. 1): i127, 2006
126. Ovarian stimulation for IVF & cancer
B.C. Tarlatzis
12th International Congress on Hormonal Steroids and Hormones & Cancer, Athens, Greece, September 2006,
Final Programme & Book of Abstracts, No. 70, p. 138
127. Testicular fine needle aspiration biopsy in the investigation of the subfertile male with azoospermia and
severe oligo-terato-asthenospermia
T. Mikos, P. Polichronou, G. Grimbizis, A. Papanicolaou, E. Athanasiou, P. Sevastiadou, D.G. Goulis, B.C.
Tarlatzis, J. Bontis, J. Papadimas
Abstracts of the 4th European Congress of Andrology and 23rd Congress of the French Speaking Society of
Andrology, Toulouse, France, December 2006, Andrologie – Journal Officiel de la Société d’Andrologie de
Langue Française 16 (4): 332-3, December 2006
128. Management of poor response – facts or myths
B.C. Tarlatzis
19th IFFS World Congress on Fertility & Sterility, Durban, South Africa, April – May 2007, Abstract Book, p. 25
58
Basil C. Tarlatzis, M.D., Ph.D.
129. Treatment strategies of polycystic ovary syndrome
B.C. Tarlatzis
19th IFFS World Congress on Fertility & Sterility, Durban, South Africa, April – May 2007, Abstract Book, p. 35
130. Fixed versus flexible antagonist initiation during ovarian stimulation for in-vitro fertilization. A randomized
controlled trial
L. Kalogeropoulou, E.M. Kolibianakis, C.A. Venetis, E.G. Papanikolaou, J. Papadimas, J. Bontis, B.C.
Tarlatzis
23rd Annual Meeting of the European Society of Human Reproduction and Embryology, Lyon, France, July 2007,
Abstracts Book, Human Reproduction 22 (Suppl. 1): P-306, i122, 2007
131. Cryopreservation of human embryos by vitrification or slow freezing: a systematic review and metaanalysis
K. Loutradi, E.M. Kolibianakis, C.A. Venetis, E.G. Papanikolaou, J. Bontis, B.C. Tarlatzis
23rd Annual Meeting of the European Society of Human Reproduction and Embryology, Lyon, France, July 2007,
Abstracts Book, Human Reproduction 22 (Suppl. 1): P-382, i150, 2007
132. Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A
systematic review and meta-analysis.
E.G. Papanikolaou, E. Kolibianakis, C. Venetis, H. Tournaye, B.C. Tarlatzis, P. Devroey
63rd Annual Meeting of the American Society for Reproductive Medicine, Washington D.C., United States of
America, October 2007, Abstracts of the Scientific Oral & Poster Sessions, Fertility and Sterility 88 (Suppl. 1): P633, S317, 2007
133.Current and potential benefits of LH activity.
B.C. Tarlatzis
Updates in Infertility Treatment 2008, Cape Town, South Africa, January 2008, Final Program and Abstract
Book, p. 24-25, 2008
134.The use of GnRH antagonists in ovarian stimulation for IVF.
B.C. Tarlatzis
Abstracts of the 13th World Congress of Gynecological Endocrinology, Florece, Italy, February - March
2008, Gynecological Endocrinology 24 (Suppl. 1): p. 18, 2008
135.The new law’s perspectives in Reproduction.
B.C. Tarlatzis
Abstracts of the Mediterranean Conferences for Reproductive Medicine Workshop: New Trends on
Controlled Ovarian Stimulation and Ovulation Indcution, Heraklion Crete, Greece, May 2008, Abstract
Book: p. 15, 2008
136. Providing superior clinical outcome .
B.C. Tarlatzis
Abstracts of the 24th ESHRE Annual Meeting: Ferring Symposium: Better Together: hCG-driven LH-activity
matters! Barcelona, Spain, July 2008, Abstract Book: p. 8-9, 2008
137. Quality of perioperative Chemoprophylaxis in Obstetrics and Gynecology in Greece, Serbia and Croatia
P. Papaioannidou, V. V. Palcevski, A. Sabo, O. Horvat, D. Vavilis, B.C. Tarlatzis, J. Bontis.
Abstracts of the 24th ESHRE Annual Meeting: Ferring Symposium: Better Together: hCG-driven LH-activity
matters! Barcelona, Spain, July 2008, Abstract Book: p. 8-9, 2008
138. Quality of perioperative Chemoprophylaxis in Obstetrics and Gynecology in Greece, Serbia and Croatia
P. Papaioannidou, V. V. Palcevski, A. Sabo, O. Horvat, D. Vavilis, B.C. Tarlatzis, J. Bontis.
Abstracts of the 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Copenhagen, Denmark, August 2008, Abstract Book: p. 54, 2008
138.Risk of gestational dibetes mellitus in women with polycystic ovary syndrome: A systematic review and
meta-analysis.
K. Toulis, D.G. Goulis, E.M. Kolibianakis, Ch.Venetis, B.C. Tarlatzis, I. Papadimas
Abstracts of the 24th International Conference on Pharmacoepidemiology & Therapeutic risk management:
59
Basil C. Tarlatzis, M.D., Ph.D.
Pharmacoepidemiology and drug safety, Copenhagen, Denmark, August 2008, Abstract Book: p. 54, 2008
139. Adiponectin levels in women with polycystic ovary syndrome: A systematic review and a meta-analysis.
K. A. Toulis, D.G. Goulis, D. Faramkiotis, N.A.Georgopoulos, E. Katsikis, B.C. Tarlatzis, I.Papadimas,
D.Panidis
Abstracts of the 7th Athens Congress on Women’s Health & Disease: Gynecoligic, Endocrine &
Reproductive Issues, Athens, Greece, September 2008, Abstract Book: p. 301-302, 2008
140.State of the ART in the era of evidence based medicine.
B.C. Tarlatzis
Abstracts of the 13th International Annual Conference: Reproductive health: Lessons from the past and
hopes for the future, Cairo, Egypt, October 2008, Abstract Book: p. 51-52, 2008
141. Increased clinical pregnacy rates by using hyaluronan in IVF: a systematic review and meta-analysis .
E.M Kolibianakis, K. Loutradi, C.A Venetis, E.G Papanikolaou,T.B Tarlatzi, J.Bontis, B.C. Tarlatzis
Abstracts of the 64th ASRM Annual Meeting: Bridge to the future of the Reproductive Medicine, San
Francisco,USA, November 2008
142. Intravenous albumin administration for the prevention of severe ovarian hyperstimulation syndrome: a
systematic review and meta-analysis.
C.A Venetis, E.M Kolibianakis, E. G. Papanikoloau, J. Bontis, B.C. Tarlatzis.
Abstracts of the 64th ASRM Annual Meeting: Bridge to the future of the Reproductive Medicine, San
Francisco,USA, November 2008
143. A systematic review and a meta-analysis on adiponectin levels in women with polycystic ovary syndrome.
K. A. Toulis, D.G. Goulis, D. Faramkiotis, N.A.Georgopoulos, E. Katsikis, B.C. Tarlatzis, I.Papadimas,
D.Panidis
Abstracts of the 11th European Congress of Endocrinology, Instabul, Turkey, April 2009
144. Gapapentin for the treatment of hot flushes in women with natural or tamoxifen-induced menopause: a
systematic review and a meta-analysis
K. A. Toulis, T. Tzellos, D. Kouvelas, D.G. Goulis, B.C. Tarlatzis, I.Papadimas, D.Panidis
Abstracts of the 11th European Congress of Endocrinology, Instabul, Turkey, April 2009
60
Basil C. Tarlatzis, M.D., Ph.D.
III. NATIONAL PUBLICATIONS:
A. JOURNALS
Total of 61 publications in national journals.
B. BOOKS
Total of 30 publications in national books.
C. PROCEEDINGS
Total of 31 publications in national proceedings.
D. ABSTRACTS
Total of 112 abstract publications.
CITATION INDEX:
Total citations of the papers published in international books:
Total citations of the papers published in international abstracts:
Total citations of the papers published in international scientific journals:
61
17
37
2688
Basil C. Tarlatzis, M.D., Ph.D.
IV. ARTICLES:
A. Editorials for The Newsletter of the European Society of Human Reproduction and Embryology
“Focus on Reproduction”
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
Just a new look? I(1): 1, 1991.
The life so short, the craft so long to learn (“Hippocrates”), I(2): 1, 1991.
Assisted reproduction: a “brave new world” or a better world? I(3): 1. 1991.
The problems of puberty, I(4): 1, 1991.
Cherchez l’ homme, 1(5): 1, 1991.
The right stuff, I(6): 1, 1991.
One year later, II(1): 1, 1992.
Hi tech babies, II(2): 1, 1992.
Corporate Members, II(3): 1, 1992.
Maternidad, II(4): 1, 1992.
The right to procreate, II(5): 1, 1992.
Growing bigger, becoming stronger, II(6): 1, 1992.
Endometriosis, III(1): 1, 1993.
Knowledge is power, III(2): 1, 1993.
The change of guards, III(3): 1, 1993.
Mission accomplished, III(4): 1, 1993.
ESHRE training course and workshop: a concern for scientific standards, III(5): 1, 1993
Membership and how to increase it, III(6): 1, 1993.
Nature’s mighty law is change - R. Burns, IV (1 & 2), 1994.
Let’s go north, IV (3 & 4), 1994.
Talking about ESHRE, IV(5), 1994.
Congratulations, V(1), 1995.
New challenges, V(2), 1995.
ESHRE Task Force, V(3), 1995.
ESHRE ’96, V(4), 1995.
AGM ’96, VI(1), 1996.
Guidelines and training, VI(2), 1996.
A change of guards, VI(3), 1996.
Membership, VI(4), 1996.
1997 Abstracts, VII(1), 1997.
B. Articles for the Newsletter of the American Society of Reproductive Medicine “ASRM News”
1. “The European Society of Human Reproduction and Embryology”, ASRM News, Vol. 33, Nol. 1, p. 23-24,
Spring 1999.
2. “ESHRE ’99 Annual Metting”, ASRM News, Vol. 33, No. 4, p. 20-21, Winter 1999.
3. “From the Past ESHREChairman” ASRM News, Vol. 35, No. 3, p. 18, Fall 2001.
4. “A View from Greece”, B.C. Tarlatzis and G.B. Maroulis, ASRM News, Vol. 36, No. 1, p. 5, Spring 2002.
C. Articles for the Newsletter of the International Federation of Fertility Socieites
1. “Message from the President: Keeping the momentum and facing the new challenges”, IFFS Newsletter, p.
2, Autumn 2007.
2. "Message from the President: Reproductive Health: It’s all about choices”, IFFS Newsletter, p. 2, Autumn
2008.
3. “Message from the President: Bringing the past with the future”, IFFS Newsletter, p.2, Spring 2008.
4. “Message from the President: Facing the Challenge of access to ART”, IFFS Newsletter, p.2, Autumn 2009.
5. “Message from the President: Screen or not to screen”, IFFS Newsletter, p. 2, Spring 2009
6. “Message from the President: Munich 2010: The Count Down”, IFFS Newsletter, p.2, Spring 2010
D. Articles for Organon’s Magazine on Women and Health
62
Basil C. Tarlatzis, M.D., Ph.D.
1. “The 9th Annual Meeting of ESHRE: Striking a balance between clinical and basic science: ORGYN, Vol
IV(1): 46-49, 1993.
2. Defeating Male Factor Infertility: ORGYN, Vol. IX(3): 24-27, 1998.
E. Prefaces
1. Preface: “Current Theory and Practice of ICSI”, Eds: Devroey, B.C. Tarlatzis, A. Van Steirteghem, Oxford
University Press, Human Reproduction, Suppl. 1, p. iii, April 1998.
2. Preface: “A child is born” (Greek edition), Eds: L. Lilsson & L. Hamberger, Athens, p. 6-7, 2004.
2. Preface: “Νέες εξελίξεις στην πρόληψη και αντιμετώπιση του γυναικολογικού καρκίνου” (Greek edition), Eds:
Θ. Αγοραστός, Α. Παπανικολάου, Β. Ταρλατζής, University Studio Press Thessaloniki, p. 9, 2009
F. Dedications
1. Dedication to Prof. R.G. Edwards: “Manual on Assisted Reproduction”. Eds: T. Rabe, K, Diedrich, T.
Strowitzki, Springer, Berlin, p. V-VII, 2000.
G. Articles in National Newspapers and Magazines
Total of 10 articles published.
63